{"DataElement":{"publicId":"4122411","version":"1","preferredName":"Prior Or Synchronous Malignant Neoplasm Histologic Diagnosis Name","preferredDefinition":"Text term describe the histology and/or subtype of the prior or synchronous malignancy.","longName":"4120507v1.0:3081850v3.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"4120507","version":"1","preferredName":"Prior Or Synchronous Malignant Neoplasm Histologic Diagnosis","preferredDefinition":"Earlier in time or order._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Occurring at the same time or rate._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"4120417v1.0:2470360v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"4120417","version":"1","preferredName":"Prior Or Synchronous Malignant Neoplasm","preferredDefinition":"Earlier in time or order.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Occurring at the same time or rate.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","longName":"C25629:C37998:C48444:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Synchronous","conceptCode":"C48444","definition":"Occurring at the same time or rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F132C2D2-0E6C-5B39-E040-BB89AD4356B5","latestVersionIndicator":"Yes","beginDate":"2014-01-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-30","modifiedBy":"ONEDATA","dateModified":"2014-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2470360","version":"1","preferredName":"Histologic Diagnosis","preferredDefinition":"Of or relating to histology.:The process of identifying a disease by the signs and symptoms.","longName":"C25526:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10C5B6F3-A63C-6A7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-04-06","modifiedBy":"ONEDATA","dateModified":"2006-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1339B23-945E-8DB3-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2014-01-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TCGA Other Malignancy Form per request by T.Lichtenberg. mc 1/30/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3081850","version":"3","preferredName":"Malignant Neoplasm Histology Name","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004_Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs._The words or language units by which a thing is known.","longName":"3081850v2.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Spindle cell carcinoma; NOS","valueDescription":"Not Otherwise Specified Sarcomatoid Carcinoma","ValueMeaning":{"publicId":"3785900","version":"1","preferredName":"Not Otherwise Specified Sarcomatoid Carcinoma","longName":"3785900","preferredDefinition":"Not characterized in any other way.: A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features. Giant cells and a sarcomatous component may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcomatoid Carcinoma","conceptCode":"C27004","definition":"A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-0750-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0769-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Seminoma; NOS","valueDescription":"Not Otherwise Specified Seminoma","ValueMeaning":{"publicId":"3785901","version":"1","preferredName":"Not Otherwise Specified Seminoma","longName":"3785901","preferredDefinition":"Not characterized in any other way.: A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Seminoma","conceptCode":"C9309","definition":"A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-0776-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-078F-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcoma; synovial; monophasic fibrous","valueDescription":"Monophasic Synovial Sarcoma","ValueMeaning":{"publicId":"3785903","version":"1","preferredName":"Monophasic Synovial Sarcoma","longName":"3785903","preferredDefinition":"A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monophasic Synovial Sarcoma","conceptCode":"C6534","definition":"A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-079C-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-07B5-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcoma; stromal; NOS","valueDescription":"Not Otherwise Specified Stromal Sarcoma","ValueMeaning":{"publicId":"3785904","version":"1","preferredName":"Not Otherwise Specified Stromal Sarcoma","longName":"3785904","preferredDefinition":"Not characterized in any other way.: A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stromal Sarcoma","conceptCode":"C6926","definition":"A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-07C2-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-07DB-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcoma; pleomorphic cell","valueDescription":"Pleomorphic Sarcoma","ValueMeaning":{"publicId":"3785905","version":"1","preferredName":"Pleomorphic Sarcoma","longName":"3785905","preferredDefinition":"Occurring in various distinct forms.  In terms of cells, having variation in the size and shape of cells or their nuclei.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic","conceptCode":"C28109","definition":"Occurring in various distinct forms.  In terms of cells, having variation in the size and shape of cells or their nuclei.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-07E8-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0801-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcoma; NOS","valueDescription":"Not Otherwise Specified Sarcoma","ValueMeaning":{"publicId":"3785906","version":"1","preferredName":"Not Otherwise Specified Sarcoma","longName":"3785906","preferredDefinition":"Not characterized in any other way.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-080E-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0827-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcoma; endometrial; stromal; NOS","valueDescription":"Not Otherwise Specified Endometrial Stromal Sarcoma","ValueMeaning":{"publicId":"3785907","version":"1","preferredName":"Not Otherwise Specified Endometrial Stromal Sarcoma","longName":"3785907","preferredDefinition":"Not characterized in any other way.: A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrial stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-0834-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-084D-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Plasmacytoma; NOS","valueDescription":"Not Otherwise Specified Plasmacytoma","ValueMeaning":{"publicId":"3785908","version":"1","preferredName":"Not Otherwise Specified Plasmacytoma","longName":"3785908","preferredDefinition":"Not characterized in any other way.: A malignant (clonal) proliferation of plasma cells that are cytologically and immunophenotypically identical to those of plasma cell myeloma, but manifest a localized osseous or extraosseous growth pattern. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plasmacytoma","conceptCode":"C9349","definition":"A malignant neoplasm characterized by the presence of a monoclonal population of plasma cells forming a tumor mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-085A-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0873-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Osteosarcoma; NOS","valueDescription":"Not Otherwise Specified Osteosarcoma","ValueMeaning":{"publicId":"3785909","version":"1","preferredName":"Not Otherwise Specified Osteosarcoma","longName":"3785909","preferredDefinition":"Not characterized in any other way.: A usually aggressive malignant bone-forming mesenchymal tumor, predominantly affecting adolescents and young adults.  It usually involves bones and less frequently extraosseous sites.  It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus).  Pain with or without a palpable mass is the most frequent clinical symptom.  It may spread to other anatomic sites, particularly the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Osteosarcoma","conceptCode":"C9145","definition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-0880-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0899-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Nerve sheath tumor; malignant peripheral","valueDescription":"Malignant Peripheral Nerve Sheath Tumor","ValueMeaning":{"publicId":"2838605","version":"1","preferredName":"Malignant Peripheral Nerve Sheath Tumor","longName":"2838605","preferredDefinition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peripheral Nerve Sheath Tumor","conceptCode":"C3798","definition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AE88-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-08AD-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lymphoma; plasmablastic","valueDescription":"Plasmablastic Lymphoma","ValueMeaning":{"publicId":"3785911","version":"1","preferredName":"Plasmablastic Lymphoma","longName":"3785911","preferredDefinition":"An aggressive diffuse large B-cell lymphoma usually arising in the setting of HIV infection and characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells.  Sites of involvement include the oral cavity, sinonasal cavity, skin, soft tissues, gastrointestinal tract, and bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plasmablastic Lymphoma","conceptCode":"C7224","definition":"An aggressive diffuse large B-cell lymphoma frequently arising in the setting of HIV infection and characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells.  Sites of involvement include the oral cavity, sinonasal cavity, skin, soft tissues, gastrointestinal tract, and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-08BA-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-08D3-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lymphoma; marginal zone; splenic; NOS","valueDescription":"Not Otherwise Specified Splenic Marginal Zone B-Cell Lymphoma","ValueMeaning":{"publicId":"3785912","version":"1","preferredName":"Not Otherwise Specified Splenic Marginal Zone B-Cell Lymphoma","longName":"3785912","preferredDefinition":"Not characterized in any other way.: A B-cell non-Hodgkin lymphoma composed of small lymphocytes which surround and replace the splenic white pulp germinal centers.  It involves the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.  The patients present with splenomegaly and the clinical course is indolent.  (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Splenic Marginal Zone Lymphoma","conceptCode":"C4663","definition":"A B-cell non-Hodgkin lymphoma composed of small lymphocytes which surround and replace the splenic white pulp germinal centers.  It involves the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.  When lymphoma cells are present in the peripheral blood, they are usually, but not always, characterized by the presence of short polar villi. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-08E0-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-08F9-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lymphoma; mantle cell","valueDescription":"Mantle Cell Lymphoma","ValueMeaning":{"publicId":"2838603","version":"1","preferredName":"Mantle Cell Lymphoma","longName":"2838603","preferredDefinition":"An aggressive, usually diffuse non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes).  Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement.  The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma.  The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mantle Cell Lymphoma","conceptCode":"C4337","definition":"A non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement. The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma. The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AE62-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"COOPERM","dateModified":"2017-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-090D-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lymphoma; B-cell; NOS","valueDescription":"Not Otherwise Specified B-Cell Neoplasm Lymphoma","ValueMeaning":{"publicId":"3785913","version":"1","preferredName":"Not Otherwise Specified B-Cell Neoplasm Lymphoma","longName":"3785913","preferredDefinition":"Not characterized in any other way.: A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow-growing) or aggressive (fast-growing). There are many different types of B-cell lymphomas, and prognosis and treatment depend on the type and stage of cancer.: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"B-Cell Neoplasm","conceptCode":"C27907","definition":"A lymphoproliferative disorder composed of neoplastic B-cells. It includes B-cell non-Hodgkin lymphomas, B-cell leukemias, plasma cell neoplasms, and B-cell proliferations of uncertain malignant potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-091B-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0934-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Hodgkin lymphoma; nodular sclerosis; NOS","valueDescription":"Not Otherwise Specified Nodular Sclerosis Hodgkin Lymphoma","ValueMeaning":{"publicId":"3785914","version":"1","preferredName":"Not Otherwise Specified Nodular Sclerosis Hodgkin Lymphoma","longName":"3785914","preferredDefinition":"Not characterized in any other way.: A subtype of classical Hodgkin lymphoma characterized by collagen bands surrounding lymphoid nodules. The lymphoid nodules contain lacunar and Reed-Sternberg cells.  Mediastinal involvement occurs in 80% of patients.  The prognosis of nodular sclerosis Hodgkin lymphoma is slightly better than that of mixed cellularity or lymphocyte depleted subtype. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nodular Sclerosis Classic Hodgkin Lymphoma","conceptCode":"C3518","definition":"A subtype of classic Hodgkin lymphoma characterized by collagen bands that surround at least one nodule, and Hodgkin and Reed-Sternberg cells with lacunar type morphology. (WHO, 2008)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-0941-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-095A-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Granulosa cell tumor; Sarcomatoid","valueDescription":"Sarcomatoid Features Granulosa Cell Tumor","ValueMeaning":{"publicId":"3785915","version":"1","preferredName":"Sarcomatoid Features Granulosa Cell Tumor","longName":"3785915","preferredDefinition":"A microscopic finding indicating the presence of cells with sarcomatoid, usually spindle cell differentiation in a tumor sample.: A slow-growing, malignant tumor, characterize by the presence of granulosa-like cells and Call-Exner bodies, that is almost always found in the ovary. In rare cases, it has also been found in the testicle.  There are two types of granulosa cell tumor that can be distinguished under the microscope: the adult and the juvenile.  The testicular juvenile granulosa cell tumors are perhaps the most common congenital testicular neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Features","conceptCode":"C39694","definition":"A microscopic finding indicating the presence of cells with sarcomatoid, usually spindle cell differentiation in a tumor sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Granulosa Cell Tumor","conceptCode":"C3070","definition":"A slow-growing sex cord-stromal tumor characterized by the presence of granulosa-like cells and Call-Exner bodies. It is almost always found in the ovary and rarely in the testis. There are two types of granulosa cell tumors: the adult and the juvenile.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-0967-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-0980-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Granulosa cell tumor; malignant","valueDescription":"Malignant Granulosa Cell Tumor","ValueMeaning":{"publicId":"3785917","version":"1","preferredName":"Malignant Granulosa Cell Tumor","longName":"3785917","preferredDefinition":"A granulosa cell tumor which has an aggressive clinical course and metastasizes to other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Granulosa Cell Tumor","conceptCode":"C4205","definition":"A granulosa cell tumor which has an aggressive clinical course and metastasizes to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-098D-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DF0AC481-09A6-CBF9-E040-BB89AD434A4F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Adenocarcinoma-Other Subtype","valueDescription":"Other Subtype Pancreatic Adenocarcinoma","ValueMeaning":{"publicId":"3402721","version":"1","preferredName":"Other Subtype Pancreatic Adenocarcinoma","longName":"3402721","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Subtype; a group forming a type within a larger type.: An adenocarcinoma which arises from the exocrine pancreas.  Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pancreatic Adenocarcinoma","conceptCode":"C8294","definition":"An adenocarcinoma which arises from the exocrine pancreas.  Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EDE5-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CD76-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Carcinoma with Osteoclast-like Giant Cells","valueDescription":"Pancreatic Osteoclast-Like Giant Cell Carcinoma","ValueMeaning":{"publicId":"3402722","version":"1","preferredName":"Pancreatic Osteoclast-Like Giant Cell Carcinoma","longName":"3402722","preferredDefinition":"A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells","conceptCode":"C5723","definition":"A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EE08-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CD80-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Undifferentiated Carcinoma","valueDescription":"Undifferentiated Pancreatic Carcinoma","ValueMeaning":{"publicId":"3402724","version":"1","preferredName":"Undifferentiated Pancreatic Carcinoma","longName":"3402724","preferredDefinition":"A carcinoma with poor prognosis that arises from the pancreas.  It is characterized by the presence of a significant malignant component that does not show differentiation.  The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Undifferentiated Carcinoma","conceptCode":"C5722","definition":"A carcinoma with poor prognosis that arises from the pancreas.  It is characterized by the presence of a significant malignant component that does not show differentiation.  The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EE2E-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CD8A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Signet Ring Cell Carcinoma","valueDescription":"Pancreatic Signet Ring Cell Carcinoma","ValueMeaning":{"publicId":"3402726","version":"1","preferredName":"Pancreatic Signet Ring Cell Carcinoma","longName":"3402726","preferredDefinition":"A rare pancreatic ductal adenocarcinoma with poor prognosis.  It is characterized by the presence of malignant signet ring cells infiltrating the pancreatic parenchyma in an individual cell pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Signet Ring Cell Carcinoma","conceptCode":"C5720","definition":"A rare pancreatic ductal adenocarcinoma with poor prognosis.  It is characterized by the presence of malignant signet ring cells infiltrating the pancreatic parenchyma in an individual cell pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EE54-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CD94-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Medullary","valueDescription":"Pancreatic Medullary Carcinoma","ValueMeaning":{"publicId":"3402728","version":"1","preferredName":"Pancreatic Medullary Carcinoma","longName":"3402728","preferredDefinition":"A pancreatic ductal adenocarcinoma characterized by poor differentiation and a prominent syncytial growth pattern.  The prognosis is more favorable compared to conventional pancreatic ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Medullary Carcinoma","conceptCode":"C95466","definition":"A pancreatic ductal adenocarcinoma characterized by poor differentiation and a prominent syncytial growth pattern.  The prognosis is more favorable compared to conventional pancreatic ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EE7A-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CD9E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Hepatoid Carcinoma","valueDescription":"Pancreatic Hepatoid Adenocarcinoma","ValueMeaning":{"publicId":"3402730","version":"1","preferredName":"Pancreatic Hepatoid Adenocarcinoma","longName":"3402730","preferredDefinition":"A rare adenocarcinoma that arises from the pancreas.  It is characterized by marked hepatocellular differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Hepatoid Adenocarcinoma","conceptCode":"C95465","definition":"A rare adenocarcinoma that arises from the pancreas.  It is characterized by marked hepatocellular differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EEA0-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDA8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Colloid (mucinous non-cystic) Carcinoma","valueDescription":"Pancreatic Mucinous Noncystic Carcinoma","ValueMeaning":{"publicId":"2581789","version":"1","preferredName":"Pancreatic Mucinous Noncystic Carcinoma","longName":"2581789","preferredDefinition":"A pancreatic adenocarcinoma, clinicopathologically distinct from conventional pancreatic ductal adenocarcinomas, with a relatively indolent behavior (5-year survival of 55%).  It often arises in association with intraductal pancreatic mucinous neoplasms. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Colloid Carcinoma","conceptCode":"C37214","definition":"An infiltrating pancreatic ductal adenocarcinoma, characterized by the presence of malignant cells floating in pools of mucin.  It has a more favorable prognosis than the conventional infiltrating ductal adenocarcinoma.  It often arises in association with intraductal pancreatic mucinous neoplasms and in some cases it may result in the development of pseudomyxoma peritonei.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDB2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Adenosquamous Carcinoma","valueDescription":"Pancreas Adenosquamous Carcinoma","ValueMeaning":{"publicId":"3402731","version":"1","preferredName":"Pancreas Adenosquamous Carcinoma","longName":"3402731","preferredDefinition":"A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon).: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreas","conceptCode":"C12393","definition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EEDA-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDBC-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreas-Adenocarcinoma Ductal Type","valueDescription":"Pancreatic Ductal Adenocarcinoma","ValueMeaning":{"publicId":"2581788","version":"1","preferredName":"Pancreatic Ductal Adenocarcinoma","longName":"2581788","preferredDefinition":"A carcinoma occurring almost exclusively in adults that probably arises from the pancreatic duct epithelium.  Most pancreatic carcinomas are ductal adenocarcinomas of which about two-thirds involve the head, with the remainder in the body and tail of the pancreas.  The patients are usually over 50 years of age.  Pain, jaundice, and loss of weight are the most common manifestations.  Ductal adenocarcinomas usually grow rapidly and are discovered after they have already spread beyond the pancreas.  Grossly, ductal adenocarcinomas are firm and poorly defined masses.  Microscopically, most ductal adenocarcinomas are characterized by well-developed glandular structures embedded in a desmoplastic stroma.  Ductal adenocarcinomas are fatal in the vast majority of cases (WHO 2000). --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Ductal Adenocarcinoma","conceptCode":"C9120","definition":"An infiltrating adenocarcinoma that arises from the epithelial cells of the pancreas.  It affects males more often than females and the patients are usually over 50 years of age.  Microscopically it is characterized by the presence of glandular (ductal) differentiation and desmoplastic stroma formation.  Signs and symptoms include pain, loss of weight, and jaundice.  It grows rapidly and is usually detected after it has metastasized to other anatomic sites.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDC6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Clear Cell Squamous Cell Carcinoma","valueDescription":"Squamous Cell Lung Carcinoma, Clear Cell Variant","ValueMeaning":{"publicId":"3139403","version":"1","preferredName":"Squamous Cell Lung Carcinoma, Clear Cell Variant","longName":"3139403","preferredDefinition":"A morphologic variant of squamous cell lung carcinoma characterized by the presence of clear cells. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma, Clear Cell Variant","conceptCode":"C45503","definition":"A morphologic variant of squamous cell lung carcinoma characterized by the presence of clear cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FECA-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDD0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)","valueDescription":"Not Otherwise Specified Squamous Cell Lung Carcinoma","ValueMeaning":{"publicId":"3139399","version":"1","preferredName":"Not Otherwise Specified Squamous Cell Lung Carcinoma","longName":"3139399","preferredDefinition":"Not characterized in any other way.: A carcinoma arising from malignant squamous bronchial epithelial cells and characterized by the presence of keratinization and/or intercellular bridges.  Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Squamous Cell Carcinoma","conceptCode":"C3493","definition":"A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FE6A-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDDA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Basaloid Squamous Cell Carcinoma","valueDescription":"Squamous Cell Lung Carcinoma, Basaloid Variant","ValueMeaning":{"publicId":"3139401","version":"1","preferredName":"Squamous Cell Lung Carcinoma, Basaloid Variant","longName":"3139401","preferredDefinition":"A morphologic variant of squamous cell lung carcinoma characterized by nuclear palisading. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Basaloid Squamous Cell Carcinoma","conceptCode":"C45507","definition":"A morphologic variant of squamous cell lung carcinoma characterized by nuclear palisading.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FE90-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDE4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Small Cell Squamous Cell Carcinoma","valueDescription":"Squamous Cell Lung Carcinoma, Small Cell Variant","ValueMeaning":{"publicId":"3088104","version":"1","preferredName":"Squamous Cell Lung Carcinoma, Small Cell Variant","longName":"3088104","preferredDefinition":"A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma, Small Cell Variant","conceptCode":"C45504","definition":"A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E20578-E7A2-8876-E040-BB89AD434ED8","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDEE-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Adenocarcinoma- Not Otherwise Specified (NOS)","valueDescription":"Lung Not Otherwise Specified Adenocarcinoma","ValueMeaning":{"publicId":"3139406","version":"1","preferredName":"Lung Not Otherwise Specified Adenocarcinoma","longName":"3139406","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: Not characterized in any other way.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FF19-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CDF8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Clear Cell Adenocarcinoma","valueDescription":"Lung Clear Cell Adenocarcinoma","ValueMeaning":{"publicId":"3139408","version":"1","preferredName":"Lung Clear Cell Adenocarcinoma","longName":"3139408","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: A cell with empty-appearing cytoplasm when viewed with a light microscope.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clear Cell","conceptCode":"C12478","definition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FF41-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE02-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Signet Ring Adenocarcinoma","valueDescription":"Lung Signet Ring Cell Adenocarcinoma","ValueMeaning":{"publicId":"3139409","version":"1","preferredName":"Lung Signet Ring Cell Adenocarcinoma","longName":"3139409","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: An epithelial neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Signet Ring Cell","conceptCode":"C12487","definition":"A neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FF68-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE0C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Mucinous Cystadenocarcinoma","valueDescription":"Lung Mucinous Cystadenocarcinoma","ValueMeaning":{"publicId":"3139410","version":"1","preferredName":"Lung Mucinous Cystadenocarcinoma","longName":"3139410","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: containing or resembling mucin.: A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cystadenocarcinoma","conceptCode":"C2971","definition":"A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FF8F-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE16-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Mucinous Adenocarcinoma","valueDescription":"Lung Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3139411","version":"1","preferredName":"Lung Mucinous Adenocarcinoma","longName":"3139411","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: containing or resembling mucin.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FFB6-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE20-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Fetal Adenocarcinoma","valueDescription":"Lung Fetus Adenocarcinoma","ValueMeaning":{"publicId":"3139412","version":"1","preferredName":"Lung Fetus Adenocarcinoma","longName":"3139412","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: An unborn or unhatched vertebrate in the later stages of development showing the main recognizable features of the mature animal.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fetus","conceptCode":"C13235","definition":"An unborn or unhatched vertebrate in the later stages of development showing the main recognizable features of the mature being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FFDD-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE2A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Micropapillary Adenocarcinoma","valueDescription":"Lung Micropapillary Pattern Adenocarcinoma","ValueMeaning":{"publicId":"3139414","version":"1","preferredName":"Lung Micropapillary Pattern Adenocarcinoma","longName":"3139414v1.00","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._A morphologic finding indicating the presence of a growth pattern dominated by the presence of small papillary structures._A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Micropapillary Growth Pattern","conceptCode":"C36181","definition":"A morphologic finding indicating the presence of a growth pattern dominated by the presence of small papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-0005-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE34-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Solid Pattern Predominant Adenocarcinoma","valueDescription":"Lung Solid Pattern Dominant Adenocarcinoma","ValueMeaning":{"publicId":"3139415","version":"1","preferredName":"Lung Solid Pattern Dominant Adenocarcinoma","longName":"3139415","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.: Pattern; anything characterized by repetition.: Exercising influence or control.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Solid","conceptCode":"C45300","definition":"The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pattern","conceptCode":"C25336","definition":"An arrangement of objects, facts, behaviors, or other things which have scientific, mathematical, geometric, statistical, or other meaning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dominant","conceptCode":"C25487","definition":"Exercising influence or control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-002E-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE3E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Bronchioloalveolar Carcinoma Mucinous","valueDescription":"Lung Mucinous Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"3139416","version":"1","preferredName":"Lung Mucinous Bronchioloalveolar Carcinoma","longName":"3139416","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: containing or resembling mucin.: A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-0055-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE48-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Bronchioloalveolar Carcinoma Nonmucinous","valueDescription":"Lung Not Mucinous Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"3139417","version":"1","preferredName":"Lung Not Mucinous Bronchioloalveolar Carcinoma","longName":"3139417","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: An operation in which a term denies or inverts the meaning of another term or construction.: containing or resembling mucin.: A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-007D-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE52-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Papillary Adenocarcinoma","valueDescription":"Lung Papillary Adenocarcinoma","ValueMeaning":{"publicId":"3139418","version":"1","preferredName":"Lung Papillary Adenocarcinoma","longName":"3139418","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: of or relating to or resembling papilla.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Papillary","conceptCode":"C14166","definition":"Of or relating to or resembling papilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-00A4-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE5C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Acinar Adenocarcinoma","valueDescription":"Lung Acinar Cell Adenocarcinoma","ValueMeaning":{"publicId":"3139420","version":"1","preferredName":"Lung Acinar Cell Adenocarcinoma","longName":"3139420","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: A secreting cell that lines an acinus (i.e. a small sac or sac-like structure).  A representative example is the acinar cell located in the pancreas that produces pancreatic enzymes and juices.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Acinar Cell","conceptCode":"C13077","definition":"A secreting cell that lines an acinus (i.e. a small sac or sac-like structure).  A representative example is the acinar cell located in the pancreas that produces pancreatic enzymes and juices.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-00CC-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE66-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Adenocarcinoma Mixed Subtype","valueDescription":"Lung Mixed Subtype Adenocarcinoma","ValueMeaning":{"publicId":"3139421","version":"1","preferredName":"Lung Mixed Subtype Adenocarcinoma","longName":"3139421","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: Involving or composed of different kinds.: Subtype; a group forming a type within a larger type.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-00F4-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE70-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Papillary Squamous Cell Caricnoma","valueDescription":"Squamous Cell Lung Carcinoma, Papillary Variant","ValueMeaning":{"publicId":"3139405","version":"1","preferredName":"Squamous Cell Lung Carcinoma, Papillary Variant","longName":"3139405","preferredDefinition":"A morphologic variant of squamous cell lung carcinoma characterized by the presence of papillary structures. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma, Papillary Variant","conceptCode":"C45502","definition":"A morphologic variant of squamous cell lung carcinoma characterized by the presence of papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A832-FEF0-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE7A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Basaloid Squamous Cell","valueDescription":"Basaloid Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3081851","version":"1","preferredName":"Basaloid Squamous Cell Carcinoma","longName":"3081851","preferredDefinition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basaloid Squamous Cell Carcinoma","conceptCode":"C54244","definition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-4668-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"SOKKERL","dateModified":"2017-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE84-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small Cell Squamous Cell","valueDescription":"Squamous Cell Lung Carcinoma, Small Cell Variant ","ValueMeaning":{"publicId":"3081852","version":"1","preferredName":"Squamous Cell Lung Carcinoma, Small Cell Variant ","longName":"3081852","preferredDefinition":"A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma, Small Cell Variant","conceptCode":"C45504","definition":"A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-468B-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE8E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Clear Cell Squamous Cell","valueDescription":"Squamous Cell Carcinoma, Clear Cell Type","ValueMeaning":{"publicId":"3081853","version":"1","preferredName":"Squamous Cell Carcinoma, Clear Cell Type","longName":"3081853","preferredDefinition":"A squamous cell carcinoma characterized by the presence of malignant cells with clear cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma, Clear Cell Type","conceptCode":"C65180","definition":"A squamous cell carcinoma characterized by the presence of malignant cells with clear cytoplasm.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-46AE-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CE98-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Papillary Squamous Cell","valueDescription":"Papillary Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3081854","version":"1","preferredName":"Papillary Squamous Cell Carcinoma","longName":"3081854","preferredDefinition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Squamous Cell Carcinoma","conceptCode":"C4102","definition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-46D1-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEA2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenosquamous","valueDescription":"Adenosquamous Carcinoma","ValueMeaning":{"publicId":"2836818","version":"1","preferredName":"Adenosquamous Carcinoma","longName":"2836818","preferredDefinition":"A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62470ADA-0687-83FB-E040-BB89AD436FBF","latestVersionIndicator":"Yes","beginDate":"2009-02-06","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-06","modifiedBy":"ONEDATA","dateModified":"2009-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEAC-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Clear Cell Adenocarcinoma","valueDescription":"Clear Cell Adenocarcinoma","ValueMeaning":{"publicId":"3081856","version":"1","preferredName":"Clear Cell Adenocarcinoma","longName":"3081856","preferredDefinition":"(kar-sin-O-ma) A rare type of tumor of the female genital tract in which the inside of the cells looks clear when viewed under a microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-472C-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEB6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous Cystadenocarcinoma","valueDescription":"Mucinous Cystadenocarcinoma","ValueMeaning":{"publicId":"3027126","version":"1","preferredName":"Mucinous Cystadenocarcinoma","longName":"3027126","preferredDefinition":"An invasive adenocarcinoma characterized by cystic changes and the presence of malignant glandular cells which contain intracytoplasmic mucin. It may arise from the ovary, pancreas, appendix, and lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Cystadenocarcinoma","conceptCode":"C3776","definition":"An invasive adenocarcinoma characterized by cystic changes and the presence of malignant glandular cells which contain intracytoplasmic mucin. It may arise from the ovary, pancreas, appendix, and lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DC6AB6-C4BE-CB06-E040-BB89AD437762","latestVersionIndicator":"Yes","beginDate":"2010-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEC0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous (Colloid) Carcinoma","valueDescription":"Mucinous Adenocarcinoma ","ValueMeaning":{"publicId":"3081857","version":"1","preferredName":"Mucinous Adenocarcinoma ","longName":"3081857","preferredDefinition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-4779-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CECA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Fetal Adenocarcinoma","valueDescription":"Fetal Adenocarcinoma","ValueMeaning":{"publicId":"3081858","version":"1","preferredName":"Fetal Adenocarcinoma","longName":"3081858","preferredDefinition":"A very rare, well differentiated morphologic variant of lung adenocarcinoma characterized by the presence of glandular structures containing glycogen-rich cells forming tubules that resemble fetal lung tubules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Fetal Adenocarcinoma","conceptCode":"C45509","definition":"A rare morphologic variant of lung adenocarcinoma characterized by the presence of glandular structures containing glycogen-rich cells forming tubules that resemble fetal lung tubules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-479C-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CED4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Rectal Mucinous Adenocarcinoma","valueDescription":"Rectal Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3088060","version":"1","preferredName":"Rectal Mucinous Adenocarcinoma","longName":"3088060","preferredDefinition":"An invasive adenocarcinoma of the rectum characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Mucinous Adenocarcinoma","conceptCode":"C7973","definition":"An invasive adenocarcinoma of the rectum characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E21F-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEDE-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Rectal Adenocarcinoma","valueDescription":"Rectal Adenocarcinoma","ValueMeaning":{"publicId":"3088062","version":"1","preferredName":"Rectal Adenocarcinoma","longName":"3088062","preferredDefinition":"An adenocarcinoma arising from the rectum.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Adenocarcinoma","conceptCode":"C9383","definition":"An adenocarcinoma arising from the rectum.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well, moderately, and poorly differentiated.  Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E245-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEE8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Colon Mucinous Adenocarcinoma","valueDescription":"Colon Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3088064","version":"1","preferredName":"Colon Mucinous Adenocarcinoma","longName":"3088064","preferredDefinition":"An invasive adenocarcinoma of the colon characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Mucinous Adenocarcinoma","conceptCode":"C7966","definition":"An invasive adenocarcinoma of the colon characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E26B-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEF2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Colon Adenocarcinoma","valueDescription":"Colon Adenocarcinoma","ValueMeaning":{"publicId":"3088065","version":"1","preferredName":"Colon Adenocarcinoma","longName":"3088065","preferredDefinition":"An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Adenocarcinoma","conceptCode":"C4349","definition":"An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated.  Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E290-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CEFC-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Oligodendroglioma","valueDescription":"Oligodendroglioma","ValueMeaning":{"publicId":"2838655","version":"1","preferredName":"Oligodendroglioma","longName":"2838655","preferredDefinition":"A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma","conceptCode":"C3288","definition":"A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A770F5-59CD-03F5-E040-BB89AD435AD2","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF06-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Astrocytoma","valueDescription":"Astrocytoma, NOS","ValueMeaning":{"publicId":"2837827","version":"1","preferredName":"Astrocytoma, NOS","longName":"2837827","preferredDefinition":"A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astrocytoma","conceptCode":"C60781","definition":"A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"628169CF-83A0-F4D3-E040-BB89AD433D78","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"REEVESD","dateModified":"2014-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF10-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Kidney Papillary Renal Cell Carcinoma","valueDescription":"Papillary Renal Cell Carcinoma","ValueMeaning":{"publicId":"2581626","version":"1","preferredName":"Papillary Renal Cell Carcinoma","longName":"2581626","preferredDefinition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Renal Cell Carcinoma","conceptCode":"C6975","definition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF1A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Kidney Clear Cell Renal Carcinoma","valueDescription":"Conventional (Clear Cell) Renal Cell Carcinoma","ValueMeaning":{"publicId":"3088074","version":"1","preferredName":"Conventional (Clear Cell) Renal Cell Carcinoma","longName":"3088074","preferredDefinition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Renal Cell Carcinoma","conceptCode":"C4033","definition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E3BF-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF24-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uterine serous endometrial adenocarcinoma","valueDescription":"Endometrial Serous Adenocarcinoma","ValueMeaning":{"publicId":"3104169","version":"1","preferredName":"Endometrial Serous Adenocarcinoma","longName":"3104169","preferredDefinition":"A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Serous Adenocarcinoma","conceptCode":"C27838","definition":"A high-grade, aggressive adenocarcinoma arising from the endometrium. It is characterized by the presence of complex papillary patterns with cellular budding. Atypical mitoses, necrosis, and psammoma bodies may be present. It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia. It tends to invade deeply into the myometrium and spreads into the lymphatic vessels. Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis. The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E99CE1-B739-EEEA-E040-BB89AD43141F","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF2E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid endometrial adenocarcinoma (Grade 3)","valueDescription":"Endometrioid endometrial adenocarcinoma (Grade 3)","ValueMeaning":{"publicId":"3104170","version":"1","preferredName":"Endometrioid endometrial adenocarcinoma (Grade 3)","longName":"3104170","preferredDefinition":"A position on a scale of intensity or amount or quality.: A number with no fractional part.::3: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E99CE1-B75C-EEEA-E040-BB89AD43141F","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF38-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid endometrial adenocarcinoma (Grade 1 or 2)","valueDescription":"Endometrioid endometrial adenocarcinoma (Grade 1 or 2)","ValueMeaning":{"publicId":"3104171","version":"1","preferredName":"Endometrioid endometrial adenocarcinoma (Grade 1 or 2)","longName":"3104171","preferredDefinition":"A position on a scale of intensity or amount or quality.: A number with no fractional part.::1: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A number with no fractional part.::2: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E99CE1-B77F-EEEA-E040-BB89AD43141F","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF42-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma, Not Otherwise Specified","valueDescription":"Squamous Cell Carcinoma","ValueMeaning":{"publicId":"2567412","version":"1","preferredName":"Squamous Cell Carcinoma","longName":"2567412","preferredDefinition":"A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D461-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-10","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF4C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Signet Ring Adenocarcinoma","valueDescription":"Signet Ring Cell Adenocarcinoma","ValueMeaning":{"publicId":"3088109","version":"1","preferredName":"Signet Ring Cell Adenocarcinoma","longName":"3088109","preferredDefinition":"An epithelial neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell","conceptCode":"C12487","definition":"A neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E20578-E828-8876-E040-BB89AD434ED8","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF56-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma, Not Otherwise Specified","valueDescription":"Not Otherwise Specified Adenocarcinoma ","ValueMeaning":{"publicId":"3081859","version":"1","preferredName":"Not Otherwise Specified Adenocarcinoma ","longName":"3081859","preferredDefinition":"Not characterized in any other way.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-47BF-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF60-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Head & Neck Squamous Cell Carcinoma","valueDescription":"Head and Neck Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3088073","version":"1","preferredName":"Head and Neck Squamous Cell Carcinoma","longName":"3088073","preferredDefinition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Squamous Cell Carcinoma","conceptCode":"C34447","definition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E39C-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"ZHANGW","dateModified":"2021-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF6A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Oligoastrocytoma","valueDescription":"Oligoastrocytoma","ValueMeaning":{"publicId":"2838647","version":"1","preferredName":"Oligoastrocytoma","longName":"2838647","preferredDefinition":"A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligoastrocytoma","conceptCode":"C4050","definition":"A WHO grade 2 tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A740CA-95EA-2FE1-E040-BB89AD4311CA","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF74-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)","valueDescription":"Follicular Variant Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"3166424","version":"1","preferredName":"Follicular Variant Thyroid Gland Papillary Carcinoma","longName":"3166424","preferredDefinition":"A morphologic variant of papillary carcinoma of the thyroid gland characterized by the absence of papillary structures, and the presence of follicular structures.  The malignant follicular cells display the nuclear characteristics that characterize the papillary adenocarcinomas of the thyroid gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Follicular Variant Thyroid Gland Papillary Carcinoma","conceptCode":"C7381","definition":"A nonencapsulated, infiltrating papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9766E8FC-EEED-9808-E040-BB89AD434090","latestVersionIndicator":"Yes","beginDate":"2010-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF7E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thyroid Papillary Carcinoma - Other, specify","valueDescription":"Other Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"3180148","version":"1","preferredName":"Other Thyroid Gland Papillary Carcinoma","longName":"3180148","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thyroid Gland Papillary Carcinoma","conceptCode":"C4035","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F7B618-622E-0C4E-E040-BB89AD435A7E","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF88-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)","valueDescription":"Tall Cell Variant Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"3166422","version":"1","preferredName":"Tall Cell Variant Thyroid Gland Papillary Carcinoma","longName":"3166422","preferredDefinition":"A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of tall malignant follicular cells, arranged in papillary and trabecular patterns.  Necrotic changes, and high mitotic activity are present. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tall Cell Variant Thyroid Gland Papillary Carcinoma","conceptCode":"C35558","definition":"A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of tall malignant follicular cells, arranged in papillary and trabecular patterns.  Necrotic changes and high mitotic activity are present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9766E8FC-EEC7-9808-E040-BB89AD434090","latestVersionIndicator":"Yes","beginDate":"2010-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF92-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Dedifferentiated liposarcoma","valueDescription":"Dedifferentiated Liposarcoma","ValueMeaning":{"publicId":"3162600","version":"1","preferredName":"Dedifferentiated Liposarcoma","longName":"3162600","preferredDefinition":"A liposarcoma of any histologic subtype mixed with a non-lipomatous, high grade sarcomatous component.  The non-lipomatous component may be present in the primary lesion or at the site of metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dedifferentiated Liposarcoma","conceptCode":"C3704","definition":"An atypical lipomatous tumor/well differentiated liposarcoma that shows progression to a usually non-lipomatous, high grade sarcoma.  The non-lipomatous sarcoma component may be present in the primary lesion or at the site of recurrence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95BA0EB9-C6DD-0EB8-E040-BB89AD437157","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"WHITES","dateCreated":"2010-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CF9C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thyroid Papillary Carcinoma - Classical/usual","valueDescription":"Conventional Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"3166450","version":"1","preferredName":"Conventional Thyroid Gland Papillary Carcinoma","longName":"3166450","preferredDefinition":"Something regarded as a normative example.: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Convention","conceptCode":"C61300","definition":"Something regarded as a normative example.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thyroid Gland Papillary Carcinoma","conceptCode":"C4035","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9766E8FC-EF1A-9808-E040-BB89AD434090","latestVersionIndicator":"Yes","beginDate":"2010-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFA6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)","valueDescription":"Gastric Adenocarcinoma","ValueMeaning":{"publicId":"3206052","version":"1","preferredName":"Gastric Adenocarcinoma","longName":"3206052","preferredDefinition":"An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals, most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a \"curative\" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Adenocarcinoma","conceptCode":"C4004","definition":"An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals.  It most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a \"curative\" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-4F8F-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFB0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach, Adenocarcinoma, Diffuse Type","valueDescription":"Diffuse Gastric Adenocarcinoma","ValueMeaning":{"publicId":"3206054","version":"1","preferredName":"Diffuse Gastric Adenocarcinoma","longName":"3206054","preferredDefinition":"An adenocarcinoma arising from the stomach.  Microscopically, it is characterized by the presence of a diffuse infiltrate, composed of individual adenocarcinoma cells or groups of adenocarcinoma cells in a fibrous or mucoid stroma.  Many cells contain mucin droplets, producing a signet-ring configuration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Diffuse Adenocarcinoma","conceptCode":"C9159","definition":"An adenocarcinoma arising from the stomach.  Microscopically, it is characterized by the presence of a diffuse infiltrate, composed of individual adenocarcinoma cells or groups of adenocarcinoma cells in a fibrous or mucoid stroma.  Many cells contain mucin droplets, producing a signet-ring configuration.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-4FB5-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFBA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)","valueDescription":"Gastric Intestinal Type Adenocarcinoma","ValueMeaning":{"publicId":"3206056","version":"1","preferredName":"Gastric Intestinal Type Adenocarcinoma","longName":"3206056","preferredDefinition":"An adenocarcinoma of the stomach arising on a background of intestinal metaplasia.  Microscopically, it is characterized by a glandular pattern and it closely resembles a colonic adenocarcinoma.  Grossly, it tends to be nodular, polypoid or ulcerated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Intestinal-Type Adenocarcinoma","conceptCode":"C9157","definition":"An adenocarcinoma of the stomach arising on a background of intestinal metaplasia.  Microscopically, it is characterized by a glandular pattern and it closely resembles a colonic adenocarcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-4FDB-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFC4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serous endometrial adenocarcinoma","valueDescription":"Endometrial Serous Adenocarcinoma","ValueMeaning":{"publicId":"3104169","version":"1","preferredName":"Endometrial Serous Adenocarcinoma","longName":"3104169","preferredDefinition":"A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Serous Adenocarcinoma","conceptCode":"C27838","definition":"A high-grade, aggressive adenocarcinoma arising from the endometrium. It is characterized by the presence of complex papillary patterns with cellular budding. Atypical mitoses, necrosis, and psammoma bodies may be present. It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia. It tends to invade deeply into the myometrium and spreads into the lymphatic vessels. Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis. The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E99CE1-B739-EEEA-E040-BB89AD43141F","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D14A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach, Intestinal Adenocarcinoma, Tubular Type","valueDescription":"Gastric Tubular Adenocarcinoma","ValueMeaning":{"publicId":"3206062","version":"1","preferredName":"Gastric Tubular Adenocarcinoma","longName":"3206062","preferredDefinition":"A variant of gastric adenocarcinoma characterized by prominent dilated or slit-like tubules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Tubular Adenocarcinoma","conceptCode":"C5473","definition":"A variant of gastric adenocarcinoma characterized by prominent dilated or slit-like tubules.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-504D-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"COOPERM","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFE2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Hepatocholangiocarcinoma (Mixed)","valueDescription":"Cholangiocarcinoma","ValueMeaning":{"publicId":"3165468","version":"1","preferredName":"Cholangiocarcinoma","longName":"3165468","preferredDefinition":"An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholangiocarcinoma","conceptCode":"C4436","definition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D7AA2D-09B1-EB1F-E040-BB89AD436E93","latestVersionIndicator":"Yes","beginDate":"2010-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFEC-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Fibrolamellar Carcinoma","valueDescription":"Fibrolamellar Hepatocellular Carcinoma","ValueMeaning":{"publicId":"3165470","version":"1","preferredName":"Fibrolamellar Hepatocellular Carcinoma","longName":"3165470","preferredDefinition":"Fibrolamellar carcinoma is a distinctive morphologic variant of liver cell carcinoma seen predominantly in young patients without cirrhosis and associated with favorable prognosis.  The tumor cells are polygonal and deeply eosinophilic embedded in a fibrous stroma.  Over half of the fibrolamellar carcinomas are resectable, and the cure rate is about 50%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrolamellar Carcinoma","conceptCode":"C4131","definition":"A distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients.  The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma.  The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D7AA2D-09D7-EB1F-E040-BB89AD436E93","latestVersionIndicator":"Yes","beginDate":"2010-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-CFF6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Hepatocellular Carcinoma","valueDescription":"Hepatocellular Carcinoma","ValueMeaning":{"publicId":"2573454","version":"1","preferredName":"Hepatocellular Carcinoma","longName":"2573454","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma","conceptCode":"C3099","definition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EBFB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"CHILLIJ","dateModified":"2007-03-27","changeDescription":"03/27/2007 - Updated with NCI Thesaurus definition (abbreviated version.)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D000-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D00A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Esophagus Squamous Cell Carcinoma","valueDescription":"Esophagus Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3295792","version":"1","preferredName":"Esophagus Squamous Cell Carcinoma","longName":"3295792","preferredDefinition":"The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.: A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus","conceptCode":"C12389","definition":"The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFAF779D-B58D-E4CB-E040-BB89AD432ABD","latestVersionIndicator":"Yes","beginDate":"2011-10-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D014-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Esophagus Adenocarcinoma, NOS","valueDescription":"Esophagus Adenocarcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"3295793","version":"1","preferredName":"Esophagus Adenocarcinoma Not Otherwise Specified","longName":"3295793","preferredDefinition":"The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus","conceptCode":"C12389","definition":"The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFAF779D-B5B4-E4CB-E040-BB89AD432ABD","latestVersionIndicator":"Yes","beginDate":"2011-10-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D01E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Head & Neck Squamous Cell Carcinoma, Spindle Cell Variant","valueDescription":"Head and Neck Squamous Cell Carcinoma Malignant Spindle Cell Neoplasm","ValueMeaning":{"publicId":"3271038","version":"1","preferredName":"Head and Neck Squamous Cell Carcinoma Malignant Spindle Cell Neoplasm","longName":"3271038","preferredDefinition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.: A malignant neoplasm characterized by then presence of atypical spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Squamous Cell Carcinoma","conceptCode":"C34447","definition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Spindle Cell Neoplasm","conceptCode":"C27091","definition":"A malignant neoplasm characterized by the presence of atypical spindle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD242CD-30EE-007A-E040-BB89AD4305C0","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D028-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed serous and endometrioid","valueDescription":"Mixed Endometrial Serous Adenocarcinoma And Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"3263635","version":"1","preferredName":"Mixed Endometrial Serous Adenocarcinoma And Endometrioid Adenocarcinoma","longName":"3263635","preferredDefinition":"Involving or composed of different kinds.: A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Endometrial Serous Adenocarcinoma","conceptCode":"C27838","definition":"A high-grade, aggressive adenocarcinoma arising from the endometrium. It is characterized by the presence of complex papillary patterns with cellular budding. Atypical mitoses, necrosis, and psammoma bodies may be present. It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia. It tends to invade deeply into the myometrium and spreads into the lymphatic vessels. Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis. The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB335DB5-1C8F-F51E-E040-BB89AD437352","latestVersionIndicator":"Yes","beginDate":"2011-08-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-23","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D032-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid endometrial adenocarcinoma (Grade 2)","valueDescription":"Endometrioid Adenocarcinoma Grade 2","ValueMeaning":{"publicId":"3263636","version":"1","preferredName":"Endometrioid Adenocarcinoma Grade 2","longName":"3263636","preferredDefinition":"A position on a scale of intensity or amount or quality.: A number with no fractional part.::2: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB335DB5-1CB6-F51E-E040-BB89AD437352","latestVersionIndicator":"Yes","beginDate":"2011-08-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-23","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D03C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid endometrial adenocarcinoma (Grade 1)","valueDescription":"Endometrioid Adenocarcinoma Grade 1","ValueMeaning":{"publicId":"3263637","version":"1","preferredName":"Endometrioid Adenocarcinoma Grade 1","longName":"3263637","preferredDefinition":"A position on a scale of intensity or amount or quality.: A number with no fractional part.::1: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB335DB5-1CDD-F51E-E040-BB89AD437352","latestVersionIndicator":"Yes","beginDate":"2011-08-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D046-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Kidney Chromophobe","valueDescription":"Chromophobe Renal Cell Carcinoma","ValueMeaning":{"publicId":"3248534","version":"1","preferredName":"Chromophobe Renal Cell Carcinoma","longName":"3248534","preferredDefinition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.  -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromophobe Renal Cell Carcinoma","conceptCode":"C4146","definition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical), eosinophilic, or oncocytic.  It has a much better prognosis than other renal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B9F2-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D050-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3241404","version":"1","preferredName":"Other","longName":"3241404","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A5D-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D05A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Tubulolobular Carcinoma","valueDescription":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","ValueMeaning":{"publicId":"3248498","version":"1","preferredName":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","longName":"3248498","preferredDefinition":"An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma, Tubulolobular Variant","conceptCode":"C97053","definition":"An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-180E-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D064-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Metaplastic Carcinoma","valueDescription":"Metaplastic Carcinoma","ValueMeaning":{"publicId":"3248487","version":"1","preferredName":"Metaplastic Carcinoma","longName":"3248487","preferredDefinition":"A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cells type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metaplastic Carcinoma","conceptCode":"C27949","definition":"A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cells type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-1718-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D06E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Carcinoma: Type Cannot Be Determined","valueDescription":"Not Otherwise Specified Invasive Carcinoma","ValueMeaning":{"publicId":"3316550","version":"1","preferredName":"Not Otherwise Specified Invasive Carcinoma","longName":"3316550","preferredDefinition":"Not characterized in any other way.: A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Invasive Carcinoma","conceptCode":"C9480","definition":"A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-5F02-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D078-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Cribiform Carcinoma","valueDescription":"Invasive Cribriform Breast Carcinoma","ValueMeaning":{"publicId":"2581150","version":"1","preferredName":"Invasive Cribriform Breast Carcinoma","longName":"2581150","preferredDefinition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Cribriform Carcinoma","conceptCode":"C5142","definition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D082-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Tubular Carcinoma","valueDescription":"Tubular Breast Carcinoma","ValueMeaning":{"publicId":"2577121","version":"1","preferredName":"Tubular Breast Carcinoma","longName":"2577121","preferredDefinition":"A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Tubular Carcinoma","conceptCode":"C9135","definition":"An invasive adenocarcinoma of the breast with a favorable prognosis.  It is composed of tubular structures lined by a single layer of epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA4E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D08C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Micropapillary Carcinoma","valueDescription":"Invasive Intraductal Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3316551","version":"1","preferredName":"Invasive Intraductal Micropapillary Breast Carcinoma","longName":"3316551","preferredDefinition":"Marked by a tendency to spread especially into healthy tissue.: An intraductal papillary carcinoma in which the neoplastic epithelial cells are arranged in micropapillary patterns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Micropapillary Ductal Carcinoma In Situ","conceptCode":"C5139","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic epithelial cells arranged in micropapillary patterns.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-5F50-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D096-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Papillary Carcinoma","valueDescription":"Invasive Papillary Carcinoma","ValueMeaning":{"publicId":"3316552","version":"1","preferredName":"Invasive Papillary Carcinoma","longName":"3316552","preferredDefinition":"Marked by a tendency to spread especially into healthy tissue.: A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papillary Carcinoma","conceptCode":"C2927","definition":"A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-5F76-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0A0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Medullary Carcinoma","valueDescription":"Thyroid Gland Medullary Carcinoma","ValueMeaning":{"publicId":"2861420","version":"1","preferredName":"Thyroid Gland Medullary Carcinoma","longName":"2861420","preferredDefinition":"A neuroendocrine carcinoma arising from the C-cells of the thyroid gland.  It is closely associated with multiple endocrine neoplasia syndromes.  Approximately 10% to 20% of medullary thyroid carcinomas are familial.  Patients usually present with a thyroid nodule that is painless and firm.  In the majority of cases nodal involvement is present at diagnosis.  Surgery is the preferred treatment for both primary lesions and recurrences.  This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Medullary Carcinoma","conceptCode":"C3879","definition":"A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67B13250-5416-3FB8-E040-BB89AD43483F","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0AA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous Carcinoma","valueDescription":"Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3293710","version":"1","preferredName":"Mucinous Adenocarcinoma","longName":"3293710","preferredDefinition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF074E37-E8CF-1C17-E040-BB89AD431694","latestVersionIndicator":"Yes","beginDate":"2011-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0B4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Carcinoma With Ductal And Lobular Features","valueDescription":"Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ Invasive Carcinoma","ValueMeaning":{"publicId":"3316553","version":"1","preferredName":"Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ Invasive Carcinoma","longName":"3316553","preferredDefinition":"The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion.: A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ","conceptCode":"C4195","definition":"The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Invasive Carcinoma","conceptCode":"C9480","definition":"A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-5FBB-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0BE-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Lobular Carcinoma","valueDescription":"Invasive Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2581147","version":"1","preferredName":"Invasive Lobular Breast Carcinoma","longName":"2581147","preferredDefinition":"An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma","conceptCode":"C7950","definition":"An infiltrating lobular adenocarcinoma of the breast.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0C8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Ductal Carcinoma","valueDescription":"Invasive Ductal Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"2581223","version":"1","preferredName":"Invasive Ductal Carcinoma, Not Otherwise Specified","longName":"2581223","preferredDefinition":"Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0D2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Prostate Adenocarcinoma, Other Subtype","valueDescription":"Other Subtype Prostate Adenocarcinoma","ValueMeaning":{"publicId":"3320077","version":"1","preferredName":"Other Subtype Prostate Adenocarcinoma","longName":"3320077","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Subtype; a group forming a type within a larger type.: An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prostate Adenocarcinoma","conceptCode":"C2919","definition":"An adenocarcinoma arising from the prostate gland.  It is one of the most common malignant tumors afflicting men.  The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland.  Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival.  Several grading systems have been proposed, of which the Gleason system is the most commonly used.  Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31E33BB-6E37-7D8D-E040-BB89AD431F32","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0E6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Prostate Adenocarcinoma","valueDescription":"Prostate Adenocarcinoma","ValueMeaning":{"publicId":"3320078","version":"1","preferredName":"Prostate Adenocarcinoma","longName":"3320078","preferredDefinition":"An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Adenocarcinoma","conceptCode":"C2919","definition":"An adenocarcinoma arising from the prostate gland.  It is one of the most common malignant tumors afflicting men.  The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland.  Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival.  Several grading systems have been proposed, of which the Gleason system is the most commonly used.  Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31E33BB-6E5A-7D8D-E040-BB89AD431F32","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0F0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach Adenocarcinoma, Signet Ring Type","valueDescription":"Signet Ring Cell Carcinoma Gastric Adenocarcinoma","ValueMeaning":{"publicId":"3333077","version":"1","preferredName":"Signet Ring Cell Carcinoma Gastric Adenocarcinoma","longName":"3333077","preferredDefinition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.: An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals, most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a \"curative\" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell Carcinoma","conceptCode":"C3774","definition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastric Adenocarcinoma","conceptCode":"C4004","definition":"An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals.  It most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a \"curative\" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B40EBBC9-DF50-C533-E040-BB89AD433BC2","latestVersionIndicator":"Yes","beginDate":"2011-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D0FA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"DLBCL associated with chronic inflammation","valueDescription":"Chronic Inflammation Associated With Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"3361337","version":"1","preferredName":"Chronic Inflammation Associated With Diffuse Large B-Cell Lymphoma","longName":"3361337","preferredDefinition":"A disease or condition that persists or progresses over a long period of time.: A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation. --2004: Joined in some kind of relationship.: Used to indicate the presence of something or someone.: This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7344AE8-28E8-FBB6-E040-BB89AD432B57","latestVersionIndicator":"Yes","beginDate":"2012-01-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D104-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"EBV positive DLBCL of the elderly","valueDescription":"Elderly Epstein-Barr Virus Positive Finding Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"3361338","version":"1","preferredName":"Elderly Epstein-Barr Virus Positive Finding Diffuse Large B-Cell Lymphoma","longName":"3361338","preferredDefinition":"An age group comprised by people 65 years of age and older.: A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations. (On-line Medical Dictionary): An observation confirming something, such as the presence of a disease, condition, or microorganism.: This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elderly","conceptCode":"C16268","definition":"An age group comprised of individuals 65 years of age and older.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7344AE8-2910-FBB6-E040-BB89AD432B57","latestVersionIndicator":"Yes","beginDate":"2012-01-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D10E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Primary cutaneous DLBCL leg type","valueDescription":"Primary Cutaneous Leg Type Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"3361339","version":"1","preferredName":"Primary Cutaneous Leg Type Diffuse Large B-Cell Lymphoma","longName":"3361339","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary): (kyoo-TAY-nee-us) Having to do with the skin.: Commonly used to refer to the whole lower limb but technically only the part between the knee and ankle.: Type; a subdivision of a particular kind of thing.: This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Cutaneous","conceptCode":"C13316","definition":"Involving the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Leg","conceptCode":"C32974","definition":"The portion of the lower extremity between the knee and the ankle. For clinical purposes this term is also used to refer to the whole inferior limb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7344AE8-2939-FBB6-E040-BB89AD432B57","latestVersionIndicator":"Yes","beginDate":"2012-01-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D118-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Primary DLBCL of the CNS","valueDescription":"Central Nervous System Primary Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"3361340","version":"1","preferredName":"Central Nervous System Primary Diffuse Large B-Cell Lymphoma","longName":"3361340","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.: Occurring first in time or sequence; original. (American Heritage Dictionary): This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7344AE8-2960-FBB6-E040-BB89AD432B57","latestVersionIndicator":"Yes","beginDate":"2012-01-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D122-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Primary mediastinal (thymic) DLBCL","valueDescription":"Primary Mediastinal Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"3361341","version":"1","preferredName":"Primary Mediastinal Diffuse Large B-Cell Lymphoma","longName":"3361341","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary): Mediastinal; related to the mediastinum.: This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mediastinal","conceptCode":"C25310","definition":"Related to the mediastinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7344AE8-2987-FBB6-E040-BB89AD432B57","latestVersionIndicator":"Yes","beginDate":"2012-01-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D12C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)","valueDescription":"Diffuse Large B-Cell Lymphoma Not Otherwise Specified","ValueMeaning":{"publicId":"3361342","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma Not Otherwise Specified","longName":"3361342","preferredDefinition":"This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7344AE8-29AD-FBB6-E040-BB89AD432B57","latestVersionIndicator":"Yes","beginDate":"2012-01-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D136-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid endometrial adenocarcinoma","valueDescription":"Endometrial Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"3475265","version":"1","preferredName":"Endometrial Endometrioid Adenocarcinoma","longName":"3475265","preferredDefinition":"A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands.  The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells.  Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Endometrioid Adenocarcinoma","conceptCode":"C6287","definition":"A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands.  The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells.  Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1D37D29-6B00-D1BD-E040-BB89AD4325DD","latestVersionIndicator":"Yes","beginDate":"2012-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-06","modifiedBy":"TSESU","dateModified":"2023-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D140-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Burkitt lymphoma (BL), classic morphology","valueDescription":"Classic Burkitt Lymphoma","ValueMeaning":{"publicId":"3613369","version":"1","preferredName":"Classic Burkitt Lymphoma","longName":"3613369","preferredDefinition":"Mature B cell, lymphoblastic, starry sky effect","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classic Burkitt Lymphoma of the Mouse Hematologic System","conceptCode":"C21917","definition":"Mature B cell, lymphoblastic, starry sky effect","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBCE4E2C-1AC8-5B69-E040-BB89AD436425","latestVersionIndicator":"Yes","beginDate":"2012-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D154-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Burkitt lymphoma (BL), atypical morphology","valueDescription":"Atypical Burkitt/Burkitt-Like Lymphoma","ValueMeaning":{"publicId":"3322767","version":"1","preferredName":"Atypical Burkitt/Burkitt-Like Lymphoma","longName":"3322767","preferredDefinition":"A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Burkitt/Burkitt-Like Lymphoma","conceptCode":"C6917","definition":"A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3714D57-A8EF-7A8F-E040-BB89AD43536C","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D15E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Undifferentiated Pleomorphic Sarcoma (UPS)","valueDescription":"Storiform-Pleomorphic Malignant Fibrous Histiocytoma","ValueMeaning":{"publicId":"3179380","version":"1","preferredName":"Storiform-Pleomorphic Malignant Fibrous Histiocytoma","longName":"3179380","preferredDefinition":"A morphologic variant of malignant fibrous histiocytoma. It is well-circumscribed tumor characterized by the presence of bizarre giant cells, spindle cells, round histiocyte-like cells, stromal chronic inflammatory cells, and nuclear pleomorphism in a prominent storiform pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Storiform-Pleomorphic Malignant Fibrous Histiocytoma","conceptCode":"C6495","definition":"A well-circumscribed sarcoma characterized by the presence of bizarre giant cells, spindle cells, round histiocyte-like cells, stromal chronic inflammatory cells, and nuclear pleomorphism in a prominent storiform pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98903582-4FB1-C5EF-E040-BB89AD431B68","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D168-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Leiomyosarcoma (LMS)","valueDescription":"Leiomyosarcoma","ValueMeaning":{"publicId":"2562491","version":"1","preferredName":"Leiomyosarcoma","longName":"2562491","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C128-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-09-27","endDate":null,"createdBy":"PWEST","dateCreated":"2002-09-27","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D172-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous Adenocarcinoma of Endocervical Type","valueDescription":"Endocervix Type Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3521931","version":"1","preferredName":"Endocervix Type Mucinous Adenocarcinoma","longName":"3521931","preferredDefinition":"The portion of the cervix which is lined by single columnar epithelium (mucosa).: Something distinguishable as an identifiable class based on common qualities.: An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocervix","conceptCode":"C12309","definition":"The portion of the cervix which is lined by single columnar epithelium (mucosa).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-6768-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D17C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid Adenocarcinoma of Endocervix","valueDescription":"Endocervix Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"3521932","version":"1","preferredName":"Endocervix Endometrioid Adenocarcinoma","longName":"3521932","preferredDefinition":"The portion of the cervix which is lined by single columnar epithelium (mucosa).: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocervix","conceptCode":"C12309","definition":"The portion of the cervix which is lined by single columnar epithelium (mucosa).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-678E-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D186-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endocervical Type of Adenocarcinoma","valueDescription":"Endocervix Type Adenocarcinoma","ValueMeaning":{"publicId":"3521933","version":"1","preferredName":"Endocervix Type Adenocarcinoma","longName":"3521933","preferredDefinition":"The portion of the cervix which is lined by single columnar epithelium (mucosa).: Something distinguishable as an identifiable class based on common qualities.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocervix","conceptCode":"C12309","definition":"The portion of the cervix which is lined by single columnar epithelium (mucosa).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-67B5-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D190-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endocervical Adenocarcinoma of the Usual Type","valueDescription":"Endocervical Carcinoma","ValueMeaning":{"publicId":"3521935","version":"1","preferredName":"Endocervical Carcinoma","longName":"3521935","preferredDefinition":"An adenocarcinoma characterized by the presence of malignant glandular epithelium resembling the endocervical epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocervical Carcinoma","conceptCode":"C28327","definition":"A carcinoma that arises from the endocervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-67DB-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D19A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Cervical Squamous Cell Carcinoma","valueDescription":"Cervical Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3521937","version":"1","preferredName":"Cervical Squamous Cell Carcinoma","longName":"3521937","preferredDefinition":"A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. The following histologic patterns have been described: Conventional squamous cell carcinoma, papillary squamous cell carcinoma, transitional cell carcinoma, lymphoepithelioma-like carcinoma, verrucous carcinoma, condylomatous carcinoma and spindle cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Squamous Cell Carcinoma","conceptCode":"C4028","definition":"A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-6801-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1A4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucin-depleted Adenocarcinoma","valueDescription":"Mucin Depletion Adenocarcinoma","ValueMeaning":{"publicId":"3521939","version":"1","preferredName":"Mucin Depletion Adenocarcinoma","longName":"3521939","preferredDefinition":"A morphologic and histochemical finding indicating depletion of mucin in the glands.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucin Depletion","conceptCode":"C82974","definition":"A morphologic and histochemical finding indicating depletion of mucin in the glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-6828-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1AE-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Prostate Adenocarcinoma Acinar Type","valueDescription":"Acinar Prostate Adenocarcinoma","ValueMeaning":{"publicId":"3686425","version":"1","preferredName":"Acinar Prostate Adenocarcinoma","longName":"3686425","preferredDefinition":"An invasive adenocarcinoma of the prostate gland composed of secretory cells.  It is the most common histologic type of prostate adenocarcinoma.  Several morphologic variants exist, including atrophic, pseudohyperplastic, foamy gland, and oncocytic variants.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Acinar Adenocarcinoma","conceptCode":"C5596","definition":"An invasive adenocarcinoma of the prostate gland composed of secretory cells.  It is the most common histologic type of prostate adenocarcinoma.  Several morphologic variants exist, including atrophic, pseudohyperplastic, foamy gland, and oncocytic variants.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B72A-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1B8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pheochromocytoma","valueDescription":"Adrenal Gland Pheochromocytoma","ValueMeaning":{"publicId":"3210721","version":"1","preferredName":"Adrenal Gland Pheochromocytoma","longName":"3210721","preferredDefinition":"A benign or malignant neuroendocrine neoplasm of the sympathetic nervous system that secretes catecholamines.  It arises from the chromaffin cells of the adrenal medulla.  Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Gland Pheochromocytoma","conceptCode":"C3326","definition":"A neuroendocrine neoplasm of the sympathetic nervous system that arises from the chromaffin cells of the adrenal medulla and secretes catecholamines. Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-943E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1C2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Paraganglioma","valueDescription":"Paraganglioma","ValueMeaning":{"publicId":"3211342","version":"1","preferredName":"Paraganglioma","longName":"3211342","preferredDefinition":"A benign or malignant neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paraganglioma","conceptCode":"C3308","definition":"A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F07D-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1CC-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Papillary Squamous Cell Carcinoma","valueDescription":"Papillary Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3081854","version":"1","preferredName":"Papillary Squamous Cell Carcinoma","longName":"3081854","preferredDefinition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Squamous Cell Carcinoma","conceptCode":"C4102","definition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-46D1-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1D6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Metaplastic Ductal Carcinoma","valueDescription":"Metaplastic Ductal Breast Carcinoma","ValueMeaning":{"publicId":"3686426","version":"1","preferredName":"Metaplastic Ductal Breast Carcinoma","longName":"3686426","preferredDefinition":"Pertaining to or characterized by metaplasia.: A carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma, not otherwise specified.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metaplastic","conceptCode":"C25566","definition":"Pertaining to or characterized by metaplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma","conceptCode":"C4017","definition":"A breast carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast. Ductal carcinomas account for about two thirds of all breast cancers. Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive breast carcinoma of no special type. The latter often spreads to the axillary lymph nodes and other anatomic sites. The two forms of ductal carcinoma often coexist.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B783-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1E0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lung Adenosquamous Carcinoma","valueDescription":"Adenosquamous Carcinoma Lung","ValueMeaning":{"publicId":"3686427","version":"1","preferredName":"Adenosquamous Carcinoma Lung","longName":"3686427","preferredDefinition":"A carcinoma composed of malignant glandular cells and malignant squamous cells. : One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B7A9-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1EA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Liver - Hepatocholangiocarcinoma (mixed)","valueDescription":"Combined Hepatocellular Carcinoma and Cholangiocarcinoma Liver","ValueMeaning":{"publicId":"3686428","version":"1","preferredName":"Combined Hepatocellular Carcinoma and Cholangiocarcinoma Liver","longName":"3686428","preferredDefinition":"A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined Hepatocellular Carcinoma and Cholangiocarcinoma","conceptCode":"C3828","definition":"A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B7CF-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1F4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Liver - Hepatocellular carcinoma","valueDescription":"Hepatocellular Carcinoma Liver","ValueMeaning":{"publicId":"3686429","version":"1","preferredName":"Hepatocellular Carcinoma Liver","longName":"3686429","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma","conceptCode":"C3099","definition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B7F5-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D1FE-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Liver - Fibrolamellar hepatocellular carcinoma","valueDescription":"Fibrolamellar Hepatocellular Carcinoma Liver","ValueMeaning":{"publicId":"3686430","version":"1","preferredName":"Fibrolamellar Hepatocellular Carcinoma Liver","longName":"3686430","preferredDefinition":"Fibrolamellar carcinoma is a distinctive morphologic variant of liver cell carcinoma seen predominantly in young patients without cirrhosis and associated with favorable prognosis.  The tumor cells are polygonal and deeply eosinophilic embedded in a fibrous stroma.  Over half of the fibrolamellar carcinomas are resectable, and the cure rate is about 50%.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrolamellar Carcinoma","conceptCode":"C4131","definition":"A distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients.  The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma.  The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B81B-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D208-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Diffuse malignant mesothelioma -Sarcomatoid","valueDescription":"Diffuse Malignant Mesothelioma, Sarcomatoid","ValueMeaning":{"publicId":"3686399","version":"1","preferredName":"Diffuse Malignant Mesothelioma, Sarcomatoid","longName":"3686399v1.00","preferredDefinition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Mesothelioma","conceptCode":"C45655","definition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Malignant Mesothelioma","conceptCode":"C8420","definition":"A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C75B23-25B9-FC0B-E040-BB89AD436DE2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D212-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Diffuse malignant mesothelioma - NOS","valueDescription":"Diffuse Malignant Mesothelioma, Not Otherwise Specified","ValueMeaning":{"publicId":"3686400","version":"1","preferredName":"Diffuse Malignant Mesothelioma, Not Otherwise Specified","longName":"3686400v1.00","preferredDefinition":"Not characterized in any other way._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Malignant Mesothelioma","conceptCode":"C8420","definition":"A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C75B23-25DF-FC0B-E040-BB89AD436DE2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D21C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Diffuse malignant mesothelioma - Epithelioid","valueDescription":"Diffuse Malignant Mesothelioma, Epithelioid","ValueMeaning":{"publicId":"3686402","version":"1","preferredName":"Diffuse Malignant Mesothelioma, Epithelioid","longName":"3686402v1.00","preferredDefinition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Mesothelioma","conceptCode":"C7985","definition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Malignant Mesothelioma","conceptCode":"C8420","definition":"A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C75B23-2606-FC0B-E040-BB89AD436DE2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D226-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Diffuse malignant mesothelioma - Desmoplastic","valueDescription":"Diffuse Malignant Mesothelioma, Desmoplastic","ValueMeaning":{"publicId":"3686403","version":"1","preferredName":"Diffuse Malignant Mesothelioma, Desmoplastic","longName":"3686403v1.00","preferredDefinition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Mesothelioma","conceptCode":"C6747","definition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Malignant Mesothelioma","conceptCode":"C8420","definition":"A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C75B23-262C-FC0B-E040-BB89AD436DE2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D230-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Infiltrating Carcinoma NOS","valueDescription":"Not Otherwise Specified Invasive Breast Carcinoma","ValueMeaning":{"publicId":"3686271","version":"1","preferredName":"Not Otherwise Specified Invasive Breast Carcinoma","longName":"3686271","preferredDefinition":"Not characterized in any other way.: A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6F8A-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D23A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Classical/Usual (Papillary NOS)","valueDescription":"Thyroid Gland Papillary Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"3686272","version":"1","preferredName":"Thyroid Gland Papillary Carcinoma, Not Otherwise Specified","longName":"3686272","preferredDefinition":"Not characterized in any other way.: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thyroid Gland Papillary Carcinoma","conceptCode":"C4035","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6FB0-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D244-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed Histology (please specify)","valueDescription":"Specify Mixed Histologic Finding","ValueMeaning":{"publicId":"3686273","version":"1","preferredName":"Specify Mixed Histologic Finding","longName":"3686273","preferredDefinition":"Be specific about something; define clearly.: Involving or composed of different kinds.: Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.: Clinical, laboratory or molecular evidence, or absence of evidence of disease. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6FD8-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D24E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Glioblastoma Multiforme (GBM)","valueDescription":"Glioblastoma","ValueMeaning":{"publicId":"3686274","version":"1","preferredName":"Glioblastoma","longName":"3686274","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6FFB-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D258-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Gastrointestinal stromal tumor; malignant","valueDescription":"Malignant Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"3686275","version":"1","preferredName":"Malignant Gastrointestinal Stromal Tumor","longName":"3686275","preferredDefinition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A mesenchymal neoplasm most commonly seen in the gastrointestinal tract. Cases involving tissues outside the gastrointestinal tract have also been reported (extragastrointestinal gastrointestinal stromal tumor). It is a specific KIT-expressing and KIT-signaling-driven mesenchymal tumor. Until recently, surgery has been the only effective therapy for this tumor. However, many patients still experience recurrence. Conventional chemotherapy and radiation therapy have been of limited value. A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-7021-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D262-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Well-differentiated leiomyosarcoma (resembling leiomyoma)","valueDescription":"Well Differentiated Leiomyosarcoma","ValueMeaning":{"publicId":"3686280","version":"1","preferredName":"Well Differentiated Leiomyosarcoma","longName":"3686280","preferredDefinition":"Grade I malignant smooth muscle neoplasm.  It is characterized by a proliferation of neoplastic spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated Leiomyosarcoma","conceptCode":"C9389","definition":"Grade I malignant smooth muscle neoplasm.  It is characterized by a proliferation of neoplastic spindle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-7077-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D26C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS","valueDescription":"Not Otherwise Specified Uterine Carcinosarcoma","ValueMeaning":{"publicId":"3686281","version":"1","preferredName":"Not Otherwise Specified Uterine Carcinosarcoma","longName":"3686281","preferredDefinition":"Not characterized in any other way.: A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uterine Carcinosarcoma","conceptCode":"C42700","definition":"A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-709D-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D276-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Poorly differentiated/ pleomorphic/ epithelioid leiomyosarcoma","valueDescription":"Conventional Leiomyosarcoma Epithelioid Leiomyosarcoma","ValueMeaning":{"publicId":"3686282","version":"1","preferredName":"Conventional Leiomyosarcoma Epithelioid Leiomyosarcoma","longName":"3686282","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.: A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conventional Leiomyosarcoma","conceptCode":"C9428","definition":"An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epithelioid Leiomyosarcoma","conceptCode":"C3700","definition":"A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-70C3-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D280-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Muscle invasive urothelial carcinoma (pT2 or above)","valueDescription":"Bladder Cancer pT2 TNM Finding v7 Urothelial Carcinoma","ValueMeaning":{"publicId":"3686283","version":"1","preferredName":"Bladder Cancer pT2 TNM Finding v7 Urothelial Carcinoma","longName":"3686283","preferredDefinition":"Bladder cancer with tumor invading the muscularis propria. (from AJCC 7th Ed.): A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT2 TNM Finding v7","conceptCode":"C89352","definition":"Bladder cancer with tumor invading the muscularis propria. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-70E9-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D28A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adrenocortical carcinoma- Usual Type","valueDescription":"Well Differentiated Adrenal Cortex Carcinoma","ValueMeaning":{"publicId":"3686286","version":"1","preferredName":"Well Differentiated Adrenal Cortex Carcinoma","longName":"3686286","preferredDefinition":"An adrenal cortex carcinoma characterized by the presence of morphologic and cytologic features reminiscent of the normal adrenal cortex and absence of sarcomatous or anaplastic features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cortical Low Grade Carcinoma","conceptCode":"C68635","definition":"A carcinoma that arises from the adrenal cortex and is characterized by the presence of twenty or less mitoses per ten square millimeters.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-710F-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D294-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adrenocortical Carcinoma- Oncocytic Type","valueDescription":"Adrenal Cortex Carcinoma, Malignant Oncocyte","ValueMeaning":{"publicId":"3686288","version":"1","preferredName":"Adrenal Cortex Carcinoma, Malignant Oncocyte","longName":"3686288v1.00","preferredDefinition":"A malignant epithelial cell with abundant eosinophilic or clear granular cytoplasm._A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Oncocyte","conceptCode":"C36942","definition":"A malignant epithelial cell with abundant eosinophilic or clear granular cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Cortical Carcinoma","conceptCode":"C9325","definition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-7136-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D29E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adrenocortical Carcinoma- Myxoid Type","valueDescription":"Adrenal Cortex Carcinoma, Myxoid Changes Present","ValueMeaning":{"publicId":"3686290","version":"1","preferredName":"Adrenal Cortex Carcinoma, Myxoid Changes Present","longName":"3686290v1.00","preferredDefinition":"A morphologic finding indicating the presence of myxoid changes in a tissue sample._A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoid Changes Present","conceptCode":"C39744","definition":"A morphologic finding indicating the presence of myxoid changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Cortical Carcinoma","conceptCode":"C9325","definition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-715D-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2A8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenosarcoma","valueDescription":"Adenosarcoma","ValueMeaning":{"publicId":"3247916","version":"1","preferredName":"Adenosarcoma","longName":"3247916","preferredDefinition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67B3AED-056E-CE90-E040-BB89AD433EDB","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2B2-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Diffuse malignant mesothelioma - Biphasic","valueDescription":"Diffuse Malignant Mesothelioma, Biphasic","ValueMeaning":{"publicId":"3686375","version":"1","preferredName":"Diffuse Malignant Mesothelioma, Biphasic","longName":"3686375v1.00","preferredDefinition":"A malignant mesothelioma characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphasic Mesothelioma","conceptCode":"C4282","definition":"A malignant mesothelioma characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffuse Malignant Mesothelioma","conceptCode":"C8420","definition":"A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B4F1-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2BC-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Desmoplastic mesothelioma","valueDescription":"Desmoplastic Mesothelioma","ValueMeaning":{"publicId":"3686377","version":"1","preferredName":"Desmoplastic Mesothelioma","longName":"3686377","preferredDefinition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Mesothelioma","conceptCode":"C6747","definition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B517-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2C6-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Conventional leiomyosarcoma","valueDescription":"Conventional Leiomyosarcoma","ValueMeaning":{"publicId":"3521460","version":"1","preferredName":"Conventional Leiomyosarcoma","longName":"3521460","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conventional Leiomyosarcoma","conceptCode":"C9428","definition":"An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4797330-51A6-D51E-E040-BB89AD4357AD","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2D0-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Clear Cell Renal Carcinoma","valueDescription":"Clear Cell Renal Carcinoma","ValueMeaning":{"publicId":"3686378","version":"1","preferredName":"Clear Cell Renal Carcinoma","longName":"3686378","preferredDefinition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.: A carcinoma arising from the epithelium of the renal parenchyma (renal cell carcinoma) or the renal pelvis (renal pelvis carcinoma).  The vast majority of renal cell carcinomas are adenocarcinomas.  The vast majority of renal pelvis carcinomas are transit","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell","conceptCode":"C12478","definition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Kidney Carcinoma","conceptCode":"C9384","definition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B547-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2DA-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Cholangiocarcinoma","valueDescription":"Cholangiocarcinoma","ValueMeaning":{"publicId":"3165468","version":"1","preferredName":"Cholangiocarcinoma","longName":"3165468","preferredDefinition":"An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholangiocarcinoma","conceptCode":"C4436","definition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D7AA2D-09B1-EB1F-E040-BB89AD436E93","latestVersionIndicator":"Yes","beginDate":"2010-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2E4-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Biphasic mesothelioma","valueDescription":"Biphasic Mesothelioma","ValueMeaning":{"publicId":"3686380","version":"1","preferredName":"Biphasic Mesothelioma","longName":"3686380","preferredDefinition":"A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic epithelioid cells and sarcomatoid features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphasic Mesothelioma","conceptCode":"C4282","definition":"A malignant mesothelioma characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B577-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2EE-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Infiltrating Lobular Carcinoma","valueDescription":"Invasive Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2581147","version":"1","preferredName":"Invasive Lobular Breast Carcinoma","longName":"2581147","preferredDefinition":"An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma","conceptCode":"C7950","definition":"An infiltrating lobular adenocarcinoma of the breast.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D2F8-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Infiltrating Ductal Carcinoma","valueDescription":"Invasive Ductal Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"2581223","version":"1","preferredName":"Invasive Ductal Carcinoma, Not Otherwise Specified","longName":"2581223","preferredDefinition":"Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D302-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Head & Neck Squamous Cell Carcinoma Basaloid Type","valueDescription":"Basaloid Head and Neck Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3686404","version":"1","preferredName":"Basaloid Head and Neck Squamous Cell Carcinoma","longName":"3686404","preferredDefinition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.: A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basaloid Squamous Cell Carcinoma","conceptCode":"C54244","definition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Head and Neck Squamous Cell Carcinoma","conceptCode":"C34447","definition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B616-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D30C-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Fibrolamellar hepatocellular carcinoma","valueDescription":"Fibrolamellar Hepatocellular Carcinoma","ValueMeaning":{"publicId":"3165470","version":"1","preferredName":"Fibrolamellar Hepatocellular Carcinoma","longName":"3165470","preferredDefinition":"Fibrolamellar carcinoma is a distinctive morphologic variant of liver cell carcinoma seen predominantly in young patients without cirrhosis and associated with favorable prognosis.  The tumor cells are polygonal and deeply eosinophilic embedded in a fibrous stroma.  Over half of the fibrolamellar carcinomas are resectable, and the cure rate is about 50%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrolamellar Carcinoma","conceptCode":"C4131","definition":"A distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients.  The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma.  The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D7AA2D-09D7-EB1F-E040-BB89AD436E93","latestVersionIndicator":"Yes","beginDate":"2010-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D316-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Epithelioid mesothelioma","valueDescription":"Epithelioid Mesothelioma","ValueMeaning":{"publicId":"3686405","version":"1","preferredName":"Epithelioid Mesothelioma","longName":"3686405","preferredDefinition":"A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Mesothelioma","conceptCode":"C7985","definition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B64F-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D320-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uterine Carcinosarcoma/ MMMT: Heterologous Type","valueDescription":"Malignant Mixed Mesodermal (Mullerian) Tumor Heterologous Elements Present Uterine Carcinosarcoma","ValueMeaning":{"publicId":"3686420","version":"1","preferredName":"Malignant Mixed Mesodermal (Mullerian) Tumor Heterologous Elements Present Uterine Carcinosarcoma","longName":"3686420v1.00","preferredDefinition":"An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements._A morphologic finding indicating the presence of tissues that do not normally occur in the specific anatomic site or are found admixed with a neoplastic cellular infiltrate of a different cellular origin._A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Mixed Mesodermal (Mullerian) Tumor","conceptCode":"C8975","definition":"An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Heterologous Elements Present","conceptCode":"C54559","definition":"A morphologic finding indicating the presence of tissues that do not normally occur in the specific anatomic site or are found admixed with a neoplastic cellular infiltrate of a different cellular origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uterine Carcinosarcoma","conceptCode":"C42700","definition":"A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B686-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D32A-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Untreated primary (de novo) GBM","valueDescription":"Primary Glioblastoma, Untreated","ValueMeaning":{"publicId":"3686421","version":"1","preferredName":"Primary Glioblastoma, Untreated","longName":"3686421","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.: Occurring first in time or sequence; original; of greatest rank or importance or value.: The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Treat","conceptCode":"C70742","definition":"Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B6AE-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D334-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Treated primary GBM","valueDescription":"Primary Glioblastoma, Treated","ValueMeaning":{"publicId":"3686422","version":"1","preferredName":"Primary Glioblastoma, Treated","longName":"3686422","preferredDefinition":"Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.: Occurring first in time or sequence; original; of greatest rank or importance or value.: The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treat","conceptCode":"C70742","definition":"Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B6D5-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D33E-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serous Cystadenocarcinoma","valueDescription":"Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"3438800","version":"1","preferredName":"Serous Cystadenocarcinoma","longName":"3438800","preferredDefinition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Cystadenocarcinoma","conceptCode":"C3778","definition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE0A5415-E62F-6FDD-E040-BB89AD4348BB","latestVersionIndicator":"Yes","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D348-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcomatoid mesothelioma","valueDescription":"Sarcomatoid Mesothelioma","ValueMeaning":{"publicId":"3686423","version":"1","preferredName":"Sarcomatoid Mesothelioma","longName":"3686423","preferredDefinition":"A diffuse malignant mesothelioma arising from the pleura and less often the peritoneum.  It is characterized by the presence of spindle cells.  Anaplastic morphologic features and multinucleated malignant cells may also be seen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Mesothelioma","conceptCode":"C45655","definition":"A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B704-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D352-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoid tumor; typical","valueDescription":"Usual Carcinoid Tumor","ValueMeaning":{"publicId":"3704506","version":"1","preferredName":"Usual Carcinoid Tumor","longName":"3704506","preferredDefinition":"That which is considered customary.: A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis. The tumor may show a variety of patterns, such as solid, trabecular, and acinar. Electron microscopy shows small secretory granules. Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity. Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen. Such cases may have an aggressive clinical course. Gastrointestinal tract and lung are common sites of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Usual","conceptCode":"C102843","definition":"That which is considered customary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D372-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D38B-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoid tumor; NOS","valueDescription":"Not Otherwise Specified Carcinoid Tumor","ValueMeaning":{"publicId":"3704507","version":"1","preferredName":"Not Otherwise Specified Carcinoid Tumor","longName":"3704507","preferredDefinition":"Not characterized in any other way.: A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis. The tumor may show a variety of patterns, such as solid, trabecular, and acinar. Electron microscopy shows small secretory granules. Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity. Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen. Such cases may have an aggressive clinical course. Gastrointestinal tract and lung are common sites of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D398-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D3B1-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoid tumor; atypical","valueDescription":"Atypical Carcinoid Tumor","ValueMeaning":{"publicId":"3248224","version":"1","preferredName":"Atypical Carcinoid Tumor","longName":"3248224","preferredDefinition":"A carcinoid tumor characterized by a high mitotic rate, often associated with the presence of necrosis and nuclear pleomorphism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Tumor G2","conceptCode":"C72074","definition":"A well-differentiated, intermediate-grade epithelial neoplasm with neuroendocrine differentiation. It usually arises from the digestive system, lung, and head and neck.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B537E2-81BD-5E57-E040-BB89AD4339B4","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D3C5-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Brenner tumor; malignant","valueDescription":"Malignant Brenner Tumor","ValueMeaning":{"publicId":"3704508","version":"1","preferredName":"Malignant Brenner Tumor","longName":"3704508","preferredDefinition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A usually benign tumor composed of solid and cystic nests of epithelial cells resembling transitional epithelium; it is surrounded by an abundant stromal component that is dense and fibroblastic in nature.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Brenner Tumor","conceptCode":"C39954","definition":"A tumor composed of solid and cystic nests of neoplastic urothelial-type cells in an abundant stromal component that is dense and fibroblastic in nature. It arises from the ovary and very rarely the paratesticular structures. It includes benign Brenner tumor, borderline Brenner tumor, and malignant Brenner tumor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D3D2-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D3EB-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; mucinous; NOS","valueDescription":"Not Otherwise Specified Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3704509","version":"1","preferredName":"Not Otherwise Specified Mucinous Adenocarcinoma","longName":"3704509","preferredDefinition":"Not characterized in any other way.: An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D3F8-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D411-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; mixed; adenocarcinoma and squamous cell carcinoma","valueDescription":"Mixed Squamous Cell Carcinoma And Adenocarcinoma","ValueMeaning":{"publicId":"3704510","version":"1","preferredName":"Mixed Squamous Cell Carcinoma And Adenocarcinoma","longName":"3704510","preferredDefinition":"Involving or composed of different kinds.: A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D420-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D439-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; mixed","valueDescription":"Mixed Adenocarcinoma","ValueMeaning":{"publicId":"3704511","version":"1","preferredName":"Mixed Adenocarcinoma","longName":"3704511","preferredDefinition":"Involving or composed of different kinds.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D446-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D45F-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; endometrioid; NOS","valueDescription":"Not Otherwise Specified Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"3704512","version":"1","preferredName":"Not Otherwise Specified Endometrioid Adenocarcinoma","longName":"3704512","preferredDefinition":"Not characterized in any other way.: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Endometrioid Adenocarcinoma","conceptCode":"C3769","definition":"An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8FCE429-D46C-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8FCE429-D485-B178-E040-BB89AD430EA5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Malignant Peripheral Nerve Sheath Tumors (MPNST)","valueDescription":"Malignant Peripheral Nerve Sheath Tumor","ValueMeaning":{"publicId":"2838605","version":"1","preferredName":"Malignant Peripheral Nerve Sheath Tumor","longName":"2838605","preferredDefinition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peripheral Nerve Sheath Tumor","conceptCode":"C3798","definition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AE88-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E9D24A-2DC0-8704-E040-BB89AD433527","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uveal Melanoma","valueDescription":"Uveal Melanoma","ValueMeaning":{"publicId":"3251352","version":"1","preferredName":"Uveal Melanoma","longName":"3251352","preferredDefinition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9ECF-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E33C6B79-AEA8-252C-E040-BB89AD43293F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mesothelioma","valueDescription":"Mesothelioma","ValueMeaning":{"publicId":"3210715","version":"1","preferredName":"Mesothelioma","longName":"3210715","preferredDefinition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesothelioma","conceptCode":"C3234","definition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-92FC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E33C6B79-AEB2-252C-E040-BB89AD43293F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Melanoma","valueDescription":"Melanoma","ValueMeaning":{"publicId":"2561514","version":"1","preferredName":"Melanoma","longName":"2561514","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BD57-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-05","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E34ADB0E-E234-65A9-E040-BB89AD433902","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Chondrosarcoma; myxoid","valueDescription":"Adult Myxoid Chondrosarcoma","ValueMeaning":{"publicId":"3704612","version":"1","preferredName":"Adult Myxoid Chondrosarcoma","longName":"3704612","preferredDefinition":"A morphologic variant of chondrosarcoma arising from soft tissue and bone, occurring in adults.  It is characterized by the presence of myxoid stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult Myxoid Chondrosarcoma","conceptCode":"C27378","definition":"A myxoid chondrosarcoma occurring in adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-39E5-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-39FE-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; urothelial; NOS","valueDescription":"Not Otherwise Specified Urothelial Carcinoma","ValueMeaning":{"publicId":"3704613","version":"1","preferredName":"Not Otherwise Specified Urothelial Carcinoma","longName":"3704613","preferredDefinition":"Not characterized in any other way.: A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3A0B-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3A24-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; squamous cell; NOS","valueDescription":"Not Otherwise Specified Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3704615","version":"1","preferredName":"Not Otherwise Specified Squamous Cell Carcinoma","longName":"3704615","preferredDefinition":"Not characterized in any other way.: Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Squamous Cell","conceptCode":"C12849","definition":"Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3A33-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3A4C-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; serous; NOS","valueDescription":"Not Otherwise Specified Serous Carcinoma","ValueMeaning":{"publicId":"3704616","version":"1","preferredName":"Not Otherwise Specified Serous Carcinoma","longName":"3704616","preferredDefinition":"Not characterized in any other way.: Of or producing or containing serum.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Serous","conceptCode":"C14168","definition":"Of or producing or containing serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3A5A-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3A73-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; renal cell; NOS","valueDescription":"Not Otherwise Specified Renal Cell Carcinoma","ValueMeaning":{"publicId":"3704617","version":"1","preferredName":"Not Otherwise Specified Renal Cell Carcinoma","longName":"3704617","preferredDefinition":"Not characterized in any other way.: Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3A80-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3A99-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; papillary; serous surface","valueDescription":"Serous Surface Papillary Carcinoma","ValueMeaning":{"publicId":"3704619","version":"1","preferredName":"Serous Surface Papillary Carcinoma","longName":"3704619","preferredDefinition":"An invasive serous adenocarcinoma arising from the ovary. Cases with identical morphology have been described arising in the peritoneum, almost exclusively in women. Morphologically, it may be a well, moderately, or poorly differentiated neoplasm. It is characterized by a papillary growth pattern often associated with the presence of psammoma bodies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Surface Papillary Carcinoma","conceptCode":"C4182","definition":"An invasive serous adenocarcinoma arising from the ovary and rarely the peritoneum. Morphologically, it may be a well, moderately, or poorly differentiated neoplasm. It is characterized by a papillary growth pattern often associated with the presence of psammoma bodies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3AA6-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3ABF-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; papillary; serous primary; peritoneum","valueDescription":"Peritoneal Papillary Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"3704620","version":"1","preferredName":"Peritoneal Papillary Serous Cystadenocarcinoma","longName":"3704620","preferredDefinition":"Of or pertaining to the peritoneum.: A malignant cystic serous epithelial neoplasm characterized by the presence of malignant glandular epithelial cells forming papillary structures. Stromal invasion is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal","conceptCode":"C25313","definition":"Of or pertaining to the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papillary Serous Cystadenocarcinoma","conceptCode":"C8377","definition":"A malignant cystic serous epithelial neoplasm characterized by the presence of malignant glandular epithelial cells forming papillary structures. Stromal invasion is present.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3ACC-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3AE5-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; papillary; NOS","valueDescription":"Not Otherwise Specified Papillary Carcinoma","ValueMeaning":{"publicId":"3704621","version":"1","preferredName":"Not Otherwise Specified Papillary Carcinoma","longName":"3704621","preferredDefinition":"Not characterized in any other way.: of or relating to or resembling papilla.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Papillary","conceptCode":"C14166","definition":"Of or relating to or resembling papilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3AF3-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B0C-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; NOS","valueDescription":"Not Otherwise Specified Carcinoma","ValueMeaning":{"publicId":"3536390","version":"1","preferredName":"Not Otherwise Specified Carcinoma","longName":"3536390","preferredDefinition":"Not characterized in any other way.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-D07A-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B20-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; neuroendocrine; NOS","valueDescription":"Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"2559503","version":"1","preferredName":"Neuroendocrine Carcinoma","longName":"2559503","preferredDefinition":"A malignant neuroendocrine tumor composed of cells containing secretory granules that stain positive for NSE and chromogranin.  Tumor cells are often round and form clusters or trabecular sheets.  Representative examples are carcinoid tumor, small cell carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B57C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B34-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; mucoepidermoid","valueDescription":"Mucoepidermoid Carcinoma","ValueMeaning":{"publicId":"3704622","version":"1","preferredName":"Mucoepidermoid Carcinoma","longName":"3704622","preferredDefinition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3B3E-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B56-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; mixed; adenocarcinoma and squamous cell","valueDescription":"Adenocarcinoma with Squamous Metaplasia","ValueMeaning":{"publicId":"2837862","version":"1","preferredName":"Adenocarcinoma with Squamous Metaplasia","longName":"2837862","preferredDefinition":"An invasive adenocarcinoma characterized by the presence of focal or extensive transformation of malignant glandular cells to squamous epithelial cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma with Squamous Metaplasia","conceptCode":"C4200","definition":"An invasive adenocarcinoma characterized by the presence of focal or extensive transformation of malignant glandular cells to squamous epithelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4941-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B6B-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; Merkel cell","valueDescription":"Merkel Cell Carcinoma","ValueMeaning":{"publicId":"3210716","version":"1","preferredName":"Merkel Cell Carcinoma","longName":"3210716","preferredDefinition":"A rare malignant cutaneous tumor seen in elderly patients.  Its usual location is on the head, neck and extremities.  The tumor is composed of small round cells with scanty cytoplasm arranged in a trabecular pattern, or in ill-defined nodules or in a diffuse pattern.  The tumor cells contain cytoplasmic membrane-bound dense core granules resembling neurosecretory granules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma","conceptCode":"C9231","definition":"A rare aggressive neuroendocrine carcinoma that usually arises from the skin. Rarely, it arises from extracutaneous sites, including the oral cavity, salivary glands, breast, vulva, and vaginal wall. The tumor is composed of small round cells with scanty cytoplasm. Merkel cell polyomavirus is implicated in the majority of cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-935E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B7F-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; medullary; NOS","valueDescription":"Medullary Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"3248489","version":"1","preferredName":"Medullary Carcinoma, Not Otherwise Specified","longName":"3248489","preferredDefinition":"A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medullary Carcinoma, Not Otherwise Specified","conceptCode":"C66718","definition":"A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-173E-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3B93-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; large cell; NOS","valueDescription":"Not Otherwise Specified Large Cell Carcinoma","ValueMeaning":{"publicId":"3704623","version":"1","preferredName":"Not Otherwise Specified Large Cell Carcinoma","longName":"3704623","preferredDefinition":"Not characterized in any other way.: These represent the least common histologic subtype of lung cancers comprising approximately 15% of all lung cancers.  The frequency is decreasing with improved classification through refined histopathological analysis of these tumors as poorly differentiated squamous cell carcinomas or adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Large Cell Carcinoma","conceptCode":"C3780","definition":"A malignant epithelial neoplasm composed of large, atypical cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3BA0-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3BB9-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; large cell; neuroendocrine","valueDescription":"Large Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"2838592","version":"1","preferredName":"Large Cell Neuroendocrine Carcinoma","longName":"2838592","preferredDefinition":"A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A5F1C9-F794-B082-E040-BB89AD436154","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"COOPERM","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3BCD-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; intracystic; NOS","valueDescription":"Not Otherwise Specified Intracystic Papillary Breast Carcinoma","ValueMeaning":{"publicId":"3704624","version":"1","preferredName":"Not Otherwise Specified Intracystic Papillary Breast Carcinoma","longName":"3704624","preferredDefinition":"Not characterized in any other way.: An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Intracystic Papillary Carcinoma","conceptCode":"C7645","definition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3BDA-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3BF3-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; granulosa cell","valueDescription":"Granulosa Cell Tumor","ValueMeaning":{"publicId":"2567190","version":"1","preferredName":"Granulosa Cell Tumor","longName":"2567190","preferredDefinition":"A slow-growing, malignant tumor, characterize by the presence of granulosa-like cells and Call-Exner bodies, that is almost always found in the ovary. In rare cases, it has also been found in the testicle.  There are two types of granulosa cell tumor that can be distinguished under the microscope: the adult and the juvenile.  The testicular juvenile granulosa cell tumors are perhaps the most common congenital testicular neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulosa Cell Tumor","conceptCode":"C3070","definition":"A slow-growing sex cord-stromal tumor characterized by the presence of granulosa-like cells and Call-Exner bodies. It is almost always found in the ovary and rarely in the testis. There are two types of granulosa cell tumors: the adult and the juvenile.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D383-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3C07-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; follicular; NOS","valueDescription":"Thyroid Gland Follicular Carcinoma","ValueMeaning":{"publicId":"3248467","version":"1","preferredName":"Thyroid Gland Follicular Carcinoma","longName":"3248467","preferredDefinition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterise the thyroid gland papillary carcinoma are absent.  It is linked to radiation and comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound and fine needle biopsy. Treatment options include: partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Follicular Carcinoma","conceptCode":"C8054","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterize the thyroid gland papillary carcinoma are absent.  Radiation exposure is a risk factor and it comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B722DF-A826-76E3-E040-BB89AD43333E","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3C1B-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; clear cell","valueDescription":"Clear Cell Carcinoma","ValueMeaning":{"publicId":"3704625","version":"1","preferredName":"Clear Cell Carcinoma","longName":"3704625","preferredDefinition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell","conceptCode":"C12478","definition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3C28-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3C41-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; basal cell; NOS","valueDescription":"Not Otherwise Specified Basal Cell Carcinoma","ValueMeaning":{"publicId":"3704626","version":"1","preferredName":"Not Otherwise Specified Basal Cell Carcinoma","longName":"3704626","preferredDefinition":"Not characterized in any other way.: Basal cell carcinoma is the most frequently seen skin cancer.  It arises from basal cells of the epidermis and pilosebaceous units.  Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like.. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities.  Basal cell carcinoma usually grows in a slow and indolent fashion.  However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone.  Distant metastases are rare.  Excision, curettage and  irradiation cure most basal cell carcinomas. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Basal Cell Carcinoma","conceptCode":"CL066969","definition":"Basal cell carcinoma is the most frequently seen skin cancer.  It arises from basal cells of the epidermis and pilosebaceous units.  Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like.. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities.  Basal cell carcinoma usually grows in a slow and indolent fashion.  However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone.  Distant metastases are rare.  Excision, curettage and  irradiation cure most basal cell carcinomas. --2002","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3C4E-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3C67-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; anaplastic; NOS","valueDescription":"Not Otherwise Specified Undifferentiated Carcinoma","ValueMeaning":{"publicId":"3704627","version":"1","preferredName":"Not Otherwise Specified Undifferentiated Carcinoma","longName":"3704627","preferredDefinition":"Not characterized in any other way.: A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Undifferentiated Carcinoma","conceptCode":"C3692","definition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3C74-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3C8D-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; adenosquamous","valueDescription":"Adenosquamous Carcinoma","ValueMeaning":{"publicId":"2836818","version":"1","preferredName":"Adenosquamous Carcinoma","longName":"2836818","preferredDefinition":"A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62470ADA-0687-83FB-E040-BB89AD436FBF","latestVersionIndicator":"Yes","beginDate":"2009-02-06","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-06","modifiedBy":"ONEDATA","dateModified":"2009-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D902E31D-3CA1-5153-E040-BB89AD437E3A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Germ cell tumor; non-seminomatous","valueDescription":"Testicular Non-Seminomatous Germ Cell Tumor","ValueMeaning":{"publicId":"2986280","version":"1","preferredName":"Testicular Non-Seminomatous Germ Cell Tumor","longName":"2986280","preferredDefinition":"A testicular germ cell tumor characterized by the absence of a seminomatous component. It includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed forms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Non-Seminomatous Germ Cell Tumor","conceptCode":"C9313","definition":"A testicular germ cell tumor characterized by the absence of a seminomatous component. It includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed forms.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D112249-868A-E0FD-E040-BB89AD432FCB","latestVersionIndicator":"Yes","beginDate":"2010-01-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DEFAFE3B-2680-8D7D-E040-BB89AD4368D0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-12","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Germ cell tumor; mixed","valueDescription":"Mixed Germ Cell Tumor","ValueMeaning":{"publicId":"3249742","version":"1","preferredName":"Mixed Germ Cell Tumor","longName":"3249742","preferredDefinition":"A malignant germ cell tumor characterized by the presence of at least two different germ cell components. The different germ cell components include choriocarcinoma, embryonal carcinoma, yolk sac tumor, teratoma, and seminoma. It occurs in the ovary, testis, and extragonadal sites including central nervous system and mediastinum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Germ Cell Tumor","conceptCode":"C4290","definition":"A malignant germ cell tumor characterized by the presence of at least two different germ cell tumor components. The different germ cell tumor components include choriocarcinoma, embryonal carcinoma, yolk sac tumor, teratoma, and seminoma. It occurs in the ovary, testis, and extragonadal sites including central nervous system and mediastinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-39AC-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DEFAFE3B-2695-8D7D-E040-BB89AD4368D0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-12","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Fibrosarcoma; NOS","valueDescription":"Not Otherwise Specified Fibrosarcoma","ValueMeaning":{"publicId":"3783687","version":"1","preferredName":"Not Otherwise Specified Fibrosarcoma","longName":"3783687","preferredDefinition":"Not characterized in any other way.: A malignant mesenchymal tumor affecting soft tissues and bone. It is classified as adult or infantile.  Infantile fibrosarcomas generally have a much more favorable prognosis than adult fibrosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fibrosarcoma","conceptCode":"C3043","definition":"A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DEFAFE3B-26A2-8D7D-E040-BB89AD4368D0","latestVersionIndicator":"Yes","beginDate":"2013-06-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DEFAFE3B-26BB-8D7D-E040-BB89AD4368D0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-12","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Ependymoma; NOS","valueDescription":"Not Otherwise Specified Ependymoma","ValueMeaning":{"publicId":"2861350","version":"1","preferredName":"Not Otherwise Specified Ependymoma","longName":"2861350","preferredDefinition":"Not characterized in any other way.: Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ependymoma","conceptCode":"C3017","definition":"A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67AE3308-C85A-84F3-E040-BB89AD437839","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DEFAFE3B-26CF-8D7D-E040-BB89AD4368D0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-12","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Giant cell 'MFH' / Undifferentiated pleomorphic sarcoma with giant cells","valueDescription":"Giant Cell Fibrous Histiocytoma","ValueMeaning":{"publicId":"3836181","version":"1","preferredName":"Giant Cell Fibrous Histiocytoma","longName":"3836181","preferredDefinition":"An undifferentiated pleomorphic sarcoma characterized by the presence of osteoclast-like giant cells and cellular pleomorphism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells","conceptCode":"C8380","definition":"An undifferentiated pleomorphic sarcoma characterized by the presence of osteoclast-like giant cells and cellular pleomorphism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2E9D24A-2D6D-8704-E040-BB89AD433527","latestVersionIndicator":"Yes","beginDate":"2013-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E451866D-E46E-A450-E040-BB89AD43701A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma","valueDescription":"Storiform-Pleomorphic Malignant Fibrous Histiocytoma","ValueMeaning":{"publicId":"3179380","version":"1","preferredName":"Storiform-Pleomorphic Malignant Fibrous Histiocytoma","longName":"3179380","preferredDefinition":"A morphologic variant of malignant fibrous histiocytoma. It is well-circumscribed tumor characterized by the presence of bizarre giant cells, spindle cells, round histiocyte-like cells, stromal chronic inflammatory cells, and nuclear pleomorphism in a prominent storiform pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Storiform-Pleomorphic Malignant Fibrous Histiocytoma","conceptCode":"C6495","definition":"A well-circumscribed sarcoma characterized by the presence of bizarre giant cells, spindle cells, round histiocyte-like cells, stromal chronic inflammatory cells, and nuclear pleomorphism in a prominent storiform pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98903582-4FB1-C5EF-E040-BB89AD431B68","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E451866D-E482-A450-E040-BB89AD43701A","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Desmoid Tumor","valueDescription":"Deep Fibromatosis/Desmoid Tumor","ValueMeaning":{"publicId":"3249213","version":"1","preferredName":"Deep Fibromatosis/Desmoid Tumor","longName":"3249213","preferredDefinition":"An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoid Fibromatosis","conceptCode":"C9182","definition":"An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1C19-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E8B052-357A-E7A7-E040-BB89AD43282F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Synovial Sarcoma - Biphasic","valueDescription":"Biphasic Synovial Sarcoma","ValueMeaning":{"publicId":"3835971","version":"1","preferredName":"Biphasic Synovial Sarcoma","longName":"3835971","preferredDefinition":"A synovial sarcoma characterized by the presence of both an epithelial and a spindle cell component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphasic Synovial Sarcoma","conceptCode":"C4279","definition":"A synovial sarcoma characterized by the presence of both an epithelial and a spindle cell component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2E8B052-3587-E7A7-E040-BB89AD43282F","latestVersionIndicator":"Yes","beginDate":"2013-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E8B052-35A0-E7A7-E040-BB89AD43282F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Synovial Sarcoma - Monophasic","valueDescription":"Monophasic Synovial Sarcoma","ValueMeaning":{"publicId":"3785903","version":"1","preferredName":"Monophasic Synovial Sarcoma","longName":"3785903","preferredDefinition":"A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monophasic Synovial Sarcoma","conceptCode":"C6534","definition":"A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF0AC481-079C-CBF9-E040-BB89AD434A4F","latestVersionIndicator":"Yes","beginDate":"2013-06-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E8B052-35B4-E7A7-E040-BB89AD43282F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Myxofibrosarcoma","valueDescription":"Myxofibrosarcoma","ValueMeaning":{"publicId":"3179361","version":"1","preferredName":"Myxofibrosarcoma","longName":"3179361","preferredDefinition":"A spectrum of malignant mesenchymal neoplasms arising from the soft tissues. It is characterized by the presence of spindle-shaped malignant cells, nuclear pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxofibrosarcoma","conceptCode":"C6496","definition":"A malignant fibroblastic neoplasm arising from the soft tissue. It is characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-860F-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E8B052-35BE-E7A7-E040-BB89AD43282F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Synovial Sarcoma","valueDescription":"Poorly Differentiated Synovial Sarcoma","ValueMeaning":{"publicId":"3835972","version":"1","preferredName":"Poorly Differentiated Synovial Sarcoma","longName":"3835972","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2E8B052-35CB-E7A7-E040-BB89AD43282F","latestVersionIndicator":"Yes","beginDate":"2013-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2E8B052-35E4-E7A7-E040-BB89AD43282F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thymoma; Type B1","valueDescription":"Thymoma Type B1","ValueMeaning":{"publicId":"4039064","version":"1","preferredName":"Thymoma Type B1","longName":"4039064","preferredDefinition":"A thymic epithelial neoplasm characterized by the presence of expanded areas which resemble the normal thymic cortex. The neoplastic epithelial cells are small and scant and there is a dense T-lymphocytic component present. Areas of medullary differentiation with or without Hassall's corpuscles are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It has a low grade malignant potential. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma Type B1","conceptCode":"C6887","definition":"A thymic epithelial neoplasm characterized by the presence of expanded areas which resemble the normal thymic cortex. The neoplastic epithelial cells are small and scant and there is a dense T-lymphocytic component present. Areas of medullary differentiation with or without Hassall's corpuscles are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It has a low grade malignant potential. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-66E4-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-66FD-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thymoma; Type AB","valueDescription":"Thymoma Type AB","ValueMeaning":{"publicId":"4039066","version":"1","preferredName":"Thymoma Type AB","longName":"4039066","preferredDefinition":"A thymic epithelial neoplasm characterized by the presence of a lymphocyte-poor component similar to that seen in type A thymoma and a lymphocyte-rich component which contains neoplastic small polygonal epithelial cells. It may be associated with myasthenia gravis and pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II or stage III tumors. The overall survival is reported to be 80-100% at 5 and 10 years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma Type AB","conceptCode":"C6885","definition":"A thymic epithelial neoplasm characterized by the presence of a lymphocyte-poor component similar to that seen in type A thymoma and a lymphocyte-rich component which contains neoplastic small polygonal epithelial cells. It may be associated with myasthenia gravis and pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II or stage III tumors. The overall survival is reported to be 80-100% at 5 and 10 years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-670A-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6723-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thymoma; Type A","valueDescription":"Thymoma Type A","ValueMeaning":{"publicId":"4039068","version":"1","preferredName":"Thymoma Type A","longName":"4039068","preferredDefinition":"A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma Type A","conceptCode":"C6454","definition":"A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-6730-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6749-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sarcoma; synovial; poorly differentiated","valueDescription":"Poorly Differentiated Synovial Sarcoma","ValueMeaning":{"publicId":"3835972","version":"1","preferredName":"Poorly Differentiated Synovial Sarcoma","longName":"3835972","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2E8B052-35CB-E7A7-E040-BB89AD43282F","latestVersionIndicator":"Yes","beginDate":"2013-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-675D-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Paraganglioma; Extra-adrenal Pheochromocytoma","valueDescription":"Extra-Adrenal Paraganglioma","ValueMeaning":{"publicId":"4039070","version":"1","preferredName":"Extra-Adrenal Paraganglioma","longName":"4039070","preferredDefinition":"A benign or malignant paraganglioma arising from sympathetic or parasympathetic paraganglia outside the adrenal gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extra-Adrenal Paraganglioma","conceptCode":"C3309","definition":"A paraganglioma arising from sympathetic or parasympathetic paraganglia outside the adrenal gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-676A-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6783-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-Seminoma; Yolk Sac Tumor","valueDescription":"Testicular Yolk Sac Tumor","ValueMeaning":{"publicId":"3895704","version":"1","preferredName":"Testicular Yolk Sac Tumor","longName":"3895704","preferredDefinition":"A non-seminomatous malignant germ cell tumor arising from the testis.  It affects infants, young children, and postpubertal males.  It is the most frequently seen testicular neoplasm during childhood.  The vast majority of patients present with an asymptomatic scrotal mass.  The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP).  It metastasizes to distant anatomic sites.  Prognostic factors relate to the clinical stage and the degree of AFP elevation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Yolk Sac Tumor","conceptCode":"C8000","definition":"A non-seminomatous malignant germ cell tumor arising from the testis.  It affects infants, young children, and postpubertal males.  It is the most frequently seen testicular neoplasm during childhood.  The vast majority of patients present with an asymptomatic scrotal mass.  The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP).  It metastasizes to distant anatomic sites.  Prognostic factors relate to the clinical stage and the degree of AFP elevation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6374574-943A-5E51-E040-BB89AD431AE9","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6797-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-Seminoma; Teratoma (Mature)","valueDescription":"Mature Testicular Teratoma","ValueMeaning":{"publicId":"3895702","version":"1","preferredName":"Mature Testicular Teratoma","longName":"3895702","preferredDefinition":"A teratoma that arises from the testis and is composed of well differentiated, adult-type tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Mature Teratoma","conceptCode":"C6355","definition":"A teratoma that arises from the testis and is composed of well differentiated, adult-type tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6374574-9414-5E51-E040-BB89AD431AE9","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-67AB-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-Seminoma; Teratoma (Immature)","valueDescription":"Immature Testicular Teratoma","ValueMeaning":{"publicId":"3895700","version":"1","preferredName":"Immature Testicular Teratoma","longName":"3895700","preferredDefinition":"A teratoma that arises from the testis and is composed of immature, fetal type-tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Immature Teratoma","conceptCode":"C6353","definition":"An immature teratoma that arises from the testis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6374574-93EE-5E51-E040-BB89AD431AE9","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-67BF-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-Seminoma; Embryonal Carcinoma","valueDescription":"Testicular Embryonal Carcinoma","ValueMeaning":{"publicId":"3895706","version":"1","preferredName":"Testicular Embryonal Carcinoma","longName":"3895706","preferredDefinition":"A malignant germ cell neoplasm arising from the testis.  It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations.  Most patients present with a testicular mass, which may be associated with pain.  More than half of the patients have metastatic disease at diagnosis.  The form of treatment following radical orchiectomy is stage dependent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Embryonal Carcinoma","conceptCode":"C6341","definition":"A malignant germ cell neoplasm arising from the testis.  It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations.  Most patients present with a testicular mass, which may be associated with pain.  More than half of the patients have metastatic disease at diagnosis.  The form of treatment following radical orchiectomy is stage dependent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6374574-9460-5E51-E040-BB89AD431AE9","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-67D3-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-Seminoma; Choriocarcinoma","valueDescription":"Testicular Choriocarcinoma","ValueMeaning":{"publicId":"3895708","version":"1","preferredName":"Testicular Choriocarcinoma","longName":"3895708","preferredDefinition":"A malignant germ cell tumor arising from the testis.  It represents the rarest of the testicular germ cell tumors. Histologically it is characterized by the presence of syncytiotrophoblasts and cytotrophoblasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Choriocarcinoma","conceptCode":"C7733","definition":"A malignant germ cell tumor arising from the testis.  It represents the rarest of the testicular germ cell tumors. Histologically it is characterized by the presence of syncytiotrophoblasts and cytotrophoblasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6374574-9486-5E51-E040-BB89AD431AE9","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-67E7-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Cholangiocarcinoma; intrahepatic","valueDescription":"Intrahepatic Cholangiocarcinoma","ValueMeaning":{"publicId":"3248570","version":"1","preferredName":"Intrahepatic Cholangiocarcinoma","longName":"3248570","preferredDefinition":"A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree.  Grossly, the malignant lesions are solid, nodular, and grayish.  Morphologically, the vast majority of cases are adenocarcinomas.  Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats.  Early detection is difficult and the prognosis is generally poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic Cholangiocarcinoma","conceptCode":"C35417","definition":"A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree.  Grossly, the malignant lesions are solid, nodular, and grayish.  Morphologically, the vast majority of cases are adenocarcinomas.  Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats.  Early detection is difficult and the prognosis is generally poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BE25-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-680F-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Cholangiocarcinoma; hilar/perihilar","valueDescription":"Hilar Cholangiocarcinoma","ValueMeaning":{"publicId":"3211149","version":"1","preferredName":"Hilar Cholangiocarcinoma","longName":"3211149","preferredDefinition":"A cholangiocarcinoma arising from the hilar ducts located at the hilar area of the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hilar Cholangiocarcinoma","conceptCode":"C36077","definition":"A carcinoma that arises from the junction, or adjacent to the junction, of the right and left hepatic ducts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D4CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6823-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Cholangiocarcinoma; distal","valueDescription":"Distal Bile Duct Carcinoma","ValueMeaning":{"publicId":"4039072","version":"1","preferredName":"Distal Bile Duct Carcinoma","longName":"4039072","preferredDefinition":"A carcinoma that arises from the distal part of the extrahepatic bile duct.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Distal Bile Duct Carcinoma","conceptCode":"C7109","definition":"A carcinoma that arises from the common bile duct distal to the insertion of the cystic duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-6831-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-684A-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; Solid Pattern Predominant","valueDescription":"Solid Growth Pattern Adenocarcinoma","ValueMeaning":{"publicId":"4039073","version":"1","preferredName":"Solid Growth Pattern Adenocarcinoma","longName":"4039073","preferredDefinition":"A microscopic finding indicating that the neoplastic cells are arranged in solid sheets in a tumor sample.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Growth Pattern","conceptCode":"C36182","definition":"A microscopic finding indicating that the neoplastic cells are arranged in solid sheets in a tumor sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-6857-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6870-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; serous","valueDescription":"Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"3438800","version":"1","preferredName":"Serous Cystadenocarcinoma","longName":"3438800","preferredDefinition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Cystadenocarcinoma","conceptCode":"C3778","definition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE0A5415-E62F-6FDD-E040-BB89AD4348BB","latestVersionIndicator":"Yes","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"ONEDATA","dateModified":"2012-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6884-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; papillary","valueDescription":"Papillary Adenocarcinoma","ValueMeaning":{"publicId":"3251702","version":"1","preferredName":"Papillary Adenocarcinoma","longName":"3251702","preferredDefinition":"A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Adenocarcinoma","conceptCode":"C2853","definition":"A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D53F-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6898-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma; clear cell","valueDescription":"Clear Cell Adenocarcinoma","ValueMeaning":{"publicId":"4039074","version":"1","preferredName":"Clear Cell Adenocarcinoma","longName":"4039074","preferredDefinition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-68A2-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-68BA-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Inflammatory 'MFH' / Undifferentiated pleomorphic sarcoma with prominent inflammation","valueDescription":"Inflammatory Malignant Fibrous Histiocytoma","ValueMeaning":{"publicId":"3836183","version":"1","preferredName":"Inflammatory Malignant Fibrous Histiocytoma","longName":"3836183","preferredDefinition":"An aggressive sarcoma characterized by the presence of occasional atypical cells which are admixed with numerous inflammatory cells.  The most common site of involvement is the retroperitoneum. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant","conceptCode":"C6497","definition":"An undifferentiated pleomorphic sarcoma characterized by the presence of numerous inflammatory cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2E9D24A-2D93-8704-E040-BB89AD433527","latestVersionIndicator":"Yes","beginDate":"2013-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFEEF4D-3A93-04E6-E040-BB89AD431C23","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uterine Carcinosarcoma/MMMT: Homologous Type","valueDescription":"Uterine Carcinosarcoma, Homologous Type","ValueMeaning":{"publicId":"4039058","version":"1","preferredName":"Uterine Carcinosarcoma, Homologous Type","longName":"4039058","preferredDefinition":"A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements that arise from the tissues of the uterus.: An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Carcinosarcoma, Homologous Type","conceptCode":"C113238","definition":"A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements that arise from the tissues of the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Mixed Mesodermal (Mullerian) Tumor","conceptCode":"C8975","definition":"An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-665E-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-6677-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thymoma; Type C","valueDescription":"Thymic Carcinoma","ValueMeaning":{"publicId":"3248551","version":"1","preferredName":"Thymic Carcinoma","longName":"3248551","preferredDefinition":"A diverse group of carcinomas of the thymus gland, previously known as thymoma type C (WHO-1999).  It includes morphologic variants derived from purely epithelial cells, as well as from cells with neuroendocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymic Carcinoma","conceptCode":"C7569","definition":"A diverse group of carcinomas of the thymus gland, previously known as thymoma type C.  It includes morphologic variants derived from purely epithelial cells, as well as from cells with neuroendocrine differentiation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BBF6-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-668B-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thymoma; Type B3","valueDescription":"Thymoma Type B3","ValueMeaning":{"publicId":"4039060","version":"1","preferredName":"Thymoma Type B3","longName":"4039060","preferredDefinition":"Also known as well-differentiated thymic carcinoma, atypical thymoma, or epithelial thymoma, this type of thymoma displays morphologic characteristics of a well-differentiated carcinoma.  The majority of cases occur in the anterior mediastinum as Masaoka stage II or stage III tumors.  It is almost always invasive, it recurs frequently, and metastasizes in approximately 20% of the cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma Type B3","conceptCode":"C7997","definition":"Also known as well-differentiated thymic carcinoma, atypical thymoma, or epithelial thymoma, this type of thymoma displays morphologic characteristics of a well-differentiated carcinoma.  The majority of cases occur in the anterior mediastinum as Masaoka stage II or stage III tumors.  It is almost always invasive, it recurs frequently, and metastasizes in approximately 20% of the cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-6698-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-66B1-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Thymoma; Type B2","valueDescription":"Thymoma Type B2","ValueMeaning":{"publicId":"4039062","version":"1","preferredName":"Thymoma Type B2","longName":"4039062","preferredDefinition":"A thymic epithelial neoplasm characterized by the presence of neoplastic large, polygonal epithelial cells with large vesicular nuclei and prominent nucleoli. The neoplastic cells are arranged around perivascular spaces and along septa. Immature T-lymphocytes are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It is a tumor of moderate malignancy. The majority of cases occur in the anterior mediastinum as Masaoka stage I, stage II, or stage III tumors. Metastatic, stage IV tumors occur less frequently.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma Type B2","conceptCode":"C6888","definition":"A thymic epithelial neoplasm characterized by the presence of neoplastic large, polygonal epithelial cells with large vesicular nuclei and prominent nucleoli. The neoplastic cells are arranged around perivascular spaces and along septa. Immature T-lymphocytes are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It is a tumor of moderate malignancy. The majority of cases occur in the anterior mediastinum as Masaoka stage I, stage II, or stage III tumors. Metastatic, stage IV tumors occur less frequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-66BE-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEFFA5EA-66D7-E8CD-E040-BB89AD4345DA","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Not applicable - liquid tumor","valueDescription":"Not Applicable Liquid Tumor","ValueMeaning":{"publicId":"4419915","version":"1","preferredName":"Not Applicable Liquid Tumor","longName":"4419915","preferredDefinition":"Determination of a value is not relevant in the current context.: A malignant tumor that originates from myeloid or lymphoid cells i.e., leukemias and lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Liquid Tumor","conceptCode":"C116915","definition":"A malignant tumor that originates from myeloid or lymphoid cells i.e., leukemias and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF6EB603-0D7C-3DD7-E040-BB89AD4370CB","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF6EB603-0D95-3DD7-E040-BB89AD4370CB","beginDate":"2019-06-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Not Applicable (no minor component)","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"2838911","version":"1","preferredName":"Not Applicable","longName":"2838911","preferredDefinition":"Determination that a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62AB59ED-A641-4EBE-E040-BB89AD4348C8","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"CLOHNES","dateModified":"2022-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0358DC9B-ACB5-1A66-E050-BB89AD435E2F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-18","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Epithelioid Cell","valueDescription":"Epithelioid Cell Melanoma","ValueMeaning":{"publicId":"3729982","version":"1","preferredName":"Epithelioid Cell Melanoma","longName":"3729982","preferredDefinition":"A melanoma characterized by the presence of malignant large epithelioid melanocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Cell Melanoma","conceptCode":"C4236","definition":"A melanoma characterized by the presence of malignant large epithelioid melanocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB36A402-8E6F-DCBB-E040-BB89AD436B1E","latestVersionIndicator":"Yes","beginDate":"2013-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"044E8618-6510-5413-E050-BB89AD43644B","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-30","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Spindle Cell","valueDescription":"Spindle Cell Melanoma","ValueMeaning":{"publicId":"3729980","version":"1","preferredName":"Spindle Cell Melanoma","longName":"3729980","preferredDefinition":"A melanoma characterized by the presence of malignant spindle-shaped melanocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spindle Cell Melanoma","conceptCode":"C4237","definition":"A melanoma characterized by the presence of malignant spindle-shaped melanocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB36A402-8E49-DCBB-E040-BB89AD436B1E","latestVersionIndicator":"Yes","beginDate":"2013-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"044E8618-6524-5413-E050-BB89AD43644B","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-09-30","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach, Intestinal Adenocarcinoma, Mucinous Type","valueDescription":"Mucinous Gastric Adenocarcinoma","ValueMeaning":{"publicId":"3206058","version":"1","preferredName":"Mucinous Gastric Adenocarcinoma","longName":"3206058","preferredDefinition":"A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Mucinous Adenocarcinoma","conceptCode":"C5248","definition":"A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-5001-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03EC2BB0-AD87-8121-E050-BB89AD43258D","beginDate":"2019-06-05","endDate":null,"createdBy":"DWARZEL","dateCreated":"2014-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Stomach, Intestinal Adenocarcinoma, Papillary Type","valueDescription":"Gastric Papillary Adenocarcinoma","ValueMeaning":{"publicId":"3206060","version":"1","preferredName":"Gastric Papillary Adenocarcinoma","longName":"3206060","preferredDefinition":"A variant of gastric adenocarcinoma with exophytic growth and elongated finger-like processes lined by cylindrical or cuboidal cells supported by fibrovascular connective tissue cores.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Papillary Adenocarcinoma","conceptCode":"C5472","definition":"A variant of gastric adenocarcinoma with exophytic growth and elongated finger-like processes lined by cylindrical or cuboidal cells supported by fibrovascular connective tissue cores.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-5027-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03EC2BB0-AD9B-8121-E050-BB89AD43258D","beginDate":"2019-06-05","endDate":null,"createdBy":"DWARZEL","dateCreated":"2014-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Other Epithelial Tumor","valueDescription":"Other Carcinoma In Situ","ValueMeaning":{"publicId":"4928859","version":"1","preferredName":"Other Carcinoma In Situ","longName":"4928859","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E520-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E539-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenoid Basal Carcinoma","valueDescription":"Cervical Adenoid Basal Carcinoma","ValueMeaning":{"publicId":"4928860","version":"1","preferredName":"Cervical Adenoid Basal Carcinoma","longName":"4928860","preferredDefinition":"A rare, low grade carcinoma that arises from the cervix. It is characterized by the presence of nests of basaloid cells with focal glandular formations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Adenoid Basal Carcinoma","conceptCode":"C40213","definition":"A rare low grade carcinoma that arises from the cervix. It is characterized by the presence of nests of basaloid cells with focal glandular formations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E543-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E55C-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenoid Cystic Carcinoma","valueDescription":"Adenoid Cystic Carcinoma","ValueMeaning":{"publicId":"4264017","version":"1","preferredName":"Adenoid Cystic Carcinoma","longName":"4264017","preferredDefinition":"A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenoid Cystic Carcinoma","conceptCode":"C2970","definition":"A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-11C3-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E570-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Glassy Cell Carcinoma","valueDescription":"Glassy Cell Carcinoma","ValueMeaning":{"publicId":"3536384","version":"1","preferredName":"Glassy Cell Carcinoma","longName":"3536384","preferredDefinition":"A malignant epithelial neoplasm composed of atypical cells with glassy cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glassy Cell Carcinoma","conceptCode":"C65159","definition":"A malignant epithelial neoplasm composed of atypical cells with glassy cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-CF6D-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E57B-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous (Colloid) Adenocarcinoma","valueDescription":"Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"2838623","version":"1","preferredName":"Mucinous Adenocarcinoma","longName":"2838623","preferredDefinition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6E019-596B-F2F6-E040-BB89AD4350E9","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"HARTLEYG","dateModified":"2017-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E586-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma; Squamotransitional","valueDescription":"Cervical Squamotransitional Carcinoma","ValueMeaning":{"publicId":"4928861","version":"1","preferredName":"Cervical Squamotransitional Carcinoma","longName":"4928861","preferredDefinition":"A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of papillary structures with fibrovascular cores. It is covered with multiple layers of atypical cells that resemble cervical intraepithelial neoplasia 3.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Squamotransitional Carcinoma","conceptCode":"C40194","definition":"A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of papillary structures with fibrovascular cores. It is covered with multiple layers of atypical cells that resemble cervical intraepithelial neoplasia 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E590-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E5A9-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma; Lymphoepithelioma-like","valueDescription":"Cervical Lymphoepithelioma-Like Carcinoma","ValueMeaning":{"publicId":"4928862","version":"1","preferredName":"Cervical Lymphoepithelioma-Like Carcinoma","longName":"4928862","preferredDefinition":"A variant of cervical squamous cell carcinoma characterized by the presence of islands of cells with uniform, vesicular nuclei and prominent nucleoli and a dense lymphocytic infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Lymphoepithelioma-Like Carcinoma","conceptCode":"C40193","definition":"A variant of cervical squamous cell carcinoma characterized by the presence of islands of cells with uniform, vesicular nuclei and prominent nucleoli and a dense lymphocytic infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E5B3-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E5CC-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma; Warty","valueDescription":"Cervical Warty Carcinoma","ValueMeaning":{"publicId":"4928864","version":"1","preferredName":"Cervical Warty Carcinoma","longName":"4928864","preferredDefinition":"A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of a warty surface and koilocytotic atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Warty Carcinoma","conceptCode":"C40191","definition":"A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of a warty surface and koilocytotic atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E5D9-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E5F2-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma; Verrucous","valueDescription":"Verrucous Carcinoma","ValueMeaning":{"publicId":"4928866","version":"1","preferredName":"Verrucous Carcinoma","longName":"4928866","preferredDefinition":"A well differentiated squamous cell carcinoma characterized by a papillary growth pattern, acanthosis, mild cytologic atypia, and pushing tumor margins. The most commonly affected anatomic sites are the oral cavity, nasal cavity, larynx, esophagus, anus, vagina, vulva, and the plantar region of the foot.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Verrucous Carcinoma","conceptCode":"C3781","definition":"A well differentiated squamous cell carcinoma characterized by a papillary growth pattern, acanthosis, mild cytologic atypia, and pushing tumor margins. The most commonly affected anatomic sites are the oral cavity, nasal cavity, larynx, esophagus, anus, vagina, vulva, and the plantar region of the foot.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E5FF-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E618-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma; Non-Keratinizing","valueDescription":"Non-Keratinizing Malignant Squamous Cell","ValueMeaning":{"publicId":"4928867","version":"1","preferredName":"Non-Keratinizing Malignant Squamous Cell","longName":"4928867","preferredDefinition":"A malignant squamous cell that does not produce keratin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Keratinizing Malignant Squamous Cell","conceptCode":"C36792","definition":"A malignant squamous cell that does not produce keratin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E622-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"COOPERM","dateModified":"2018-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E63B-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma; Keratinizing","valueDescription":"Keratinizing Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3151598","version":"1","preferredName":"Keratinizing Squamous Cell Carcinoma","longName":"3151598","preferredDefinition":"Squamous cell carcinomas with morphologically prominent production of keratin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Keratinizing Squamous Cell Carcinoma","conceptCode":"C4105","definition":"Squamous cell carcinomas with morphologically prominent production of keratin.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92AA5017-9507-97FA-E040-BB89AD4328FF","latestVersionIndicator":"Yes","beginDate":"2010-10-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-15","modifiedBy":"COOPERM","dateModified":"2018-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C8123EC-E64F-9C16-E050-BB89AD436144","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Bronchoalveolar","valueDescription":"Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"2837829","version":"1","preferredName":"Bronchioloalveolar Carcinoma","longName":"2837829","preferredDefinition":"A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-47D8-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C830EE1-9F02-6D65-E050-BB89AD43693C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lepidic predominant adenocarcinoma","valueDescription":"Lepidic Predominant Adenocarcinoma","ValueMeaning":{"publicId":"4928891","version":"1","preferredName":"Lepidic Predominant Adenocarcinoma","longName":"4928891","preferredDefinition":"A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lepidic Adenocarcinoma","conceptCode":"C123160","definition":"A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C830EE1-9F0C-6D65-E050-BB89AD43693C","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"COOPERM","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C830EE1-9F25-6D65-E050-BB89AD43693C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Minimally invasive adenocarcinoma","valueDescription":"Minimally Invasive Lesion Adenocarcinoma","ValueMeaning":{"publicId":"4928893","version":"1","preferredName":"Minimally Invasive Lesion Adenocarcinoma","longName":"4928893","preferredDefinition":"A lesion in which the neoplastic epithelial cells invade into but not through the capsule that surround the neoplasm, or invade the entire thickness of the capsule, or invade vessels surrounding the capsule.  Unlike widely invasive lesions, the minimally invasive lesions cannot be recognized as carcinomas on clinical and surgical grounds.  The diagnosis can only be established microscopically.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lesion","conceptCode":"C60986","definition":"A lesion in which the neoplastic epithelial cells invade into but not through the capsule that surround the neoplasm, or invade the entire thickness of the capsule, or invade vessels surrounding the capsule.  Unlike widely invasive lesions, the minimally invasive lesions cannot be recognized as carcinomas on clinical and surgical grounds.  The diagnosis can only be established microscopically.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C830EE1-9F33-6D65-E050-BB89AD43693C","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C830EE1-9F4C-6D65-E050-BB89AD43693C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma, small cell, NOS","valueDescription":"Not Otherwise Specified Small Cell Carcinoma","ValueMeaning":{"publicId":"4928894","version":"1","preferredName":"Not Otherwise Specified Small Cell Carcinoma","longName":"4928894","preferredDefinition":"Not characterized in any other way.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C830EE1-9F59-6D65-E050-BB89AD43693C","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C830EE1-9F72-6D65-E050-BB89AD43693C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-Small Cell Lung Cancer (NOS)","valueDescription":"Not Otherwise Specified Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"4928895","version":"1","preferredName":"Not Otherwise Specified Non-Small Cell Lung Carcinoma","longName":"4928895","preferredDefinition":"Not characterized in any other way.: A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C830EE1-9F7C-6D65-E050-BB89AD43693C","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C830EE1-9F95-6D65-E050-BB89AD43693C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"B-cell lymphoma (unclassifiable) with features intermediate between DLBCL and Burkitt lymphoma","valueDescription":"High Grade B-Cell Lymphoma, Not Otherwise Specified","ValueMeaning":{"publicId":"3928524","version":"1","preferredName":"High Grade B-Cell Lymphoma, Not Otherwise Specified","longName":"3928524","preferredDefinition":"An aggressive lymphoma with morphologic features of both diffuse large B-cell lymphoma and Burkitt lymphoma, but without rearrangement of MYC gene, BCL2 gene and/or BCL6 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade B-Cell Lymphoma, Not Otherwise Specified","conceptCode":"C80291","definition":"High-grade B-cell lymphoma with blastoid features or features between diffuse large B-cell lymphoma and Burkitt lymphoma that lacks MYC, BCL2, and BCL6 gene rearrangements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E96DEF43-3C79-7609-E040-BB89AD4366AC","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C830EE1-9FA9-6D65-E050-BB89AD43693C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive Adenocarcinoma","valueDescription":"Invasive Adenocarcinoma","ValueMeaning":{"publicId":"4117371","version":"1","preferredName":"Invasive Adenocarcinoma","longName":"4117371","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCE4EA-4A4C-BBE9-E040-BB89AD430980","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22A4EFEF-167B-5805-E050-BB89AD43048F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uveal Melanoma; Spindle Cell","valueDescription":"Uveal Melanoma Spindle Cell","ValueMeaning":{"publicId":"5102452","version":"1","preferredName":"Uveal Melanoma Spindle Cell","longName":"5102452","preferredDefinition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.: A melanoma characterized by the presence of malignant spindle-shaped melanocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Spindle Cell Melanoma","conceptCode":"C4237","definition":"A melanoma characterized by the presence of malignant spindle-shaped melanocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2943127D-2A45-B863-E050-BB89AD430AA9","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2943127D-2A5E-B863-E050-BB89AD430AA9","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Uveal Melanoma; Epithelioid Cell","valueDescription":"Uveal Melanoma Epithelioid Cell","ValueMeaning":{"publicId":"5102451","version":"1","preferredName":"Uveal Melanoma Epithelioid Cell","longName":"5102451","preferredDefinition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.: A melanoma characterized by the presence of malignant large epithelioid melanocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epithelioid Cell Melanoma","conceptCode":"C4236","definition":"A melanoma characterized by the presence of malignant large epithelioid melanocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2943127D-2A1F-B863-E050-BB89AD430AA9","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2943127D-2A38-B863-E050-BB89AD430AA9","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Medullary Carcinoma, NOS","valueDescription":"Medullary Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"3248489","version":"1","preferredName":"Medullary Carcinoma, Not Otherwise Specified","longName":"3248489","preferredDefinition":"A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medullary Carcinoma, Not Otherwise Specified","conceptCode":"C66718","definition":"A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-173E-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2A5DB38D-EC9A-8A01-E050-BB89AD435388","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-27","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Unclassified (Renal Cell Carcinoma NOS)","valueDescription":"Unclassified Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118711","version":"1","preferredName":"Unclassified Renal Cell Carcinoma","longName":"5118711","preferredDefinition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified Renal Cell Carcinoma","conceptCode":"C27892","definition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-3928-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AFC3522-3941-B863-E050-BB89AD4335E0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Collecting Duct Renal Cell Carcinoma","valueDescription":"Collecting Tube Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118713","version":"1","preferredName":"Collecting Tube Renal Cell Carcinoma","longName":"5118713","preferredDefinition":"The final section of a renal tubule in the nephron between the distal convoluted tubule and the ureter comprising of principal and intercalated cells. The collecting tube acts to reabsorb sodium and water while secreting potassium and maintaining acid-base homeostasis.: The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Tube","conceptCode":"C32344","definition":"The final section of a renal tubule in the nephron between the distal convoluted tubule and the ureter comprising of principal and intercalated cells. The collecting tube acts to reabsorb sodium and water while secreting potassium and maintaining acid-base homeostasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-394F-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AFC3522-3968-B863-E050-BB89AD4335E0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Papillary Renal Cell Carcinoma","valueDescription":"Papillary Renal Cell Carcinoma","ValueMeaning":{"publicId":"2581626","version":"1","preferredName":"Papillary Renal Cell Carcinoma","longName":"2581626","preferredDefinition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Renal Cell Carcinoma","conceptCode":"C6975","definition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AFC3522-3972-B863-E050-BB89AD4335E0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Chromophobe Renal Cell Carcinoma","valueDescription":"Chromophobe Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118714","version":"1","preferredName":"Chromophobe Renal Cell Carcinoma","longName":"5118714","preferredDefinition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromophobe Renal Cell Carcinoma","conceptCode":"C4146","definition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical), eosinophilic, or oncocytic.  It has a much better prognosis than other renal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-397C-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AFC3522-3994-B863-E050-BB89AD4335E0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25615A71-8D89-ABF2-E050-BB89AD437C1C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Unclassifiable B-cell lymphoma","valueDescription":"Unclassified B-Cell Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"5054335","version":"1","preferredName":"Unclassified B-Cell Non-Hodgkin Lymphoma","longName":"5054335","preferredDefinition":"Not arranged or included in any specific grouping.: The most common type of non-Hodgkin lymphoma.  It includes the most frequently seen morphologic variants which are: diffuse large B-cell lymphoma, follicular lymphoma, small lymphocytic lymphoma and marginal zone B-cell lymphoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified","conceptCode":"C64486","definition":"Not arranged or included in any specific grouping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"B-Cell Non-Hodgkin Lymphoma","conceptCode":"C3457","definition":"The most common type of non-Hodgkin lymphoma.  It includes the most frequently seen morphologic variants which are: diffuse large B-cell lymphoma, follicular lymphoma, small lymphocytic lymphoma and marginal zone B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25615A71-8D96-ABF2-E050-BB89AD437C1C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25615A71-8DAF-ABF2-E050-BB89AD437C1C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-11-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small Cell Carcinoma, NOS","valueDescription":"Not Otherwise Specified Small Cell Carcinoma","ValueMeaning":{"publicId":"4928894","version":"1","preferredName":"Not Otherwise Specified Small Cell Carcinoma","longName":"4928894","preferredDefinition":"Not characterized in any other way.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C830EE1-9F59-6D65-E050-BB89AD43693C","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3BBA7D-AA41-1A62-E050-BB89AD4357A6","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Burkitt Lymphoma, NOS","valueDescription":"Not Otherwise Specified Burkitt Lymphoma","ValueMeaning":{"publicId":"5271753","version":"1","preferredName":"Not Otherwise Specified Burkitt Lymphoma","longName":"5271753","preferredDefinition":"Not characterized in any other way.: A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Burkitt Lymphoma","conceptCode":"C2912","definition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"333DCE92-55C9-FA0F-E050-BB89AD436B7F","latestVersionIndicator":"Yes","beginDate":"2016-05-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-05-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"333DCE92-55E2-FA0F-E050-BB89AD436B7F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-05-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed Ductal and Lobular","valueDescription":"Mixed Ductal And Lobular","ValueMeaning":{"publicId":"5724607","version":"1","preferredName":"Mixed Ductal And Lobular","longName":"5724607","preferredDefinition":"Involving or composed of different kinds.: Related to, or having the quality of, a duct.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Of or relating to or resembling a lobule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Ductal","conceptCode":"C25732","definition":"Related to, or having the quality of, a duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lobular","conceptCode":"C25557","definition":"Of or relating to or resembling a lobule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B6C10BE-4CE6-51A2-E053-F662850AF095","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2017-03-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4B6C10BE-4CFF-51A2-E053-F662850AF095","beginDate":"2019-06-05","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2017-03-23","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Other Histology (Please Specify)","valueDescription":"Other Histology Specify","ValueMeaning":{"publicId":"5727159","version":"1","preferredName":"Other Histology Specify","longName":"5727159","preferredDefinition":"Different than the one(s) previously specified or mentioned.: The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.: Be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BDE74F1-DA7B-7D8C-E053-F662850AA84F","latestVersionIndicator":"Yes","beginDate":"2017-03-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BDE74F1-DA94-7D8C-E053-F662850AA84F","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-29","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Non-squamous cell carcinoma","valueDescription":"Non-squamous cell carcinoma","ValueMeaning":{"publicId":"2932105","version":"1","preferredName":"Non-squamous cell carcinoma","longName":"2932105","preferredDefinition":"A poorly differentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular or squamous differentiation.  There is a male predilection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Large Cell Carcinoma","conceptCode":"C4450","definition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70DF89DB-8A04-2C9A-E040-BB89AD4367D1","latestVersionIndicator":"Yes","beginDate":"2009-08-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"490F1673-FB9C-0D96-E053-F662850ADBE0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Intermediate Atypical Carcinoma","valueDescription":"Intermediate Atypical Prostate Carcinoma","ValueMeaning":{"publicId":"5916883","version":"1","preferredName":"Intermediate Atypical Prostate Carcinoma","longName":"5916883","preferredDefinition":"An aggressive, castration-resistant, histologically distinct, metastatic carcinoma arising from the prostate gland. It is characterized by the presence of a pure population of cytologically bland malignant epithelial cells with moderate to abundant cytoplasm and rare mitotic figures. The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Atypical Prostate Carcinoma","conceptCode":"C136972","definition":"An aggressive, castration-resistant, histologically distinct, metastatic carcinoma arising from the prostate gland. It is characterized by the presence of a pure population of cytologically bland malignant epithelial cells with moderate to abundant cytoplasm and rare mitotic figures. The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55A5628C-8BDC-47B1-E053-F662850AEFFA","latestVersionIndicator":"Yes","beginDate":"2017-07-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55A5628C-8BF5-47B1-E053-F662850AEFFA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-31","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma, type cannot be determined","valueDescription":"Undetermined Type Carcinoma","ValueMeaning":{"publicId":"6029500","version":"1","preferredName":"Undetermined Type Carcinoma","longName":"6029500","preferredDefinition":"A term referring to the lack of definitive criteria for classification of a finding.: Something distinguishable as an identifiable class based on common qualities.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undetermined","conceptCode":"C124294","definition":"A term referring to the lack of definitive criteria for classification of a finding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E24E01C-BDDD-1608-E053-F662850A1B5E","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E24E01C-BDF6-1608-E053-F662850A1B5E","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Undifferentiated Carcinoma","valueDescription":"Undifferentiated Carcinoma","ValueMeaning":{"publicId":"2838871","version":"1","preferredName":"Undifferentiated Carcinoma","longName":"2838871","preferredDefinition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Carcinoma","conceptCode":"C3692","definition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A9E389-5897-FD59-E040-BB89AD432A90","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E24E01C-BE00-1608-E053-F662850A1B5E","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Neuroendocrine Carcinoma (poorly differentiated)","valueDescription":"Poorly Differentiated Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6029501","version":"1","preferredName":"Poorly Differentiated Neuroendocrine Carcinoma","longName":"6029501","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E24E01C-BE0D-1608-E053-F662850A1B5E","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E24E01C-BE26-1608-E053-F662850A1B5E","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serrated Adenocarcinoma","valueDescription":"Serrated Glandular Architecture Adenocarcinoma","ValueMeaning":{"publicId":"6029502","version":"1","preferredName":"Serrated Glandular Architecture Adenocarcinoma","longName":"6029502","preferredDefinition":"The common saw-tooth architectural pattern observed within hyperplastic polyps.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serrated Glandular Architecture","conceptCode":"C42599","definition":"The common saw-tooth architectural pattern observed within hyperplastic polyps.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E24E01C-BE33-1608-E053-F662850A1B5E","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E24E01C-BE4C-1608-E053-F662850A1B5E","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Signet ring Cell Carcinoma","valueDescription":"Signet Ring Cell Carcinoma","ValueMeaning":{"publicId":"3248560","version":"1","preferredName":"Signet Ring Cell Carcinoma","longName":"3248560","preferredDefinition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell Carcinoma","conceptCode":"C3774","definition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BD41-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E24E01C-BE60-1608-E053-F662850A1B5E","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E24E01C-BE6A-1608-E053-F662850A1B5E","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"High-grade neuroendocrine carcinoma (small cell type)","valueDescription":"Pancreatic Small Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"2838839","version":"1","preferredName":"Pancreatic Small Cell Neuroendocrine Carcinoma","longName":"2838839","preferredDefinition":"An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas.  It is characterized by the presence of malignant small cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Small Cell Neuroendocrine Carcinoma","conceptCode":"C95583","definition":"An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A9743A-23D9-8C94-E040-BB89AD4308C2","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"HARTLEYG","dateModified":"2017-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A205098-B6AD-4248-E053-F662850ACE75","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-26","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Intraductal papillary mucinous neoplasm (IPMN, Side duct)","valueDescription":"Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm","ValueMeaning":{"publicId":"5656781","version":"1","preferredName":"Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm","longName":"5656781","preferredDefinition":"An intraductal papillary-mucinous neoplasm of the pancreas that arises in one of the branches of the main pancreatic duct.  It usually has an indolent behavior.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm","conceptCode":"C113665","definition":"An intraductal papillary-mucinous neoplasm of the pancreas that arises in one of the branches of the main pancreatic duct.  It usually has an indolent behavior.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"481AB059-7395-279A-E053-F662850A8C35","latestVersionIndicator":"Yes","beginDate":"2017-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A205098-B6C1-4248-E053-F662850ACE75","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-26","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Intraductal papillary mucinous neoplasm (IPMN, main duct/mixed)","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","ValueMeaning":{"publicId":"5611394","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","longName":"5611394","preferredDefinition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","conceptCode":"C38342","definition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E429E5-2C76-4AE2-E053-F662850A4EE8","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A205098-B6D6-4248-E053-F662850ACE75","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-26","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"NOS","valueDescription":"Not Otherwise Specified","ValueMeaning":{"publicId":"2853071","version":"1","preferredName":"Not Otherwise Specified","longName":"2853071","preferredDefinition":"Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"657898D4-807A-7305-E040-BB89AD437E47","latestVersionIndicator":"Yes","beginDate":"2009-03-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-75B3-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Atypical Teratoid/Rhabdoid Tumor","valueDescription":"Atypical Teratoid/Rhabdoid Tumor","ValueMeaning":{"publicId":"2578728","version":"1","preferredName":"Atypical Teratoid/Rhabdoid Tumor","longName":"2578728","preferredDefinition":"Atypical teratoid/rhabdoid tumor (WHO grade IV) is a malignant embryonal CNS tumor which occurs in children and is composed of rhabdoid cells, with or without fields resembling a classical primitive neuroectodermal tumor (PNET), epithelial tissue and neoplastic mesenchyme. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Teratoid/Rhabdoid Tumor","conceptCode":"C6906","definition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0095-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-75C7-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Central Nervous System Ganglioneuroblastoma","valueDescription":"Cerebral Ganglioneuroblastoma","ValueMeaning":{"publicId":"5043624","version":"1","preferredName":"Cerebral Ganglioneuroblastoma","longName":"5043624","preferredDefinition":"A supratentorial primitive neuroectodermal tumor characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells and ganglion cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Ganglioneuroblastoma","conceptCode":"C92629","definition":"A malignant central nervous system neoplasm characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells and ganglion cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-3578-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-75DB-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Central Nervous System Neuroblastoma","valueDescription":"Central Nervous System Neuroblastoma","ValueMeaning":{"publicId":"6028602","version":"1","preferredName":"Central Nervous System Neuroblastoma","longName":"6028602","preferredDefinition":"A neuroblastoma arising from the cerebral hemispheres.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Neuroblastoma","conceptCode":"C4826","definition":"A neuroblastoma arising from the central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E1DCE3A-75E7-7D2F-E053-F662850A6FA2","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-75FF-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Medulloepithelioma","valueDescription":"Medulloepithelioma","ValueMeaning":{"publicId":"3251356","version":"1","preferredName":"Medulloepithelioma","longName":"3251356","preferredDefinition":"A rare, usually aggressive malignant embryonal neoplasm of the central nervous system occurring in children.  It is characterized by the presence of neuroepithelial cells which form papillary, trabecular, or tubular structures. Symptoms include headache, nausea, and vomiting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Medulloepithelioma","conceptCode":"C4327","definition":"A rare, usually aggressive malignant embryonal neoplasm of the central nervous system occurring in children. It is characterized by the presence of neuroepithelial cells which form papillary, trabecular, or tubular structures and absence of C19MC amplification. Symptoms include headache, nausea, and vomiting.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9F25-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-7614-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"ETMR","valueDescription":"Ependymoblastoma","ValueMeaning":{"publicId":"2568654","version":"1","preferredName":"Ependymoblastoma","longName":"2568654","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered","conceptCode":"C4915","definition":"An aggressive embryonal tumor with multilayered rosettes characterized by the presence of amplification of the C19MC region on chromosome 19 (19q13.42).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-7628-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Gliosarcoma","valueDescription":"Gliosarcoma","ValueMeaning":{"publicId":"2578705","version":"1","preferredName":"Gliosarcoma","longName":"2578705","preferredDefinition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gliosarcoma","conceptCode":"C3796","definition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-763C-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Giant Cell Glioblastoma","valueDescription":"Giant Cell Glioblastoma","ValueMeaning":{"publicId":"2578703","version":"1","preferredName":"Giant Cell Glioblastoma","longName":"2578703","preferredDefinition":"A rare histological variant of Glioblastoma (WHO grade IV) with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network and a high frequency of TP53 mutations. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Glioblastoma","conceptCode":"C4325","definition":"A rare histological variant of glioblastoma with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network, and a high frequency of TP53 mutations. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-7650-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pilocytic Astrocytoma","valueDescription":"Pilocytic astrocytoma","ValueMeaning":{"publicId":"2578708","version":"1","preferredName":"Pilocytic astrocytoma","longName":"2578708","preferredDefinition":"Pilocytic Astrocytoma, the most common glioma in children, is a WHO grade I astrocytic tumor. It is a generally well circumscribed, slowly growing, often cystic, astrocytoma. It is histologically characterized by a biphasic pattern with varying proportion of compacted bipolar cells which may have Rosenthal fibers (tapered corkscrew-shaped, brightly eosinophilic, intracytoplasmic hyaline masses) and loose textured multipolar cells with microcysts and granular bodies. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilocytic Astrocytoma","conceptCode":"C4047","definition":"A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults.  Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-7664-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Anaplastic Ganglioglioma","valueDescription":"Anaplastic ganglioglioma","ValueMeaning":{"publicId":"2572932","version":"1","preferredName":"Anaplastic ganglioglioma","longName":"2572932","preferredDefinition":"Anaplastic Ganglioglioma (WHO grade III) is a neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. These anaplastic changes in the glial component and high MIB-1 and TP53 labelling indices may indicate aggressive behavior.  However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Ganglioglioma","conceptCode":"C4717","definition":"A WHO grade III neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. The anaplastic changes in the glial component and high MIB-1 and TP53 labeling indices may indicate aggressive behavior. However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-7678-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Anaplastic Pleomorphic Xanthoastrocytoma","valueDescription":"Anaplastic Pleomorphic Xanthoastrocytoma","ValueMeaning":{"publicId":"5525097","version":"1","preferredName":"Anaplastic Pleomorphic Xanthoastrocytoma","longName":"5525097","preferredDefinition":"A WHO grade III pleomorphic xanthoastrocytoma characterized by the presence of five or more mitoses per 10 high-power fields. Necrosis may be present. Patients have shorter survival rates when compared to those with WHO grade II pleomorphic xanthoastrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Pleomorphic Xanthoastrocytoma","conceptCode":"C129327","definition":"A WHO grade 3 pleomorphic xanthoastrocytoma characterized by the presence of five or more mitoses per 10 high-power fields. Necrosis may be present. Patients have shorter survival rates when compared to those with WHO grade 2 pleomorphic xanthoastrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F12FE8D-C807-5079-E053-F662850A582D","latestVersionIndicator":"Yes","beginDate":"2016-10-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-768C-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Anaplastic Oligodendroglioma","valueDescription":"Anaplastic oligodendroglioma","ValueMeaning":{"publicId":"2572933","version":"1","preferredName":"Anaplastic oligodendroglioma","longName":"2572933","preferredDefinition":"A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma","conceptCode":"C4326","definition":"A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-76A0-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Anaplastic Astrocytoma","valueDescription":"Anaplastic astrocytoma","ValueMeaning":{"publicId":"2572930","version":"1","preferredName":"Anaplastic astrocytoma","longName":"2572930","preferredDefinition":"A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-76B4-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Medulloblastoma with Extensive Nodularity","valueDescription":"Medulloblastoma with Extensive Nodularity","ValueMeaning":{"publicId":"5043640","version":"1","preferredName":"Medulloblastoma with Extensive Nodularity","longName":"5043640","preferredDefinition":"A medulloblastoma characterized by nodularity and neuronal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma with Extensive Nodularity","conceptCode":"C5407","definition":"A medulloblastoma characterized by nodularity and neuronal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2434C622-BE52-E3B1-E050-BB89AD43792A","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-76C8-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Desmoplastic/Nodular Medulloblastoma","valueDescription":"Desmoplastic/Nodular Medulloblastoma","ValueMeaning":{"publicId":"5043620","version":"1","preferredName":"Desmoplastic/Nodular Medulloblastoma","longName":"5043620","preferredDefinition":"A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic/Nodular Medulloblastoma","conceptCode":"C4956","definition":"A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24345169-3505-3953-E050-BB89AD434EF8","latestVersionIndicator":"Yes","beginDate":"2015-11-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-76DC-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Large Cell/Anaplastic Medulloblastoma","valueDescription":"Large Cell/Anaplastic Medulloblastoma","ValueMeaning":{"publicId":"6028604","version":"1","preferredName":"Large Cell/Anaplastic Medulloblastoma","longName":"6028604","preferredDefinition":"A medulloblastoma composed of sheets of large cells mixed with cells characterized by marked nuclear pleomorphism and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell/Anaplastic Medulloblastoma","conceptCode":"C129436","definition":"A medulloblastoma composed of sheets of large cells mixed with cells characterized by marked nuclear pleomorphism and high mitotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E1DCE3A-76E9-7D2F-E053-F662850A6FA2","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1DCE3A-7702-7D2F-E053-F662850A6FA2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Pancreatoblastoma","valueDescription":"Pancreatoblastoma","ValueMeaning":{"publicId":"3251704","version":"1","preferredName":"Pancreatoblastoma","longName":"3251704","preferredDefinition":"A rare malignant epithelial neoplasm arising from the pancreas. The vast majority of cases occur during childhood. It is characterized by acinar differentiation, the formation of squamoid corpuscles, and the formation of stromal bands. Patients may present with an abdominal mass. Symptoms include pain, weight loss, and diarrhea. It may metastasize to lymph nodes, liver, and distant anatomic sites. Children who do not have metastatic disease at the time of diagnosis usually have a favorable clinical outcome when treated with a combination of surgery and chemotherapy. However, children with metastatic disease at presentation or adult patients usually have a poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatoblastoma","conceptCode":"C4265","definition":"A rare malignant epithelial neoplasm arising from the pancreas. The vast majority of cases occur during childhood. It is characterized by acinar differentiation, the formation of squamoid corpuscles, and the formation of stromal bands. Patients may present with an abdominal mass. Symptoms include pain, weight loss, and diarrhea. It may metastasize to lymph nodes, liver, and distant anatomic sites. Children who do not have metastatic disease at the time of diagnosis usually have a favorable clinical outcome when treated with a combination of surgery and chemotherapy. However, children with metastatic disease at presentation or adult patients usually have a poor prognosis.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D579-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-19B3-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Inflammatory myofibroblastic tumor","valueDescription":"Inflammatory Myofibroblastic Tumor","ValueMeaning":{"publicId":"3249211","version":"1","preferredName":"Inflammatory Myofibroblastic Tumor","longName":"3249211","preferredDefinition":"A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Myofibroblastic Tumor","conceptCode":"C6481","definition":"A multinodular intermediate fibroblastic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1BF3-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-19BD-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Solid pseudopapillary neoplasm","valueDescription":"Solid Pseudopapillary Neoplasm of the Pancreas","ValueMeaning":{"publicId":"3252120","version":"1","preferredName":"Solid Pseudopapillary Neoplasm of the Pancreas","longName":"3252120","preferredDefinition":"A low-grade malignant neoplasm that arises from the exocrine pancreas. It is characterized by the presence of uniform cells that form solid and pseudopapillary patterns, cystic changes, and hemorrhage. Perineural invasion, vascular invasion, and invasion into surrounding tissues may be present. It usually presents as an encapsulated, solitary, and lobulated pancreatic mass. It is usually found incidentally during physical examination or it may present with abdominal discomfort and pain. It occurs predominantly in young women. Complete removal of the tumor is curative in the majority of cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Pseudopapillary Neoplasm of the Pancreas","conceptCode":"C37212","definition":"A low-grade malignant neoplasm that arises from the exocrine pancreas. It is characterized by the presence of uniform cells that form solid and pseudopapillary patterns, cystic changes, and hemorrhage. Perineural invasion, vascular invasion, and invasion into surrounding tissues may be present. It usually presents as an encapsulated, solitary, and lobulated pancreatic mass. It is usually found incidentally during physical examination or it may present with abdominal discomfort and pain. It occurs predominantly in young women. Complete removal of the tumor is curative in the majority of cases.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A781D14A-E6E6-8A44-E040-BB89AD4310FD","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-19D1-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed acinar-neuroendocrine carcinoma","valueDescription":"Mixed Acinar-Endocrine Carcinoma","ValueMeaning":{"publicId":"2581796","version":"1","preferredName":"Mixed Acinar-Endocrine Carcinoma","longName":"2581796v1.00","preferredDefinition":"A carcinoma that arises from the pancreas showing a mixture of acinar and neuroendocrine malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mixed Acinar-Neuroendocrine Carcinoma","conceptCode":"C6878","definition":"A carcinoma that arises from the pancreas showing a mixture of acinar and neuroendocrine malignant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C91-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-19E5-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed ductal-neuroendocrine carcinoma","valueDescription":"Mixed Ductal-Endocrine Carcinoma","ValueMeaning":{"publicId":"2574561","version":"1","preferredName":"Mixed Ductal-Endocrine Carcinoma","longName":"2574561v1.00","preferredDefinition":"A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mixed Ductal-Neuroendocrine Carcinoma","conceptCode":"C6879","definition":"A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F04E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-19FA-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Acinar cell cystadenocarcinoma","valueDescription":"Pancreatic Acinar Cell Cystadenocarcinoma","ValueMeaning":{"publicId":"2581795","version":"1","preferredName":"Pancreatic Acinar Cell Cystadenocarcinoma","longName":"2581795","preferredDefinition":"A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Acinar Cell Cystadenocarcinoma","conceptCode":"C5727","definition":"A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C90-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"CURTIST","dateModified":"2007-12-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-1A0E-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed acinar-ductal carcinoma","valueDescription":"Mixed Acinar-Ductal Carcinoma of the Pancreas","ValueMeaning":{"publicId":"5983662","version":"1","preferredName":"Mixed Acinar-Ductal Carcinoma of the Pancreas","longName":"5983662","preferredDefinition":"A carcinoma that arises from the pancreas showing either extensive mucin accumulation and acinar neoplastic cells or a mixture of columnar or signet-ring cells and acinar neoplastic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mixed Acinar-Ductal Carcinoma","conceptCode":"C95458","definition":"A carcinoma that arises from the pancreas showing either extensive mucin accumulation and acinar neoplastic cells or a mixture of columnar or signet-ring cells and acinar neoplastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A0D5742-1A1B-0F42-E053-F662850AEF64","latestVersionIndicator":"Yes","beginDate":"2017-09-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-1A34-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Acinar cell carcinoma","valueDescription":"Acinar Cell Carcinoma","ValueMeaning":{"publicId":"2558157","version":"1","preferredName":"Acinar Cell Carcinoma","longName":"2558157","preferredDefinition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acinar Cell Carcinoma","conceptCode":"C3768","definition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B03A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-1A3E-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous cystic neoplasms (MCN)","valueDescription":"Pancreatic Mucinous-Cystic Neoplasm","ValueMeaning":{"publicId":"3251476","version":"1","preferredName":"Pancreatic Mucinous-Cystic Neoplasm","longName":"3251476","preferredDefinition":"A non-invasive or invasive cystic epithelial neoplasm that affects almost exclusively females.  It is characterized by the presence of columnar mucin-producing epithelial cells and ovarian-type stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mucinous-Cystic Neoplasm","conceptCode":"C41247","definition":"A non-invasive or invasive cystic epithelial neoplasm that affects almost exclusively females.  It is characterized by the presence of columnar mucin-producing epithelial cells and ovarian-type stroma formation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A765DE36-34DC-FA28-E040-BB89AD435559","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A0D5742-1A78-0F42-E053-F662850AEF64","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive adenocarcinoma arising from IPMN","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma","ValueMeaning":{"publicId":"5983664","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma","longName":"5983664","preferredDefinition":"A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of a focal or multifocal invasive carcinomatous component.  The invasive carcinoma is either colloid or ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma","conceptCode":"C5726","definition":"A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of a focal or multifocal invasive carcinomatous component.  The invasive carcinoma is either colloid or ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A0D5742-1A4B-0F42-E053-F662850AEF64","latestVersionIndicator":"Yes","beginDate":"2017-09-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A2F8C7A-EF74-71C5-E053-F662850AD5AF","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-27","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Large Cell/Anaplastic MB","valueDescription":"Large Cell Medulloblastoma","ValueMeaning":{"publicId":"2578725","version":"1","preferredName":"Large Cell Medulloblastoma","longName":"2578725","preferredDefinition":"Large Cell Medulloblastoma is a variant of Medulloblastoma (about 4% of cases). Some features of the tumor cells are large, round and/or pleomorphic nuclei with prominent nucleoli and a more abundant cytoplasm than that found in the classic medulloblastoma. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Medulloblastoma","conceptCode":"C6904","definition":"A medulloblastoma composed of large cells with prominent nucleoli and a larger amount of cytoplasm in contrast with the cells of the classic medulloblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0092-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B63DA16-4221-44BA-E053-F662850AFA9B","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-12","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Classic MB","valueDescription":"Classic Medulloblastoma","ValueMeaning":{"publicId":"6003575","version":"1","preferredName":"Classic Medulloblastoma","longName":"6003575","preferredDefinition":"A medulloblastoma composed of malignant cells with hyperchromatic nucleus and scanty cytoplasm.  Homer Wright rosettes may be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classic Medulloblastoma","conceptCode":"C54039","definition":"A medulloblastoma composed of malignant cells with hyperchromatic nucleus and scanty cytoplasm.  Homer Wright rosettes may be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B63DA16-422E-44BA-E053-F662850AFA9B","latestVersionIndicator":"Yes","beginDate":"2017-10-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B63DA16-4247-44BA-E053-F662850AFA9B","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-12","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Indeterminate MB","valueDescription":"Indeterminate Medulloblastoma","ValueMeaning":{"publicId":"6004379","version":"1","preferredName":"Indeterminate Medulloblastoma","longName":"6004379","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.: A malignant, invasive embryonal neoplasm arising from the cerebellum. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BAC8630-58E9-18E9-E053-F662850ACDCA","latestVersionIndicator":"Yes","beginDate":"2017-10-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BAC8630-5902-18E9-E053-F662850ACDCA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Ductal breast carcinoma in situ","valueDescription":"Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"2581232","version":"1","preferredName":"Ductal Breast Carcinoma In Situ","longName":"2581232","preferredDefinition":"Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts. There is no evidence of invasion of the basement membrane. Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5D69F93B-91ED-7944-E053-F662850A107D","beginDate":"2019-06-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-11-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small cell neuroendocrine carcinoma","valueDescription":"Colorectal Small Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6036355","version":"1","preferredName":"Colorectal Small Cell Neuroendocrine Carcinoma","longName":"6036355","preferredDefinition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon or rectum.  It is characterized by the presence of malignant small cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Small Cell Neuroendocrine Carcinoma","conceptCode":"C43587","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon or rectum.  It is characterized by the presence of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8A8324-BB96-2321-E053-F662850AE4CC","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F8A8324-BBAF-2321-E053-F662850AE4CC","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Micropapillary carcinoma","valueDescription":"Micropapillary Pattern Carcinoma","ValueMeaning":{"publicId":"6036356","version":"1","preferredName":"Micropapillary Pattern Carcinoma","longName":"6036356","preferredDefinition":"A morphologic finding indicating the presence of an architectural pattern dominated by the presence of small papillary structures.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Micropapillary Growth Pattern","conceptCode":"C36181","definition":"A morphologic finding indicating the presence of a growth pattern dominated by the presence of small papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F8A8324-BBBC-2321-E053-F662850AE4CC","latestVersionIndicator":"Yes","beginDate":"2017-12-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F8A8324-BBD5-2321-E053-F662850AE4CC","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-04","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Invasive carcinoma arising in MCN","valueDescription":"Pancreatic Invasive Mucinous Cystadenocarcinoma","ValueMeaning":{"publicId":"2581793","version":"1","preferredName":"Pancreatic Invasive Mucinous Cystadenocarcinoma","longName":"2581793v1.00","preferredDefinition":"A cystic epithelial neoplasm characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and a focal or extensive invasive carcinomatous component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma","conceptCode":"C41246","definition":"A cystic epithelial neoplasm characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and a focal or extensive invasive carcinomatous component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5A2088FC-A814-6AFF-E053-F662850A0ACB","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-26","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Minimally invasive adenocarcinoma, mucinous","valueDescription":"Mucinous Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"5438094","version":"1","preferredName":"Mucinous Bronchioloalveolar Carcinoma","longName":"5438094","preferredDefinition":"A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Mucinous Adenocarcinoma","conceptCode":"C7268","definition":"A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-689E-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"COOPERM","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-0250-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma in situ, nonmucinous","valueDescription":"Non-Mucinous Lung Adenocarcinoma In Situ","ValueMeaning":{"publicId":"6077900","version":"1","preferredName":"Non-Mucinous Lung Adenocarcinoma In Situ","longName":"6077900","preferredDefinition":"Lung adenocarcinoma in situ characterized by the presence of type II pneumocyte and/or Clara cell differentiation. Almost all cases of lung adenocarcinoma in situ are non-mucinous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Mucinous Adenocarcinoma In Situ","conceptCode":"C136716","definition":"Lung adenocarcinoma in situ characterized by the presence of type II pneumocyte and/or Clara cell differentiation. Almost all cases of lung adenocarcinoma in situ are non-mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65BDFB8B-025E-31AA-E053-F662850AA84C","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"ONEDATA","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-0277-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma in situ, mucinous","valueDescription":"Mucinous Lung Adenocarcinoma In Situ","ValueMeaning":{"publicId":"6077902","version":"1","preferredName":"Mucinous Lung Adenocarcinoma In Situ","longName":"6077902","preferredDefinition":"A very rare lung adenocarcinoma in situ variant characterized by the presence of tall columnar cells with basal nuclei and abundant cytoplasmic mucin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Mucinous Adenocarcinoma In Situ","conceptCode":"C136717","definition":"A very rare lung adenocarcinoma in situ variant characterized by the presence of tall columnar cells with basal nuclei and abundant cytoplasmic mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65BDFB8B-0284-31AA-E053-F662850AA84C","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"ONEDATA","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-029D-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Colloid adenocarcinoma","valueDescription":"Lung Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"5210947","version":"1","preferredName":"Lung Mucinous Adenocarcinoma","longName":"5210947","preferredDefinition":"A morphologic variant of lung adenocarcinoma characterized by the presence of mucin pools containing islands of well differentiated adenocarcinoma cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Colloid Adenocarcinoma","conceptCode":"C45512","definition":"A morphologic variant of lung adenocarcinoma characterized by the presence of mucin pools containing islands of well differentiated adenocarcinoma cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C843-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-02B1-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Enteric adenocarcinoma","valueDescription":"Lung Enteric Adenocarcinoma","ValueMeaning":{"publicId":"6077904","version":"1","preferredName":"Lung Enteric Adenocarcinoma","longName":"6077904","preferredDefinition":"A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Enteric Adenocarcinoma","conceptCode":"C136710","definition":"A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65BDFB8B-02BF-31AA-E053-F662850AA84C","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"ONEDATA","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-02D8-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Minimally invasive adenocarcinoma, nonmucinous","valueDescription":"Non-Mucinous Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"5210953","version":"1","preferredName":"Non-Mucinous Bronchioloalveolar Carcinoma","longName":"5210953","preferredDefinition":"A morphologic variant of bronchiolo-alveolar lung carcinoma characterized by the presence of Clara cells and/or type II cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Non-Mucinous Adenocarcinoma","conceptCode":"C7269","definition":"A morphologic variant of minimally invasive lung  adenocarcinoma characterized by the presence of Clara cells and/or type II cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C8CA-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-02EC-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Solid adenocarcinoma","valueDescription":"Solid Adenocarcinoma","ValueMeaning":{"publicId":"6077905","version":"1","preferredName":"Solid Adenocarcinoma","longName":"6077905","preferredDefinition":"The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid","conceptCode":"C45300","definition":"The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65BDFB8B-02FA-31AA-E053-F662850AA84C","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"ONEDATA","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65BDFB8B-0313-31AA-E053-F662850AA84C","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma; small cell; gastric neuroendocrine","valueDescription":"Gastric Small Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6270496","version":"1","preferredName":"Gastric Small Cell Neuroendocrine Carcinoma","longName":"6270496","preferredDefinition":"An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach.  It is characterized by the presence of malignant small cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Small Cell Neuroendocrine Carcinoma","conceptCode":"C6764","definition":"An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach.  It is characterized by the presence of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA4D373-11E5-675B-E053-F662850ADED0","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA4D373-1200-675B-E053-F662850ADED0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma with lymphoid stroma (medullary carcinoma)","valueDescription":"Gastric Carcinoma with Lymphoid Stroma","ValueMeaning":{"publicId":"6270498","version":"1","preferredName":"Gastric Carcinoma with Lymphoid Stroma","longName":"6270498","preferredDefinition":"A rare adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of prominent lymphocytic stromal infiltration and poorly formed tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Carcinoma with Lymphoid Stroma","conceptCode":"C95748","definition":"A rare adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of prominent lymphocytic stromal infiltration and poorly formed tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA4D373-120D-675B-E053-F662850ADED0","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA4D373-1226-675B-E053-F662850ADED0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Hepatoid adenocarcinoma","valueDescription":"Hepatoid Adenocarcinoma","ValueMeaning":{"publicId":"3252191","version":"1","preferredName":"Hepatoid Adenocarcinoma","longName":"3252191","preferredDefinition":"An adenocarcinoma with morphologic characteristics similar to hepatocellular carcinoma, arising from an anatomic site other than the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatoid Adenocarcinoma","conceptCode":"C66950","definition":"An adenocarcinoma with morphologic characteristics similar to hepatocellular carcinoma, arising from an anatomic site other than the liver.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A787FC31-B3F0-9711-E040-BB89AD431F86","latestVersionIndicator":"Yes","beginDate":"2011-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-08","modifiedBy":"COOPERM","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA4D373-123A-675B-E053-F662850ADED0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed adenoneuroendocrine carcinoma","valueDescription":"Gastric Mixed Adenoneuroendocrine Carcinoma","ValueMeaning":{"publicId":"6270494","version":"1","preferredName":"Gastric Mixed Adenoneuroendocrine Carcinoma","longName":"6270494","preferredDefinition":"A carcinoma that arises from the stomach and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Mixed Adenoneuroendocrine Carcinoma","conceptCode":"C95886","definition":"A carcinoma that arises from the stomach and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA4D373-11BF-675B-E053-F662850ADED0","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BA4D373-11D8-675B-E053-F662850ADED0","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Desmoid Sarcoma","valueDescription":"Deep Fibromatosis/Desmoid Tumor Sarcoma","ValueMeaning":{"publicId":"6333793","version":"1","preferredName":"Deep Fibromatosis/Desmoid Tumor Sarcoma","longName":"6333793","preferredDefinition":"An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.: A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoid Fibromatosis","conceptCode":"C9182","definition":"An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E60C767-E651-6728-E053-F662850A3DBB","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E60C767-E66C-6728-E053-F662850A3DBB","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-11","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed adenoneuroendocrine carcinoma","valueDescription":"Digestive System Mixed Adenoneuroendocrine Carcinoma","ValueMeaning":{"publicId":"6324219","version":"1","preferredName":"Digestive System Mixed Adenoneuroendocrine Carcinoma","longName":"6324219","preferredDefinition":"A carcinoma that arises from the digestive system and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30% of either component should be present for the diagnosis to be made.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Digestive System Mixed Adenoneuroendocrine Carcinoma","conceptCode":"C95406","definition":"A carcinoma that arises from the digestive system and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30% of either component should be present for the diagnosis to be made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AF300-FCA9-5AC6-E053-F662850A07A5","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D9AF300-FCC2-5AC6-E053-F662850A07A5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Neuroendocrine carcinoma, large cell","valueDescription":"Large Cell Carcinoma Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6324220","version":"1","preferredName":"Large Cell Carcinoma Neuroendocrine Carcinoma","longName":"6324220","preferredDefinition":"A malignant epithelial neoplasm composed of large, atypical cells.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Carcinoma","conceptCode":"C3780","definition":"A malignant epithelial neoplasm composed of large, atypical cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AF300-FCCF-5AC6-E053-F662850A07A5","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"ONEDATA","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D9AF300-FCE8-5AC6-E053-F662850A07A5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Neuroendocrine carcinoma, small cell","valueDescription":"Small Cell Carcinoma Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6324221","version":"1","preferredName":"Small Cell Carcinoma Neuroendocrine Carcinoma","longName":"6324221","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AF300-FCF5-5AC6-E053-F662850A07A5","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"ONEDATA","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D9AF300-FD0E-5AC6-E053-F662850A07A5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Moderately-differentiated neuroendocrine carcinoma","valueDescription":"Moderately Differentiated Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6324222","version":"1","preferredName":"Moderately Differentiated Neuroendocrine Carcinoma","longName":"6324222","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AF300-FD1B-5AC6-E053-F662850A07A5","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"ONEDATA","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D9AF300-FD34-5AC6-E053-F662850A07A5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Well-differentiated neuroendocrine carcinoma","valueDescription":"Well Differentiated Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6324223","version":"1","preferredName":"Well Differentiated Neuroendocrine Carcinoma","longName":"6324223","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AF300-FD41-5AC6-E053-F662850A07A5","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"ONEDATA","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D9AF300-FD5A-5AC6-E053-F662850A07A5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma with peculiar aspects","valueDescription":"Unusual Aspect Adenocarcinoma","ValueMeaning":{"publicId":"6324225","version":"1","preferredName":"Unusual Aspect Adenocarcinoma","longName":"6324225","preferredDefinition":"Out of the ordinary, uncommon, or unexpected.: A characteristic to be considered; a distinct feature or element.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unusual","conceptCode":"C77967","definition":"Out of the ordinary, uncommon, or unexpected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Aspect","conceptCode":"C61468","definition":"A characteristic to be considered; a distinct feature or element.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D9AF300-FD69-5AC6-E053-F662850A07A5","latestVersionIndicator":"Yes","beginDate":"2018-06-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"ONEDATA","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6D9AF300-FD82-5AC6-E053-F662850A07A5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-01","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma, gastric foveolar type","valueDescription":"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type","ValueMeaning":{"publicId":"5529208","version":"1","preferredName":"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type","longName":"5529208","preferredDefinition":"A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that are similar to gastric foveolar epithelial cells.","context":"TEST","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type","conceptCode":"C95508","definition":"A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that are similar to gastric foveolar epithelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F501BB8-9BE7-2BF2-E053-F662850AC833","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3B2A-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma, biliary type","valueDescription":"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type","ValueMeaning":{"publicId":"6408772","version":"1","preferredName":"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type","longName":"6408772","preferredDefinition":"A well or moderately differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of malignant tubular glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type","conceptCode":"C96936","definition":"A well or moderately differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of malignant tubular glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7405CC0D-3B38-4A8B-E053-F662850A0DB5","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3B51-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinoma, intestinal type","valueDescription":"Intestinal-Type Adenocarcinoma","ValueMeaning":{"publicId":"6408774","version":"1","preferredName":"Intestinal-Type Adenocarcinoma","longName":"6408774","preferredDefinition":"An adenocarcinoma arising from epithelium which has undergone intestinal metaplasia. Representative examples include gastric, gallbladder, and ampulla of Vater intestinal type adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal-Type Adenocarcinoma","conceptCode":"C4126","definition":"An adenocarcinoma arising from epithelium which has undergone intestinal metaplasia. Representative examples include gastric, gallbladder, and ampulla of Vater intestinal type adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7405CC0D-3B5E-4A8B-E053-F662850A0DB5","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3B77-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous cystic neoplasm with an associated invasive carcinoma","valueDescription":"Bile Duct Cystadenocarcinoma","ValueMeaning":{"publicId":"3248921","version":"1","preferredName":"Bile Duct Cystadenocarcinoma","longName":"3248921","preferredDefinition":"A mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma","conceptCode":"C4130","definition":"A mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6C95D61-6CCF-89F7-E040-BB89AD4362F4","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3B8B-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Intraductal papillary neoplasm with an associated invasive carcinoma","valueDescription":"Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma","ValueMeaning":{"publicId":"6408776","version":"1","preferredName":"Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma","longName":"6408776","preferredDefinition":"A papillary epithelial neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.  For intraductal papillary neoplasms of the intrahepatic bile ducts, the carcinomatous component is an intrahepatic cholangiocarcinoma; for intraductal papillary neoplasms of the extrahepatic bile ducts, the carcinomatous component is an adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma","conceptCode":"C96810","definition":"An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7405CC0D-3B98-4A8B-E053-F662850A0DB5","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3BB1-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Combined hepatocellular-cholangiocarcinoma","valueDescription":"Combined Hepatocellular Carcinoma and Cholangiocarcinoma","ValueMeaning":{"publicId":"3248682","version":"1","preferredName":"Combined Hepatocellular Carcinoma and Cholangiocarcinoma","longName":"3248682","preferredDefinition":"A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined Hepatocellular Carcinoma and Cholangiocarcinoma","conceptCode":"C3828","definition":"A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6C6E274-6BE9-2DEF-E040-BB89AD4337BB","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3BC5-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Melanoma, NOS","valueDescription":"Not Otherwise Specified Melanoma","ValueMeaning":{"publicId":"6408777","version":"1","preferredName":"Not Otherwise Specified Melanoma","longName":"6408777","preferredDefinition":"Not characterized in any other way.: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7405CC0D-3BD2-4A8B-E053-F662850A0DB5","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3BEB-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Nevoid melanoma","valueDescription":"Nevoid Melanoma","ValueMeaning":{"publicId":"6408779","version":"1","preferredName":"Nevoid Melanoma","longName":"6408779","preferredDefinition":"A rare variant of melanoma occurring mostly in adults in their fifth decade. Morphologically it resembles an ordinary compound or dermal nevus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nevoid Melanoma","conceptCode":"C54662","definition":"A rare variant of cutaneous melanoma occurring mostly in adults in their fifth decade. Morphologically it resembles an ordinary compound or dermal nevus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7405CC0D-3BF8-4A8B-E053-F662850A0DB5","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3C11-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Melanoma arising in a giant congenital nevus","valueDescription":"Melanoma Arising in Giant Congenital Nevus","ValueMeaning":{"publicId":"6408781","version":"1","preferredName":"Melanoma Arising in Giant Congenital Nevus","longName":"6408781","preferredDefinition":"A melanoma arising in a giant congenital melanocytic nevus. The risk of developing a melanoma in a giant congenital melanocytic nevus has been reported to be between 5% and 50%. The incidence of developing melanoma is higher before the age of 10 and in adult life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma Arising in Giant Congenital Nevus","conceptCode":"C4235","definition":"A melanoma arising in a giant congenital melanocytic nevus. The risk of developing a melanoma in a giant congenital melanocytic nevus has been reported to be between 5% and 50%. The incidence of developing melanoma is higher before the age of 10 and in adult life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7405CC0D-3C1F-4A8B-E053-F662850A0DB5","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3C38-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Melanoma arising from blue nevus","valueDescription":"Blue Nevus-Like Melanoma","ValueMeaning":{"publicId":"2569599","version":"1","preferredName":"Blue Nevus-Like Melanoma","longName":"2569599","preferredDefinition":"A melanoma of the skin resembling a benign blue nevus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma Arising from Blue Nevus","conceptCode":"C4240","definition":"A rare melanoma which develops in a pre-existing blue nevus. It occurs more frequently on the scalp, face, orbit, back, buttocks, extremities, hands, and feet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DCEC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2004-05-13","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3C4C-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Desmoplastic melanoma","valueDescription":"Desmoplastic Melanoma","ValueMeaning":{"publicId":"2581228","version":"1","preferredName":"Desmoplastic Melanoma","longName":"2581228","preferredDefinition":"A melanoma of the skin characterized by a proliferation of atypical spindled melanocytes in the dermis, in a background of abundant collagen. It usually presents as an amelanotic raised nodular lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Melanoma","conceptCode":"C37257","definition":"A melanoma of the skin characterized by a proliferation of atypical spindled melanocytes in the dermis, in a background of abundant collagen. It usually presents as an amelanotic raised nodular lesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A59-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3C61-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Acral lentiginous melanoma","valueDescription":"Acral Lentiginous Melanoma","ValueMeaning":{"publicId":"4263936","version":"1","preferredName":"Acral Lentiginous Melanoma","longName":"4263936","preferredDefinition":"A form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin.  It presents as a pigmented macular lesion with irregular borders.  Morphologically, it consists of atypical spindled and dendritic melanocytes.  The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acral Lentiginous Melanoma","conceptCode":"C4022","definition":"A form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin.  It presents as a pigmented macular lesion with irregular borders.  Morphologically, it consists of atypical spindled and dendritic melanocytes.  The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63D55FF-3484-F699-E040-BB89AD433A6C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3C76-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Lentigo maligna melanoma","valueDescription":"Lentigo Maligna Melanoma","ValueMeaning":{"publicId":"2569595","version":"1","preferredName":"Lentigo Maligna Melanoma","longName":"2569595","preferredDefinition":"(A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lentigo Maligna Melanoma","conceptCode":"C9151","definition":"A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DCE8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2004-05-13","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3C8B-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Nodular melanoma","valueDescription":"Nodular Melanoma","ValueMeaning":{"publicId":"2569596","version":"1","preferredName":"Nodular Melanoma","longName":"2569596","preferredDefinition":"An aggressive form of melanoma, frequently metastasizing to the lymph nodes. It presents as a papular or nodular raised skin lesion. It comprises approximately 10-15% of melanomas. Morphologically, it often displays an epithelioid appearance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Nodular Melanoma","conceptCode":"C4225","definition":"An aggressive form of melanoma, frequently metastasizing to the lymph nodes.  It presents as a papular or nodular raised skin lesion.  It comprises approximately 10-15% of melanomas.  Morphologically, it often displays an epithelioid appearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DCE9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2004-05-13","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3CA0-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Superficial spreading melanoma","valueDescription":"Superficial Spreading Melanoma","ValueMeaning":{"publicId":"4264987","version":"1","preferredName":"Superficial Spreading Melanoma","longName":"4264987","preferredDefinition":"A type of melanoma that typically occurs in light-skinned individuals ranging in age from young adults to the elderly.  Risk factors include extensive sun exposure during childhood, a family history of melanoma, and the presence of dysplastic nevi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low-CSD Melanoma","conceptCode":"C9152","definition":"A type of melanoma that typically occurs in light-skinned individuals ranging in age from young adults to the elderly.  Risk factors include extensive sun exposure during childhood, a family history of melanoma, and the presence of dysplastic nevi.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3E87-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405CC0D-3CB5-4A8B-E053-F662850A0DB5","beginDate":"2019-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Seromucinous borderline tumor/atypical proliferative seromucinous tumor with microinvasion","valueDescription":"Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion","ValueMeaning":{"publicId":"6691993","version":"1","preferredName":"Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion","longName":"6691993","preferredDefinition":"A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic serous and mucinous epithelial cells, atypia, and the presence of microinvasion of the ovarian stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion","conceptCode":"C159313","definition":"A low grade ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells. Microinvasion of the ovarian stroma is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8696A8CA-FA44-231A-E053-F662850A9016","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"869AF5A6-FFFF-07AC-E053-F662850ABC16","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid carcinoma","valueDescription":"Ovarian Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"5210934","version":"1","preferredName":"Ovarian Endometrioid Adenocarcinoma","longName":"5210934","preferredDefinition":"An endometrioid adenocarcinoma arising from the ovary.  It comprises 10% to 25% of all primary ovarian carcinomas.  Grossly, endometrioid carcinoma may present as a cystic or solid mass.  Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma.  As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Endometrioid Adenocarcinoma","conceptCode":"C7979","definition":"An endometrioid adenocarcinoma arising from the ovary.  It comprises 10% to 25% of all primary ovarian carcinomas.  Grossly, endometrioid carcinoma may present as a cystic or solid mass.  Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma.  As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C706-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"TSESU","dateModified":"2023-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8696A8CA-FA38-231A-E053-F662850A9016","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serous borderline tumor-micropapillary variant/noninvasive low-grade serous carcinoma","valueDescription":"SEROUS TUMOR OF LOW MALIGNANT POTENTIAL","ValueMeaning":{"publicId":"2560032","version":"1","preferredName":"SEROUS TUMOR OF LOW MALIGNANT POTENTIAL","longName":"2560032","preferredDefinition":"A non-invasive serous neoplasm that arises from the ovary and shows micropapillary and/or cribriform architectural patterns.  It is composed of round epithelial cells with scant cytoplasm and moderate nuclear atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma","conceptCode":"C122585","definition":"A non-invasive serous neoplasm that arises from the ovary and shows micropapillary and/or cribriform architectural patterns.  It is composed of round epithelial cells with scant cytoplasm and moderate nuclear atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B78D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"DWARZEL","dateModified":"2019-03-21","changeDescription":"Added concept, verified with EVS team - DW 03-21-2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8696A8CA-FA71-231A-E053-F662850A9016","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serous borderline tumor/atypical proliferative serous tumor with microinvasion","valueDescription":"Borderline Tumors With Microinvasion","ValueMeaning":{"publicId":"3247943","version":"1","preferredName":"Borderline Tumors With Microinvasion","longName":"3247943","preferredDefinition":"An ovarian epithelial tumor characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor with Microinvasion","conceptCode":"C40027","definition":"A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-70B0-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8696A8CA-FA85-231A-E053-F662850A9016","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serous borderline tumor/atypical proliferative serous tumor","valueDescription":"Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor","ValueMeaning":{"publicId":"6691995","version":"1","preferredName":"Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor","longName":"6691995","preferredDefinition":"A non-invasive serous neoplasm that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign ovarian serous tumors, but less as compared to low-grade ovarian serous carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor","conceptCode":"C122584","definition":"A non-invasive serous neoplasm that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign ovarian serous tumors, but less as compared to low-grade ovarian serous carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8696A8CA-FA92-231A-E053-F662850A9016","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8696A8CA-FAAB-231A-E053-F662850A9016","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Serous tubal intraepithelial carcinoma (STIC)","valueDescription":"Serous Tubal Intraepithelial Carcinoma","ValueMeaning":{"publicId":"6690573","version":"1","preferredName":"Serous Tubal Intraepithelial Carcinoma","longName":"6690573","preferredDefinition":"A non-invasive serous carcinoma arising from the fallopian tube.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Tubal Intraepithelial Carcinoma","conceptCode":"C126449","definition":"A non-invasive serous carcinoma arising from the fallopian tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86461630-3922-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"ONEDATA","dateModified":"2019-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8696A8CA-FAB5-231A-E053-F662850A9016","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous borderline tumor/atypical proliferative mucinous tumor with microinvasion","valueDescription":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion","ValueMeaning":{"publicId":"6692015","version":"1","preferredName":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion","longName":"6692015","preferredDefinition":"A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and microinvasion of the ovarian stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion","conceptCode":"C159311","definition":"A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and microinvasion of the ovarian stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8697464F-1342-40D2-E053-F662850ACF73","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8697464F-135B-40D2-E053-F662850ACF73","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous borderline tumor/atypical proliferative mucinous tumor with intraepithelial carcinoma","valueDescription":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma","ValueMeaning":{"publicId":"6692016","version":"1","preferredName":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma","longName":"6692016","preferredDefinition":"A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and the presence of intraepithelial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma","conceptCode":"C159312","definition":"A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and the presence of intraepithelial carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8697464F-1367-40D2-E053-F662850ACF73","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8697464F-1380-40D2-E053-F662850ACF73","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma, subtype cannot be determined","valueDescription":"CUPS - 199.1; Carcinoma Unknown Primary","ValueMeaning":{"publicId":"2572639","version":"1","preferredName":"CUPS - 199.1; Carcinoma Unknown Primary","longName":"2572639","preferredDefinition":"A carcinoma which has metastasized from an unknown primary anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma of Unknown Primary","conceptCode":"C3812","definition":"A carcinoma which has metastasized from an unknown primary anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E8CC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-05","modifiedBy":"LUY","dateModified":"2015-02-24","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/24/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86980BE3-E7D9-0A04-E053-F662850AA355","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Brenner tumor, borderline/atypical proliferative Brenner tumor","valueDescription":"Borderline Ovarian Brenner Tumor","ValueMeaning":{"publicId":"3247930","version":"1","preferredName":"Borderline Ovarian Brenner Tumor","longName":"3247930","preferredDefinition":"A Brenner tumor of the ovary characterized by papillary structures, nuclear cytologic atypia, and absense of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Brenner Tumor","conceptCode":"C9459","definition":"A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of neoplastic atypical urothelial-type cells in a fibrotic stroma without evidence of invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-6F69-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86980BE3-E7ED-0A04-E053-F662850AA355","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Seromucinous carcinoma","valueDescription":"Ovarian Seromucinous Carcinoma","ValueMeaning":{"publicId":"5210929","version":"1","preferredName":"Ovarian Seromucinous Carcinoma","longName":"5210929","preferredDefinition":"A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Seromucinous Carcinoma","conceptCode":"C40090","definition":"A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C683-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86980BE3-E801-0A04-E053-F662850AA355","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed malignant germ cell tumor","valueDescription":"Ovarian Mixed Germ Cell Tumor","ValueMeaning":{"publicId":"6692771","version":"1","preferredName":"Ovarian Mixed Germ Cell Tumor","longName":"6692771","preferredDefinition":"An ovarian malignant germ cell tumor characterized by the presence of at least two different germ cell tumor components. The most common combination of germ cell tumors is dysgerminoma and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Mixed Germ Cell Tumor","conceptCode":"C8114","definition":"An ovarian malignant germ cell tumor characterized by the presence of at least two different germ cell tumor components. The most common combination of germ cell tumors is dysgerminoma and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-23C4-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-23DD-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma arising from a teratoma","valueDescription":"Ovarian Dermoid Cyst with Secondary Carcinoma","ValueMeaning":{"publicId":"6692773","version":"1","preferredName":"Ovarian Dermoid Cyst with Secondary Carcinoma","longName":"6692773","preferredDefinition":"A secondary carcinoma that has developed in an ovarian dermoid cyst.  In the majority of cases, the secondary carcinoma is a squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Dermoid Cyst with Secondary Carcinoma","conceptCode":"C39997","definition":"A secondary carcinoma that has developed in an ovarian dermoid cyst.  In the majority of cases, the secondary carcinoma is a squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-23EA-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-2403-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Immature teratoma","valueDescription":"Immature Ovarian Teratoma","ValueMeaning":{"publicId":"6692774","version":"1","preferredName":"Immature Ovarian Teratoma","longName":"6692774","preferredDefinition":"An immature teratoma arising from the ovary.  It usually affects females in their first two decades of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immature Ovarian Teratoma","conceptCode":"C8111","definition":"An immature teratoma arising from the ovary.  It usually affects females in their first two decades of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-240F-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-2428-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Yolk sac tumor (endodermal sinus tumor)","valueDescription":"Ovarian Yolk Sac Tumor","ValueMeaning":{"publicId":"6692776","version":"1","preferredName":"Ovarian Yolk Sac Tumor","longName":"6692776","preferredDefinition":"A usually rapidly growing malignant germ cell tumor arising from the ovary.  It usually occurs in children and adolescents.  Signs and symptoms include abdominal pain and a large abdominal or pelvic mass.  The serum alpha-fetoprotein is almost always elevated preoperatively.  Morphologically, there is marked heterogeneity due to numerous patterns of differentiation coexisting in the same tumor.  The most common pattern is reticular.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Yolk Sac Tumor","conceptCode":"C8107","definition":"A usually rapidly growing malignant germ cell tumor arising from the ovary.  It usually occurs in children and adolescents.  Signs and symptoms include abdominal pain and a large abdominal or pelvic mass.  The serum alpha-fetoprotein is almost always elevated preoperatively.  Morphologically, there is marked heterogeneity due to numerous patterns of differentiation coexisting in the same tumor.  The most common pattern is reticular.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-2435-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-244E-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Dysgerminoma","valueDescription":"Ovarian Dysgerminoma","ValueMeaning":{"publicId":"4722795","version":"1","preferredName":"Ovarian Dysgerminoma","longName":"4722795","preferredDefinition":"A malignant germ cell tumor arising from the ovary.  Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei.  The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Dysgerminoma","conceptCode":"C8106","definition":"A malignant germ cell tumor arising from the ovary.  Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei.  The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-24C7-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-2462-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Granulosa cell tumor, juvenile type","valueDescription":"Juvenile Type Ovarian Granulosa Cell Tumor","ValueMeaning":{"publicId":"6692778","version":"1","preferredName":"Juvenile Type Ovarian Granulosa Cell Tumor","longName":"6692778","preferredDefinition":"A granulosa cell tumor that affects females in the first three decades of life.  In young girls it may present with pseudoprecocity.  In women during reproductive years, it may present with menstrual abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juvenile Ovarian Granulosa Cell Tumor","conceptCode":"C7289","definition":"An ovarian granulosa cell tumor that affects females in the first three decades of life. It presents unilaterally as stage I disease in the vast majority of cases. The prognosis is usually good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-246F-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-2488-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Granulosa cell tumor, adult type","valueDescription":"Adult Type Ovarian Granulosa Cell Tumor","ValueMeaning":{"publicId":"6692780","version":"1","preferredName":"Adult Type Ovarian Granulosa Cell Tumor","longName":"6692780","preferredDefinition":"A granulosa cell tumor that affects middle aged or postmenopausal women.  Patients may present with uterine bleeding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult Ovarian Granulosa Cell Tumor","conceptCode":"C7288","definition":"A low-grade malignant sex cord-stromal tumor that occurs in the ovary and affects middle aged to post-menopausal women. It is composed of granulosa cells in an often fibrothecomatous stroma. The neoplastic cells may form various patterns including the microfollicular, which is characterized by the presence of Call-Exner bodies, macrofollicular, insular, trabecular, and diffuse pattern. Signs and symptoms include abdominal mass, hemoperitoneum, and ascites. Estrogenic and rarely androgenic manifestations may be present. The vast majority of cases present as stage I tumors; however, all tumors have a potential for aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-2495-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-24AE-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Undifferentiated carcinoma","valueDescription":"Undifferentiated Ovarian Carcinoma","ValueMeaning":{"publicId":"5210913","version":"1","preferredName":"Undifferentiated Ovarian Carcinoma","longName":"5210913","preferredDefinition":"An aggressive carcinoma arising from the ovary.  Most patients present with advanced disease.  Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Undifferentiated Carcinoma","conceptCode":"C4509","definition":"An aggressive carcinoma arising from the ovary.  Most patients present with advanced disease.  Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C509-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-24C2-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Transitional cell carcinoma","valueDescription":"Ovarian Transitional Cell Carcinoma","ValueMeaning":{"publicId":"5210915","version":"1","preferredName":"Ovarian Transitional Cell Carcinoma","longName":"5210915","preferredDefinition":"A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells.  There is no morphologic evidence of a benign or borderline Brenner tumor component present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Transitional Cell Carcinoma","conceptCode":"C5240","definition":"A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C52F-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-24D6-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Ovarian Squamous Cell Carcinoma","ValueMeaning":{"publicId":"5210918","version":"1","preferredName":"Ovarian Squamous Cell Carcinoma","longName":"5210918","preferredDefinition":"A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Squamous Cell Carcinoma","conceptCode":"C40093","definition":"A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C57A-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-24E0-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small cell carcinoma, hypercalcemic type","valueDescription":"Ovarian Small Cell Carcinoma, Hypercalcemic Type","ValueMeaning":{"publicId":"6692783","version":"1","preferredName":"Ovarian Small Cell Carcinoma, Hypercalcemic Type","longName":"6692783","preferredDefinition":"An undifferentiated small cell carcinoma that arises from the ovary and is associated with hypercalcemia.  Electron microscopic studies show neurosecretory granules are either absent or, when present, are in small numbers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Small Cell Carcinoma, Hypercalcemic Type","conceptCode":"C40439","definition":"An undifferentiated small cell carcinoma that arises from the ovary and is associated with hypercalcemia.  Electron microscopic studies show neurosecretory granules are either absent or, when present, are in small numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86994792-24ED-67BF-E053-F662850AA585","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86994792-2506-67BF-E053-F662850AA585","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucinous borderline tumor/atypical proliferative mucinous tumor","valueDescription":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor","ValueMeaning":{"publicId":"6691992","version":"1","preferredName":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor","longName":"6691992","preferredDefinition":"A non-invasive neoplasm that arises from the ovary and is composed of gastrointestinal-type, mucin-containing epithelial cells.  It shows greater cellular proliferation and cytologic atypia as compared to benign ovarian mucinous tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor","conceptCode":"C122586","definition":"A non-invasive neoplasm that arises from the ovary and is composed of gastrointestinal-type, mucin-containing epithelial cells.  It shows greater cellular proliferation and cytologic atypia as compared to benign ovarian mucinous tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8696A8CA-FA0B-231A-E053-F662850A9016","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8698FFAA-B1EE-0A77-E053-F662850A69FF","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Clear cell borderline tumor/atypical proliferative clear cell tumor","valueDescription":"Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor","ValueMeaning":{"publicId":"6692796","version":"1","preferredName":"Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor","longName":"6692796","preferredDefinition":"A non-invasive clear cell adenofibromatous neoplasm that arises from the ovary. It is characterized by the presence of atypia in the glandular epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor","conceptCode":"C126308","definition":"A non-invasive clear cell adenofibromatous neoplasm that arises from the ovary. It is characterized by the presence of atypia in the glandular epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8698FFAA-B1FB-0A77-E053-F662850A69FF","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"ONEDATA","dateModified":"2019-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8698FFAA-B214-0A77-E053-F662850A69FF","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid borderline tumor/atypical proliferative endometrioid tumor","valueDescription":"Borderline Tumors With Microinvasion Endometrioid","ValueMeaning":{"publicId":"3247941","version":"1","preferredName":"Borderline Tumors With Microinvasion Endometrioid","longName":"3247941","preferredDefinition":"A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor","conceptCode":"C7983","definition":"An epithelial neoplasm that arises from the ovary characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-706A-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8698FFAA-B228-0A77-E053-F662850A69FF","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Seromucinous borderline tumor/atypical proliferative seromucinous tumor","valueDescription":"Borderline Ovarian Mixed Epithelial Tumor","ValueMeaning":{"publicId":"3247936","version":"1","preferredName":"Borderline Ovarian Mixed Epithelial Tumor","longName":"3247936","preferredDefinition":"A low grade ovarian epithelial tumor composed of an admixture of two or more of the five major cell types: serous, mucinous, endometrioid, clear cell, and Brenner/transitional.  The second or second and third cell types must comprise alone or together at least 10% of the tumor epithelium. The majority of patients present with stage I tumor and a minority present with bilateral disease. Morphologically, it shows papillae with detached cell clusters.  Microinvasion may be seen rarely. (WHO 2003)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor","conceptCode":"C7281","definition":"A low grade, non-invasive ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-6FDB-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8698FFAA-B250-0A77-E053-F662850A69FF","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-15","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrioid borderline tumor/atypical proliferative endometrioid tumor with microinvasion","valueDescription":"Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion","ValueMeaning":{"publicId":"6693102","version":"1","preferredName":"Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion","longName":"6693102","preferredDefinition":"A low grade ovarian epithelial neoplasm characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells, and microinvasion of the ovarian stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion","conceptCode":"C159486","definition":"A low grade ovarian epithelial neoplasm characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. Microinvasion of the ovarian stroma is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86A9929E-7926-63F1-E053-F662850A8792","latestVersionIndicator":"Yes","beginDate":"2019-04-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-16","modifiedBy":"ONEDATA","dateModified":"2019-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86A9929E-793F-63F1-E053-F662850A8792","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mixed epithelial borderline (atypical proliferative) tumor","valueDescription":"Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor","ValueMeaning":{"publicId":"6693103","version":"1","preferredName":"Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor","longName":"6693103","preferredDefinition":"A low grade, non-invasive mixed epithelial proliferative neoplasm that arises from the ovary. In most cases is composed of serous and endocervical-type mucinous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor","conceptCode":"C158616","definition":"A low grade, non-invasive mixed epithelial proliferative neoplasm that arises from the ovary. In most cases is composed of serous and endocervical-type mucinous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86A9929E-794B-63F1-E053-F662850A8792","latestVersionIndicator":"Yes","beginDate":"2019-04-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-16","modifiedBy":"ONEDATA","dateModified":"2019-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86A9929E-7964-63F1-E053-F662850A8792","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-16","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinoma cuniculatum","valueDescription":"Oral Cavity Verrucous Carcinoma","ValueMeaning":{"publicId":"6785159","version":"1","preferredName":"Oral Cavity Verrucous Carcinoma","longName":"6785159","preferredDefinition":"A well differentiated squamous cell carcinoma arising from the oral cavity.  It is an exophytic, warty, slow growing tumor, usually affecting older males.  Chronic use of smokeless tobacco is associated with the development of verrucous carcinoma in the oral cavity.  Five year disease-free survival rates between 80% and 90% have been reported in patients who underwent extensive surgical removal of the tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Cavity Verrucous Carcinoma","conceptCode":"C8174","definition":"A well differentiated squamous cell carcinoma arising from the oral cavity.  It is an exophytic, warty, slow growing tumor, usually affecting older males.  Chronic use of smokeless tobacco is associated with the development of verrucous carcinoma in the oral cavity.  Five year disease-free survival rates between 80% and 90% have been reported in patients who underwent extensive surgical removal of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2A5F-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2A78-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Lymphoepithelial carcinoma","valueDescription":"Nasopharyngeal Type Undifferentiated Carcinoma","ValueMeaning":{"publicId":"6785161","version":"1","preferredName":"Nasopharyngeal Type Undifferentiated Carcinoma","longName":"6785161","preferredDefinition":"A nonkeratinizing carcinoma which occurs predominantly in the nasopharynx but also in the tonsils and rarely in other anatomic sites.  It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal-Type Undifferentiated Carcinoma","conceptCode":"C4107","definition":"A nonkeratinizing carcinoma which occurs predominantly in the nasopharynx but also in the tonsils and rarely in other anatomic sites.  It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2A85-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2AA0-1634-E053-F662850A77C2","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Sebaceous adenocarcinoma","valueDescription":"Head and Neck Sebaceous Carcinoma","ValueMeaning":{"publicId":"6785162","version":"1","preferredName":"Head and Neck Sebaceous Carcinoma","longName":"6785162","preferredDefinition":"A sebaceous carcinoma that arises from the skin in the head and neck.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Sebaceous Carcinoma","conceptCode":"C160978","definition":"A sebaceous carcinoma that arises from the head and neck region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA08855-6DB5-4D5A-E053-F662850AC4D2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA08855-6DCE-4D5A-E053-F662850AC4D2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Poorly differentiated carcinoma, large cell neuroendocrine","valueDescription":"Head and Neck Large Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6785163","version":"1","preferredName":"Head and Neck Large Cell Neuroendocrine Carcinoma","longName":"6785163","preferredDefinition":"A large cell neuroendocrine carcinoma that arises from the head and neck.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Large Cell Neuroendocrine Carcinoma","conceptCode":"C160982","definition":"A large cell neuroendocrine carcinoma that arises from the head and neck.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA08855-6DDA-4D5A-E053-F662850AC4D2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA08855-6DF3-4D5A-E053-F662850AC4D2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Poorly differentiated carcinoma, small cell neuroendocrine","valueDescription":"Head and Neck Small Cell Carcinoma","ValueMeaning":{"publicId":"6785164","version":"1","preferredName":"Head and Neck Small Cell Carcinoma","longName":"6785164","preferredDefinition":"A small cell carcinoma that arises from the head and neck.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Small Cell Neuroendocrine Carcinoma","conceptCode":"C160981","definition":"A small cell neuroendocrine carcinoma that arises from the head and neck.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA08855-6DFF-4D5A-E053-F662850AC4D2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA08855-6E18-4D5A-E053-F662850AC4D2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Squamous cell carcinoma, primary","valueDescription":"Primary Neoplasm Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6776197","version":"1","preferredName":"Primary Neoplasm Squamous Cell Carcinoma","longName":"6776197","preferredDefinition":"A tumor at the original site of origin.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7C58-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7C71-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucoepidermoid carcinoma","valueDescription":"Mucoepidermoid Carcinoma","ValueMeaning":{"publicId":"3704622","version":"1","preferredName":"Mucoepidermoid Carcinoma","longName":"3704622","preferredDefinition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3B3E-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7C7B-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"NUT carcinoma","valueDescription":"NUT Carcinoma","ValueMeaning":{"publicId":"6776199","version":"1","preferredName":"NUT Carcinoma","longName":"6776199","preferredDefinition":"A rare, highly aggressive and lethal carcinoma that affects children and young adults.  It arises from midline epithelial structures, most commonly the head, neck, and mediastinum.  It is a poorly differentiated carcinoma and is characterized by mutations and rearrangement of the NUT gene.  A balanced translocation t(15;19) is present that results in the creation of a fusion gene involving the NUT gene, most commonly BRD4-NUT fusion gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NUT Carcinoma","conceptCode":"C45716","definition":"A rare, highly aggressive and lethal carcinoma that affects children and young adults.  It arises from midline epithelial structures, most commonly the head, neck, and mediastinum.  It is a poorly differentiated carcinoma and is characterized by mutations and rearrangement of the NUT gene.  A balanced translocation t(15;19) is present that results in the creation of a fusion gene involving the NUT gene, most commonly BRD4-NUT fusion gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7C88-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7CA1-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sinonasal undifferentiated carcinoma","valueDescription":"Sinonasal Undifferentiated Carcinoma","ValueMeaning":{"publicId":"6776201","version":"1","preferredName":"Sinonasal Undifferentiated Carcinoma","longName":"6776201","preferredDefinition":"A rare, highly aggressive carcinoma that arises from the sinonasal tract.  It is characterized by the presence of small to medium size malignant cells.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Undifferentiated Carcinoma","conceptCode":"C54294","definition":"A rare, highly aggressive carcinoma that arises from the sinonasal tract.  It is characterized by the presence of small to medium size malignant cells.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7CAE-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7CC7-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Minor salivary gland carcinoma","valueDescription":"Minor Salivary Gland Carcinoma","ValueMeaning":{"publicId":"6776203","version":"1","preferredName":"Minor Salivary Gland Carcinoma","longName":"6776203","preferredDefinition":"A carcinoma that arises from the minor salivary glands.  Representative examples include adenoid cystic carcinoma, acinic cell carcinoma, polymorphous low grade adenocarcinoma, and mucinous adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minor Salivary Gland Carcinoma","conceptCode":"C5957","definition":"A carcinoma that arises from the minor salivary glands.  Representative examples include adenoid cystic carcinoma, acinic cell carcinoma, polymorphous low grade adenocarcinoma, and mucinous adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7CD4-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7CED-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Large cell neuroendocrine carcinoma, HPV positive","valueDescription":"Human Papillomavirus Positive Large Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6776204","version":"1","preferredName":"Human Papillomavirus Positive Large Cell Neuroendocrine Carcinoma","longName":"6776204","preferredDefinition":"Indicates that human papillomavirus has been detected in a sample.: A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus Positive","conceptCode":"C128839","definition":"Indicates that human papillomavirus has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7CFA-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7D13-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Large cell neuroendocrine carcinoma, HPV negative","valueDescription":"Human Papillomavirus Negative Large Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6776205","version":"1","preferredName":"Human Papillomavirus Negative Large Cell Neuroendocrine Carcinoma","longName":"6776205","preferredDefinition":"Indicates that human papillomavirus has not been detected in a sample.: A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus Negative","conceptCode":"C131488","definition":"Indicates that human papillomavirus has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7D20-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7D39-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small cell neuroendocrine carcinoma, HPV positive","valueDescription":"Human Papillomavirus Positive Small Cell Carcinoma","ValueMeaning":{"publicId":"6776206","version":"1","preferredName":"Human Papillomavirus Positive Small Cell Carcinoma","longName":"6776206","preferredDefinition":"Indicates that human papillomavirus has been detected in a sample.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus Positive","conceptCode":"C128839","definition":"Indicates that human papillomavirus has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7D46-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7D5F-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small cell neuroendocrine carcinoma, HPV negative","valueDescription":"Human Papillomavirus Negative Small Cell Carcinoma","ValueMeaning":{"publicId":"6776207","version":"1","preferredName":"Human Papillomavirus Negative Small Cell Carcinoma","longName":"6776207","preferredDefinition":"Indicates that human papillomavirus has not been detected in a sample.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus Negative","conceptCode":"C131488","definition":"Indicates that human papillomavirus has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7D6C-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7D85-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Nasopharyngeal papillary adenocarcinoma","valueDescription":"Nasopharyngeal Papillary Adenocarcinoma","ValueMeaning":{"publicId":"6776209","version":"1","preferredName":"Nasopharyngeal Papillary Adenocarcinoma","longName":"6776209","preferredDefinition":"A rare, low-grade exophytic adenocarcinoma with papillary growth that arises from the epithelium of the nasopharynx.  If it is completely removed, the prognosis is excellent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Low Grade Papillary Adenocarcinoma","conceptCode":"C54400","definition":"A low-grade exophytic adenocarcinoma with papillary growth that arises from the epithelium of the nasopharynx. If it is completely removed, the prognosis is excellent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7D92-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7DAB-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Adenocarcinomas (non-salivary gland type)","valueDescription":"Negation Salivary Gland Adenocarcinoma","ValueMeaning":{"publicId":"6776210","version":"1","preferredName":"Negation Salivary Gland Adenocarcinoma","longName":"6776210","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Salivary Gland","conceptCode":"C12426","definition":"An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7DB9-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7DD2-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Hypopharyngeal squamous cell carcinoma","valueDescription":"Hypopharyngeal Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6776212","version":"1","preferredName":"Hypopharyngeal Squamous Cell Carcinoma","longName":"6776212","preferredDefinition":"A squamous cell carcinoma arising from the hypopharynx.  Signs and symptoms include dysphagia, hemoptysis, and the presence of a neck mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypopharyngeal Squamous Cell Carcinoma","conceptCode":"C4043","definition":"A squamous cell carcinoma arising from the hypopharynx.  Signs and symptoms include dysphagia, hemoptysis, and the presence of a neck mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7DDF-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7DF8-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Oropharyngeal squamous cell carcinoma, HPV status unknown","valueDescription":"Oropharyngeal Carcinoma Human Papillomavirus Status Unknown Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6776213","version":"1","preferredName":"Oropharyngeal Carcinoma Human Papillomavirus Status Unknown Squamous Cell Carcinoma","longName":"6776213","preferredDefinition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx.: A strain of papillomavirus that can infect the skin and mucous membranes of humans.: A condition or state at a particular time.: Not known, not observed, not recorded, or refused.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal Carcinoma","conceptCode":"C9105","definition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Human Papillomavirus","conceptCode":"C14226","definition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7E08-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7E21-69CA-E053-F662850AE722","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Poorly differentiated neuroendocrine carcinoma, large cell","valueDescription":"Large Cell Neuroendocrine Carcinoma Poorly Differentiated","ValueMeaning":{"publicId":"6776214","version":"1","preferredName":"Large Cell Neuroendocrine Carcinoma Poorly Differentiated","longName":"6776214","preferredDefinition":"A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.: Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AB22F55-7E2E-69CA-E053-F662850AE722","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AB22F55-7E47-69CA-E053-F662850AE722","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Mucosal melanoma","valueDescription":"Mucosal Melanoma","ValueMeaning":{"publicId":"4319892","version":"1","preferredName":"Mucosal Melanoma","longName":"4319892","preferredDefinition":"A melanoma that arises from a mucosal site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucosal Melanoma","conceptCode":"C114828","definition":"A melanoma that arises from a mucosal site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F971C6DB-2E91-E194-E040-BB89AD430734","latestVersionIndicator":"Yes","beginDate":"2014-05-15","endDate":null,"createdBy":"PWEST","dateCreated":"2014-05-15","modifiedBy":"ONEDATA","dateModified":"2014-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A9A577E-6E88-28E0-E053-F662850A703D","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Poorly differentiated neuroendocrine carcinoma, small cell","valueDescription":"Poorly Differentiated Small Cell Carcinoma","ValueMeaning":{"publicId":"6775247","version":"1","preferredName":"Poorly Differentiated Small Cell Carcinoma","longName":"6775247","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A9A577E-6EBC-28E0-E053-F662850A703D","latestVersionIndicator":"Yes","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"ONEDATA","dateModified":"2019-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A9A577E-6ED5-28E0-E053-F662850A703D","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Carcinosarcoma","valueDescription":"Carcinosarcoma","ValueMeaning":{"publicId":"3248559","version":"1","preferredName":"Carcinosarcoma","longName":"3248559","preferredDefinition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinosarcoma","conceptCode":"C34448","definition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BD1E-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A982E4D-3B70-6855-E053-F662850A5F6A","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Myoepithelial carcinoma","valueDescription":"Malignant Myoepithelioma","ValueMeaning":{"publicId":"3248547","version":"1","preferredName":"Malignant Myoepithelioma","longName":"3248547","preferredDefinition":"An infiltrating malignant epithelial neoplasm characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Myoepithelioma","conceptCode":"C7596","definition":"An infiltrating malignant tumor characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BB70-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A982E4D-3B66-6855-E053-F662850A5F6A","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Squamous cell carcinoma, conventional","valueDescription":"Convention Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6788531","version":"1","preferredName":"Convention Squamous Cell Carcinoma","longName":"6788531","preferredDefinition":"Something regarded as a normative example.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Convention","conceptCode":"C61300","definition":"Something regarded as a normative example.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDADE54-5426-02E3-E053-F662850AF61E","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDADE54-543F-02E3-E053-F662850AF61E","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Salivary oncocytic carcinoma","valueDescription":"Salivary Gland Oncocytic Carcinoma","ValueMeaning":{"publicId":"6921703","version":"1","preferredName":"Salivary Gland Oncocytic Carcinoma","longName":"6921703","preferredDefinition":"A high grade adenocarcinoma that arises from the salivary glands. The vast majority of cases have been described in the parotid gland.  It is characterized by the presence of malignant oncocytes.  It recurs and metastasizes to regional or distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Oncocytic Adenocarcinoma","conceptCode":"C62194","definition":"A high grade adenocarcinoma that arises from the salivary glands. The vast majority of cases have been described in the parotid gland.  It is characterized by the presence of malignant oncocytes.  It recurs and metastasizes to regional or distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"921F17EB-A72D-444E-E053-F662850AAEC8","latestVersionIndicator":"Yes","beginDate":"2019-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-09","modifiedBy":"ONEDATA","dateModified":"2019-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"921F17EB-A746-444E-E053-F662850AAEC8","beginDate":"2019-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-09","modifiedBy":"ONEDATA","dateModified":"2019-09-09","deletedIndicator":"No"},{"value":"Oncocytic carcinoma","valueDescription":"Oxyphilic Adenocarcinoma","ValueMeaning":{"publicId":"3248544","version":"1","preferredName":"Oxyphilic Adenocarcinoma","longName":"3248544","preferredDefinition":"An adenocarcinoma characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). Representative examples include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, and salivary gland oncocytic carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncocytic Adenocarcinoma","conceptCode":"C3679","definition":"An adenocarcinoma characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). Representative examples include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, and salivary gland oncocytic carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BAE7-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"921F17EB-A75A-444E-E053-F662850AAEC8","beginDate":"2019-06-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-09","modifiedBy":"ONEDATA","dateModified":"2019-09-09","deletedIndicator":"No"},{"value":"Non-intestinal adenocarcinoma","valueDescription":"Sinonasal Adenocarcinoma, Non-Intestinal-Type","ValueMeaning":{"publicId":"6785141","version":"1","preferredName":"Sinonasal Adenocarcinoma, Non-Intestinal-Type","longName":"6785141","preferredDefinition":"An adenocarcinoma that arises from the sinonasal tract. It is characterized by the absence of features that resemble intestinal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Adenocarcinoma, Non-Intestinal-Type ","conceptCode":"C160977","definition":"An adenocarcinoma that arises from the sinonasal tract. It is characterized by the absence of features that resemble intestinal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2875-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-288E-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Intestinal adenocarcinoma, mixed pattern","valueDescription":"Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern","ValueMeaning":{"publicId":"6785142","version":"1","preferredName":"Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern","longName":"6785142","preferredDefinition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a mixture of growth patterns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern","conceptCode":"C161000","definition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a mixture of growth patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-289A-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-28B3-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Intestinal adenocarcinoma, mucinous pattern","valueDescription":"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern","ValueMeaning":{"publicId":"6785143","version":"1","preferredName":"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern","longName":"6785143","preferredDefinition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of malignant glandular cells with intracytoplasmic mucin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern","conceptCode":"C160995","definition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of malignant glandular cells with intracytoplasmic mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-28BF-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-28D8-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Intestinal adenocarcinoma, solid pattern","valueDescription":"Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern","ValueMeaning":{"publicId":"6785144","version":"1","preferredName":"Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern","longName":"6785144","preferredDefinition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a solid growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern","conceptCode":"C160987","definition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a solid growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-28E4-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-28FD-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Intestinal adenocarcinoma, colonic pattern","valueDescription":"Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern","ValueMeaning":{"publicId":"6785145","version":"1","preferredName":"Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern","longName":"6785145","preferredDefinition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a tubuloglandular growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern","conceptCode":"C160986","definition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a tubuloglandular growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2909-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2922-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Intestinal adenocarcinoma, papillary pattern","valueDescription":"Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern","ValueMeaning":{"publicId":"6785146","version":"1","preferredName":"Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern","longName":"6785146","preferredDefinition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a papillary growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern","conceptCode":"C160984","definition":"An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a papillary growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-292E-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2947-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Squamous cell carcinoma, nonkeratinizing","valueDescription":"Non-Keratinizing Sinonasal Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6785148","version":"1","preferredName":"Non-Keratinizing Sinonasal Squamous Cell Carcinoma","longName":"6785148","preferredDefinition":"A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Non-Keratinizing Squamous Cell Carcinoma","conceptCode":"C54287","definition":"A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2954-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-296D-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"HPV-unrelated squamous cell carcinoma","valueDescription":"p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6785150","version":"1","preferredName":"p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma","longName":"6785150","preferredDefinition":"An oropharyngeal squamous cell carcinoma which is negative for p16INK4a by immunohistochemistry. This negative immunohistochemistry result does not exclude human papillomavirus infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma","conceptCode":"C147906","definition":"An oropharyngeal squamous cell carcinoma which is negative for p16INK4a by immunohistochemistry. This negative immunohistochemistry result does not exclude human papillomavirus infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-297A-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2993-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"HPV-mediated squamous cell carcinoma","valueDescription":"Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6785152","version":"1","preferredName":"Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma","longName":"6785152","preferredDefinition":"A squamous cell carcinoma associated with human papilloma type 16 virus, arising from the oropharynx.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal Human Papillomavirus-Related Squamous Cell Carcinoma","conceptCode":"C87055","definition":"A squamous cell carcinoma that arises from the oropharynx and is associated with human papillomavirus type 16 infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-29A0-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-29B9-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Marginal zone lymphoma, NOS","valueDescription":"Marginal Zone Lymphoma Not Otherwise Specified","ValueMeaning":{"publicId":"6859290","version":"1","preferredName":"Marginal Zone Lymphoma Not Otherwise Specified","longName":"6859290","preferredDefinition":"A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues.  It is characterized by the presence of small to medium sized atypical lymphocytes.  It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of extranodal disease; and splenic marginal zone B-cell lymphoma, which affects the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Marginal Zone Lymphoma","conceptCode":"C4341","definition":"A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues.  It is characterized by the presence of small to medium sized atypical lymphocytes.  It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of extranodal disease; and splenic marginal zone B-cell lymphoma, which affects the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A67B18-A4B0-33DB-E053-F662850A68F6","latestVersionIndicator":"Yes","beginDate":"2019-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90A67B18-A4C9-33DB-E053-F662850A68F6","beginDate":"2019-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","deletedIndicator":"No"},{"value":"Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)","valueDescription":"Chronic Lymphocytic Leukemia And/Or Small Lymphocytic Lymphoma","ValueMeaning":{"publicId":"6859291","version":"1","preferredName":"Chronic Lymphocytic Leukemia And/Or Small Lymphocytic Lymphoma","longName":"6859291","preferredDefinition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001): Used to indicate that either or both of two items or options may be valid.: A non-Hodgkin lymphoma composed of monomorphic small, round B-lymphocytes in the lymph nodes.  When the lymphoid process predominantly involves the bone marrow and the peripheral blood it is called chronic lymphocytic leukemia. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Lymphocytic Lymphoma","conceptCode":"C7540","definition":"A non-Hodgkin lymphoma composed of monomorphic small, round B-lymphocytes in the lymph nodes.  When the lymphoid process predominantly involves the bone marrow and the peripheral blood it is called chronic lymphocytic leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A67B18-A4D7-33DB-E053-F662850A68F6","latestVersionIndicator":"Yes","beginDate":"2019-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90A67B18-A4F0-33DB-E053-F662850A68F6","beginDate":"2019-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","deletedIndicator":"No"},{"value":"Follicular lymphoma","valueDescription":"Follicular Lymphoma","ValueMeaning":{"publicId":"3088584","version":"1","preferredName":"Follicular Lymphoma","longName":"3088584","preferredDefinition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Lymphoma","conceptCode":"C3209","definition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E3DD57-D19B-A26A-E040-BB89AD437117","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-18","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90A67B18-A4FA-33DB-E053-F662850A68F6","beginDate":"2019-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-21","modifiedBy":"ONEDATA","dateModified":"2019-08-21","deletedIndicator":"No"},{"value":"High grade serous carcinoma","valueDescription":"High Grade Ovarian Serous Adenocarcinoma","ValueMeaning":{"publicId":"6742161","version":"1","preferredName":"High Grade Ovarian Serous Adenocarcinoma","longName":"6742161","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.: An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ovarian Serous Adenocarcinoma","conceptCode":"C7550","definition":"An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88416AFE-1A0F-1513-E053-F662850AA523","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1A28-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Low grade serous carcinoma","valueDescription":"Low Grade Ovarian Serous Adenocarcinoma","ValueMeaning":{"publicId":"6742163","version":"1","preferredName":"Low Grade Ovarian Serous Adenocarcinoma","longName":"6742163","preferredDefinition":"A slow-growing serous adenocarcinoma that arises from the ovary.  It usually originates from borderline neoplastic processes or adenofibromas.  It is characterized by the presence of low grade cytologic features and infrequent mitotic figures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Low Grade Serous Adenocarcinoma","conceptCode":"C105556","definition":"A slow-growing serous adenocarcinoma that arises from the ovary.  It usually originates from borderline neoplastic processes or adenofibromas.  It is characterized by the presence of low grade cytologic features and infrequent mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88416AFE-1A35-1513-E053-F662850AA523","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1A4E-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Small cell carcinoma, pulmonary type","valueDescription":"Ovarian Small Cell Carcinoma, Pulmonary Type","ValueMeaning":{"publicId":"6742165","version":"1","preferredName":"Ovarian Small Cell Carcinoma, Pulmonary Type","longName":"6742165","preferredDefinition":"An aggressive small cell neuroendocrine carcinoma that arises from the ovary.  Morphologically, it resembles the small cell carcinoma that arises from the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Small Cell Carcinoma, Pulmonary-Type","conceptCode":"C40440","definition":"An aggressive small cell neuroendocrine carcinoma that arises from the ovary.  Morphologically, it resembles the small cell carcinoma that arises from the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88416AFE-1A5B-1513-E053-F662850AA523","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1A74-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Choriocarcinoma, non-gestational","valueDescription":"Non-Gestational Ovarian Choriocarcinoma","ValueMeaning":{"publicId":"6742167","version":"1","preferredName":"Non-Gestational Ovarian Choriocarcinoma","longName":"6742167","preferredDefinition":"A malignant germ cell tumor that arises from the ovary and is composed of cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts.  The prognosis is less favorable than gestational choriocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Gestational Ovarian Choriocarcinoma","conceptCode":"C39991","definition":"A malignant germ cell tumor that arises from the ovary and is composed of cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts.  The prognosis is less favorable than gestational choriocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88416AFE-1A81-1513-E053-F662850AA523","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1A9A-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Embryonal carcinoma","valueDescription":"Embryonal Carcinoma","ValueMeaning":{"publicId":"2838044","version":"1","preferredName":"Embryonal Carcinoma","longName":"2838044","preferredDefinition":"A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Carcinoma","conceptCode":"C3752","definition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62837FF7-8551-6F46-E040-BB89AD433964","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1AA4-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Other sex cord-stromal tumor","valueDescription":"Other Sex Cord-Stromal Tumor","ValueMeaning":{"publicId":"6742168","version":"1","preferredName":"Other Sex Cord-Stromal Tumor","longName":"6742168","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A neoplasm arising in the ovary or testis. It is composed of granulosa cells, Leydig cells, Sertoli cells, and fibroblasts. Each of these cell types may constitute the only cellular component that is present in the neoplasm or it may be mixed with other cell types in various combinations. The prognosis can not always be predicted on histologic grounds alone. Approximately, 10% of these tumors may metastasize. Representative examples include granulosa cell tumor, Leydig cell tumor, Sertoli cell tumor, and tumors of the thecoma-fibroma group.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sex Cord-Stromal Tumor","conceptCode":"C3794","definition":"A neoplasm arising in the ovary or testis. It is composed of granulosa cells, Leydig cells, Sertoli cells, and fibroblasts. Each of these cell types may constitute the only cellular component that is present in the neoplasm or it may be mixed with other cell types in various combinations. The prognosis can not always be predicted on histologic grounds alone. Approximately, 10% of these tumors may metastasize. Representative examples include granulosa cell tumor, Leydig cell tumor, Sertoli cell tumor, and tumors of the thecoma-fibroma group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88416AFE-1AB1-1513-E053-F662850AA523","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"ONEDATA","dateModified":"2019-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1ACA-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Sertoli-Leydig cell tumor","valueDescription":"Ovarian Sertoli-Leydig Cell Tumor","ValueMeaning":{"publicId":"3210869","version":"1","preferredName":"Ovarian Sertoli-Leydig Cell Tumor","longName":"3210869","preferredDefinition":"A benign or malignant sex cord-stromal tumor arising from the ovary. It is characterized by the presence of neoplastic Leydig cells. Signs and symptoms include hirsutism, menorrhagia and metrorrhagia. It may be associated with trisomy 8.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Sertoli-Leydig Cell Tumor","conceptCode":"C2880","definition":"A benign or malignant sex cord-stromal tumor arising from the ovary. It is characterized by the presence of neoplastic Leydig cells. Signs and symptoms include hirsutism, menorrhagia and metrorrhagia. It may be associated with trisomy 8.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-AD3C-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88416AFE-1ADE-1513-E053-F662850AA523","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-05-06","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Intraductal carcinoma","valueDescription":"Salivary Gland Low Grade Cribriform Cystadenocarcinoma","ValueMeaning":{"publicId":"6785154","version":"1","preferredName":"Salivary Gland Low Grade Cribriform Cystadenocarcinoma","longName":"6785154","preferredDefinition":"A rare, low-grade adenocarcinoma that arises from the salivary glands.  It is characterized by the presence of cystic structures lined by ductal cells which are arranged in cribriform patterns.  Adjacent ducts show intraductal proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Intraductal Carcinoma","conceptCode":"C62192","definition":"A rare, low-grade adenocarcinoma that arises from the salivary glands.  It is characterized by the presence of cystic structures lined by ductal cells which are arranged in cribriform patterns.  Adjacent ducts show intraductal proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-29DA-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-29F3-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Secretory carcinoma","valueDescription":"Mammary Analog Secretory Carcinoma of Salivary Gland","ValueMeaning":{"publicId":"6785156","version":"1","preferredName":"Mammary Analog Secretory Carcinoma of Salivary Gland","longName":"6785156","preferredDefinition":"A rare, low-grade carcinoma of the salivary gland with favorable clinical outcome.  It usually arises from the parotid gland and less often from the minor salivary glands.  It shares the same histopathologic features and molecular characteristics (ETV6 gene rearrangement) with secretory breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Secretory Carcinoma","conceptCode":"C123384","definition":"A rare, low-grade carcinoma of the salivary gland with favorable clinical outcome.  It usually arises from the parotid gland and less often from the minor salivary glands.  It shares the same histopathologic features and molecular characteristics (ETV6 gene rearrangement) with secretory breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2A00-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2A19-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Polymorphous adenocarcinoma, classic","valueDescription":"Salivary Gland Polymorphous Low Grade Adenocarcinoma","ValueMeaning":{"publicId":"3248539","version":"1","preferredName":"Salivary Gland Polymorphous Low Grade Adenocarcinoma","longName":"3248539","preferredDefinition":"A low grade malignant epithelial neoplasm arising from the salivary gland. It usually arises from the oral cavity, with approximately 60% of the cases involving the palate. The most common presenting sign is a painless mass in the palate. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. There is a variety of morphologic patterns which may be present within an individual tumor, including lobular, papillary, papillary-cystic, cribriform, and trabecular pattern. It usually has a favorable clinical outcome and a low metastatic potential.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Polymorphous Adenocarcinoma","conceptCode":"C35702","definition":"A low grade malignant epithelial neoplasm arising from the salivary gland. It usually arises from the oral cavity, with approximately 60% of the cases involving the palate. The most common presenting sign is a painless mass in the palate. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. There is a variety of morphologic patterns which may be present within an individual tumor, including lobular, papillary, papillary-cystic, cribriform, and trabecular pattern. It usually has a favorable clinical outcome and a low metastatic potential.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BA76-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA212CA-2A52-1634-E053-F662850A77C2","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Mucinous tubular and spindle renal cell carcinoma","valueDescription":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","ValueMeaning":{"publicId":"5210420","version":"1","preferredName":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","longName":"5210420","preferredDefinition":"A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance.  Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Tubular and Spindle Cell Carcinoma of the Kidney","conceptCode":"C39807","definition":"A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance.  Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-65D0-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DBD1-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"t(6;11) renal cell carcinoma","valueDescription":"Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB","ValueMeaning":{"publicId":"6789037","version":"1","preferredName":"Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB","longName":"6789037","preferredDefinition":"An extremely rare renal cell carcinoma affecting young patients. It is characterized by the presence of the specific chromosomal translocation t(6;11);(p21;q12) which fuses the MALAT1 gene with the TFEB transcription factor gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TFEB-Rearranged Renal Cell Carcinoma","conceptCode":"C37210","definition":"A rare renal cell carcinoma affecting young patients. It is characterized by the presence of the chromosomal translocation t(6;11) which fuses the TFEB transcription factor gene, located on chromosome 6, with the MALAT1 gene, located on chromosome 11.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DBDF-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DBF8-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Xp11 translocation renal cell carcinoma","valueDescription":"Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions","ValueMeaning":{"publicId":"5210414","version":"1","preferredName":"Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions","longName":"5210414","preferredDefinition":"A group of kidney carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2.  These translocations result in the creation of gene fusions involving the TFE3 gene.  Patients are usually children and young adults.  Morphologically, the malignant epithelial cells form papillary patterns.  The clinical behavior of this group of carcinomas is largely unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TFE3-Rearranged Renal Cell Carcinoma","conceptCode":"C27891","definition":"A group of renal cell carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the creation of gene fusions involving the TFE3 gene. Patients are usually children and young adults. Morphologically, the malignant epithelial cells form papillary patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-6549-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC0C-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"MiT family translocation renal cell carcinoma","valueDescription":"MiT Family Translocation-Associated Renal Cell Carcinoma","ValueMeaning":{"publicId":"6789039","version":"1","preferredName":"MiT Family Translocation-Associated Renal Cell Carcinoma","longName":"6789039","preferredDefinition":"A renal cell carcinoma (RCC) usually seen in children or young adults. It is characterized by papillary, alveolar and nested growth patterns with clear and eosinophilic cells. The carcinomas range from microscopic lesions to clinically symptomatic tumors. It is associated with translocations/gene fusions involving members of the MiT family of transcription factors, including TFE3 and TFEB. There are two subtypes; RCCs associated with Xp11 translocations and TFE3 gene fusions and RCCs with t(6:11) translocations resulting in MALAT1-TFEB gene fusions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma with MiT Translocations","conceptCode":"C154494","definition":"A renal cell carcinoma usually seen in children or young adults. It is characterized by papillary, alveolar and nested growth patterns with clear and eosinophilic cells. The carcinomas range from microscopic lesions to clinically symptomatic tumors. It is associated with translocations/gene fusions involving members of the MiT family of transcription factors. There are two subtypes: TFE3-rearranged renal cell carcinoma [Xp11 translocation renal cell carcinoma] and TFEB-rearranged renal cell carcinoma [t(6;11) renal cell carcinoma].","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DC19-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC32-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Renal medullary carcinoma","valueDescription":"Kidney Medullary Carcinoma","ValueMeaning":{"publicId":"5210416","version":"1","preferredName":"Kidney Medullary Carcinoma","longName":"5210416","preferredDefinition":"A recently described type of renal carcinoma, affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Medullary Carcinoma","conceptCode":"C7572","definition":"A type of renal carcinoma affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-656F-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC3C-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Collecting duct carcinoma","valueDescription":"Carcinoma of the Collecting Ducts of Bellini","ValueMeaning":{"publicId":"2581666","version":"1","preferredName":"Carcinoma of the Collecting Ducts of Bellini","longName":"2581666","preferredDefinition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Duct Carcinoma","conceptCode":"C6194","definition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-09","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC46-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Papillary renal cell carcinoma, Type 2","valueDescription":"Type 2 papillary renal cell carcinoma","ValueMeaning":{"publicId":"3104934","version":"1","preferredName":"Type 2 papillary renal cell carcinoma","longName":"3104934v1.00","preferredDefinition":"A papillary renal cell carcinoma characterized by the presence of papillae covered by cells of a higher nuclear grade as compared to type 1 papillary renal cell carcinoma. The cells have eosinophilic cytoplasm and pseudostratified nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 2 Papillary Renal Cell Carcinoma","conceptCode":"C27887","definition":"A papillary renal cell carcinoma characterized by the presence of papillae covered by cells of a higher nuclear grade as compared to type 1 papillary renal cell carcinoma. The cells have eosinophilic cytoplasm and pseudostratified nuclei.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"880FA7DD-4B58-5166-E040-BB89AD436741","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC5A-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Papillary renal cell carcinoma, Type 1","valueDescription":"Type 1 papillary renal cell carcinoma","ValueMeaning":{"publicId":"3104935","version":"1","preferredName":"Type 1 papillary renal cell carcinoma","longName":"3104935v1.00","preferredDefinition":"A papillary renal cell carcinoma characterized by the presence of papillae covered by small cells with scant amount of cytoplasm. The cells are arranged in a single layer on the basement membrane of the papillae.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 1 Papillary Renal Cell Carcinoma","conceptCode":"C27886","definition":"A papillary renal cell carcinoma characterized by the presence of papillae covered by small cells with scant amount of cytoplasm. The cells are arranged in a single layer on the basement membrane of the papillae.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"880FA7DD-4B7B-5166-E040-BB89AD436741","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC6E-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Multilocular cystic clear cell renal cell neoplasm of low malignant potential","valueDescription":"Multilocular Cystic Renal Cell Carcinoma","ValueMeaning":{"publicId":"5210418","version":"1","preferredName":"Multilocular Cystic Renal Cell Carcinoma","longName":"5210418","preferredDefinition":"A rare type of renal cell carcinoma.  It is a well-circumscribed multicystic mass without solid areas.  The inner lining of the cystic structures is composed of clear cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multilocular Cystic Renal Neoplasm of Low Malignant Potential","conceptCode":"C4524","definition":"A rare kidney neoplasm of low malignant potential.  It is a well-circumscribed multicystic mass without solid areas.  The inner lining of the cystic structures is composed of clear cells. It usually presents as a unilateral solitary mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-65AA-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC82-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Clear cell renal cell carcinoma","valueDescription":"Clear Cell Renal Cell Carcinoma","ValueMeaning":{"publicId":"3248533","version":"1","preferredName":"Clear Cell Renal Cell Carcinoma","longName":"3248533","preferredDefinition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Renal Cell Carcinoma","conceptCode":"C4033","definition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B9CF-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DC8D-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Acantholytic Cuniculatum","valueDescription":"Acantholytic Cuniculatum","ValueMeaning":{"publicId":"6776196","version":"1","preferredName":"Acantholytic Cuniculatum","longName":"6776196","preferredDefinition":"Acantholytic Cuniculatum","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AA9DC49-3B1E-1DBE-E053-F662850A4A1F","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AA9DC49-3B37-1DBE-E053-F662850A4A1F","beginDate":"2019-06-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Acantholytic squamous cell skin carcinoma","valueDescription":"Acantholytic Squamous Cell Skin Carcinoma","ValueMeaning":{"publicId":"4263939","version":"1","preferredName":"Acantholytic Squamous Cell Skin Carcinoma","longName":"4263939v1.00","preferredDefinition":"A histologic variant of squamous cell carcinoma that arises from the skin. It is characterized by loosening of the intercellular bridges between the malignant cells which results in acantholysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Acantholytic Squamous Cell Carcinoma","conceptCode":"C4460","definition":"A histologic variant of squamous cell carcinoma that arises from the skin. It is characterized by loosening of the intercellular bridges between the malignant cells which results in acantholysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63D55FF-34E4-F699-E040-BB89AD433A6C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"CLOHNES","dateModified":"2023-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AA9DC49-3B4B-1DBE-E053-F662850A4A1F","beginDate":"2019-05-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Neuroendocrine prostate carcinoma (NEPC)","valueDescription":"Prostate Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"6814231","version":"1","preferredName":"Prostate Neuroendocrine Carcinoma","longName":"6814231","preferredDefinition":"A small cell or rarely a large cell neuroendocrine carcinoma that arises from the prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Neuroendocrine Carcinoma","conceptCode":"C158912","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the prostate gland. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D430FCC-01AA-40BD-E053-F662850AF8E0","latestVersionIndicator":"Yes","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D430FCC-01C3-40BD-E053-F662850AF8E0","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"Isolated intraductal carcinoma","valueDescription":"Isolation Intraductal Prostate Carcinoma","ValueMeaning":{"publicId":"6814232","version":"1","preferredName":"Isolation Intraductal Prostate Carcinoma","longName":"6814232","preferredDefinition":"A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements.: An intra-acinar and/or intraductal neoplastic epithelial proliferation in the prostate gland that has some features of high-grade prostatic intraepithelial neoplasia but exhibits much greater architectural and/or cytological atypia, typically associated with high-grade, high-stage prostate carcinoma. (WHO 2016)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Isolation","conceptCode":"C25549","definition":"A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prostate Intraductal Carcinoma","conceptCode":"C161022","definition":"An intra-acinar and/or intraductal neoplastic epithelial proliferation in the prostate gland that has some features of high-grade prostatic intraepithelial neoplasia but exhibits much greater architectural and/or cytological atypia, typically associated with high-grade, high-stage prostate carcinoma. (WHO 2016)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D430FCC-01D0-40BD-E053-F662850AF8E0","latestVersionIndicator":"Yes","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D430FCC-01E9-40BD-E053-F662850AF8E0","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"Carcinoma; small-cell neuroendocrine; prostate","valueDescription":"Prostate Small Cell Carcinoma","ValueMeaning":{"publicId":"2581148","version":"1","preferredName":"Prostate Small Cell Carcinoma","longName":"2581148","preferredDefinition":"A neuroendocrine carcinoma of the prostate gland with unfavorable prognosis. It is composed of small cells containing neurosecretory granules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Small Cell Neuroendocrine Carcinoma","conceptCode":"C6766","definition":"A rare small cell neuroendocrine carcinoma that arises from the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A09-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D430FCC-01FD-40BD-E053-F662850AF8E0","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"Adenocarcinoma, prostate ductal","valueDescription":"Prostate Ductal Adenocarcinoma","ValueMeaning":{"publicId":"2577131","version":"1","preferredName":"Prostate Ductal Adenocarcinoma","longName":"2577131","preferredDefinition":"A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Ductal Adenocarcinoma","conceptCode":"C6813","definition":"A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA58-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D430FCC-0211-40BD-E053-F662850AF8E0","beginDate":"2019-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-09","modifiedBy":"ONEDATA","dateModified":"2019-07-09","deletedIndicator":"No"},{"value":"Renal cell carcinoma, unclassified","valueDescription":"Unclassified Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118711","version":"1","preferredName":"Unclassified Renal Cell Carcinoma","longName":"5118711","preferredDefinition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified Renal Cell Carcinoma","conceptCode":"C27892","definition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-3928-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DB00-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Succinate dehydrogenase (SDH) deficient renal cell carcinoma","valueDescription":"Succinate Dehydrogenase-Deficient Renal Cell Carcinoma","ValueMeaning":{"publicId":"6789028","version":"1","preferredName":"Succinate Dehydrogenase-Deficient Renal Cell Carcinoma","longName":"6789028","preferredDefinition":"A very rare renal cell carcinoma that usually affects young adults. It is characterized by the presence of vacuolated, eosinophilic to clear neoplastic cells and loss of immunohistochemical expression of succinate dehydrogenase (SDH) B. In most cases germline mutations in an SDH gene (SDHA, SDHB, SDHC, or SDHD gene) are present. It has a relatively good prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Succinate Dehydrogenase-Deficient Renal Cell Carcinoma","conceptCode":"C156464","definition":"A very rare renal cell carcinoma that usually affects young adults. It is characterized by mutations in one of the four subunits of the SDH complex (SDHA, SDHB, SDHC, or SDHD gene). Most frequently, the mutations occur in the SDHB subunit. It has a relatively good prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DB0D-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DB26-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma","valueDescription":"Hereditary Leiomyomatosis and Renal Cell Cancer","ValueMeaning":{"publicId":"6789030","version":"1","preferredName":"Hereditary Leiomyomatosis and Renal Cell Cancer","longName":"6789030","preferredDefinition":"An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to leiomyomas of the skin and uterus, renal cell carcinoma, and leiomyosarcoma of the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Leiomyomatosis and Renal Cell Carcinoma","conceptCode":"C51302","definition":"An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to renal cell carcinoma, leiomyomas of the skin and uterus, and leiomyosarcoma of the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DB33-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DB4C-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Clear cell papillary renal cell carcinoma","valueDescription":"Clear Cell Papillary Renal Neoplasm","ValueMeaning":{"publicId":"6789032","version":"1","preferredName":"Clear Cell Papillary Renal Neoplasm","longName":"6789032","preferredDefinition":"An encapsulated epithelial neoplasm that arises from the kidney. It is composed of cytologically bland epithelial cells with clear cytoplasm forming tubular and papillary patterns. The nuclei are arranged linearly away from the basement membrane. Tumor necrosis, perirenal invasion, and vascular invasion are not present. The clinical course is indolent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Papillary Renal Tumor","conceptCode":"C121955","definition":"An encapsulated epithelial neoplasm that arises from the kidney. It is composed of cytologically bland epithelial cells with clear cytoplasm forming tubular and papillary patterns. The nuclei are arranged linearly away from the basement membrane. Tumor necrosis, perirenal invasion, and vascular invasion are not present. The clinical course is indolent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DB59-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DB72-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Acquired cystic disease associated renal cell carcinoma","valueDescription":"Acquired Cystic Disease-Associated Renal Cell Carcinoma","ValueMeaning":{"publicId":"6789034","version":"1","preferredName":"Acquired Cystic Disease-Associated Renal Cell Carcinoma","longName":"6789034","preferredDefinition":"The most common renal cell carcinoma that develops in patients with end-stage renal disease and acquired cystic disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Cystic Disease-Associated Renal Cell Carcinoma","conceptCode":"C157718","definition":"The most common renal cell carcinoma that develops in patients with end-stage renal disease and acquired cystic disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DB7F-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DB98-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Tubulocystic renal cell carcinoma","valueDescription":"Tubulocystic Renal Cell Carcinoma","ValueMeaning":{"publicId":"6789035","version":"1","preferredName":"Tubulocystic Renal Cell Carcinoma","longName":"6789035","preferredDefinition":"A rare, cytologically high grade carcinoma that arises from the renal parenchyma. It is characterized by the presence of prominently dilated cystic spaces in a bland, fibrotic stroma. The lining cells have large irregular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Necrosis and mitotic figures are not present. It rarely metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubulocystic Renal Cell Carcinoma","conceptCode":"C126303","definition":"A rare, cytologically high grade carcinoma that arises from the renal parenchyma. It is characterized by the presence of prominently dilated cystic spaces in a bland, fibrotic stroma. The lining cells have large irregular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Necrosis and mitotic figures are not present. It rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DBA4-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BDAECC9-DBBD-02E9-E053-F662850AABB5","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","deletedIndicator":"No"},{"value":"Phyllodes Tumor","valueDescription":"Phyllodes Tumor","ValueMeaning":{"publicId":"3293674","version":"1","preferredName":"Phyllodes Tumor","longName":"3293674","preferredDefinition":"A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phyllodes Tumor","conceptCode":"C2977","definition":"A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF074E37-E51B-1C17-E040-BB89AD431694","latestVersionIndicator":"Yes","beginDate":"2011-10-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1A0DBC-52F3-7994-E053-F662850A8233","beginDate":"2019-06-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Basal cell adenocarcinoma","valueDescription":"Salivary Gland Basal Cell Adenocarcinoma","ValueMeaning":{"publicId":"5053392","version":"1","preferredName":"Salivary Gland Basal Cell Adenocarcinoma","longName":"5053392","preferredDefinition":"A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells.  While morphologically resembling basal cell carcinomas, it is a distinct entity.  The tumor is not encapsulated, may invade locally, and less frequently may metastasize.  It usually occurs in older patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Basal Cell Adenocarcinoma","conceptCode":"C3678","definition":"A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells.  While morphologically resembling basal cell carcinomas, it is a distinct entity.  The tumor is not encapsulated, may invade locally, and less frequently may metastasize.  It usually occurs in older patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"253E0DBD-46A1-EA96-E050-BB89AD434FF8","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A956DE3-1059-246C-E053-F662850ABDDA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Epithelial-myoepithelial carcinoma","valueDescription":"Epithelial-Myoepithelial Carcinoma","ValueMeaning":{"publicId":"3248470","version":"1","preferredName":"Epithelial-Myoepithelial Carcinoma","longName":"3248470","preferredDefinition":"A malignant neoplasm which occurs mostly in the major salivary glands (most frequently in the parotid gland), but also in the minor salivary glands of the oral mucosa and the tracheobronchial tree. It is characterized by the presence of ductal structures which are lined by an inner layer of cuboidal epithelial-type cells and an outer layer of myoepithelial cells with clear or eosinophilic cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial-Myoepithelial Carcinoma","conceptCode":"C4199","definition":"A malignant neoplasm which occurs mostly in the major salivary glands (most frequently in the parotid gland), but also in the minor salivary glands of the oral mucosa and the tracheobronchial tree. It is characterized by the presence of ductal structures which are lined by an inner layer of cuboidal epithelial-type cells and an outer layer of myoepithelial cells with clear or eosinophilic cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B722DF-A86F-76E3-E040-BB89AD43333E","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A956DE3-106D-246C-E053-F662850ABDDA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Salivary duct carcinoma","valueDescription":"Salivary Duct Carcinoma","ValueMeaning":{"publicId":"3248530","version":"1","preferredName":"Salivary Duct Carcinoma","longName":"3248530","preferredDefinition":"An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Duct Carcinoma","conceptCode":"C5904","definition":"An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B986-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A956DE3-1081-246C-E053-F662850ABDDA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Spindle cell squamous cell carcinoma","valueDescription":"Spindle Cell (Sarcomatoid) Squamous Cell Skin Carcinoma","ValueMeaning":{"publicId":"6774948","version":"1","preferredName":"Spindle Cell (Sarcomatoid) Squamous Cell Skin Carcinoma","longName":"6774948","preferredDefinition":"A squamous cell carcinoma of the skin with a prominent spindle cell component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Spindle Cell Squamous Carcinoma","conceptCode":"C4666","definition":"A squamous cell carcinoma of the skin with a prominent spindle cell component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A956DE3-10AC-246C-E053-F662850ABDDA","latestVersionIndicator":"Yes","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"ONEDATA","dateModified":"2019-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A956DE3-10C5-246C-E053-F662850ABDDA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Basaloid squamous cell carcinoma","valueDescription":"Basaloid Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3248555","version":"1","preferredName":"Basaloid Squamous Cell Carcinoma","longName":"3248555","preferredDefinition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basaloid Squamous Cell Carcinoma","conceptCode":"C54244","definition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BC57-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A956DE3-10CF-246C-E053-F662850ABDDA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Hybrid squamous cell carcinoma","valueDescription":"Hybrid Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6769947","version":"1","preferredName":"Hybrid Squamous Cell Carcinoma","longName":"6769947","preferredDefinition":"Being comprised of mixed attributes or parts.: Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hybrid","conceptCode":"C128790","definition":"Being comprised of mixed attributes or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Squamous Cell","conceptCode":"C12849","definition":"Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A70903-3658-2FE4-E053-F662850A2FF0","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-24","modifiedBy":"ONEDATA","dateModified":"2019-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A956DE3-1116-246C-E053-F662850ABDDA","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"HARTLEYG","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"Endometrial rhabdomyosarcoma","valueDescription":"Endometrial rhabdomyosarcoma","ValueMeaning":{"publicId":"7024614","version":"1","preferredName":"Endometrial rhabdomyosarcoma","longName":"7024614","preferredDefinition":"A rare malignant heterologous neoplasm with skeletal muscle differentiation arising from the uterine corpus. It usually manifests with vaginal bleeding. The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Rhabdomyosarcoma","conceptCode":"C127058","definition":"A rare malignant heterologous neoplasm with skeletal muscle differentiation arising from the uterine corpus. It usually manifests with vaginal bleeding. The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"959A8920-FC2D-580A-E053-F662850AE2F4","latestVersionIndicator":"Yes","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"HARTLEYG","dateModified":"2019-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"959A8920-FC46-580A-E053-F662850AE2F4","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","deletedIndicator":"No"},{"value":"Endometrioid carcinoma, NOS","valueDescription":"Endometrial Carcinoma","ValueMeaning":{"publicId":"5581346","version":"1","preferredName":"Endometrial Carcinoma","longName":"5581346","preferredDefinition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Carcinoma","conceptCode":"C7558","definition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B92E-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"959A8920-FC5A-580A-E053-F662850AE2F4","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","deletedIndicator":"No"},{"value":"De-differentiated carcinoma","valueDescription":"Endometrial Dedifferentiated Carcinoma","ValueMeaning":{"publicId":"7024616","version":"1","preferredName":"Endometrial Dedifferentiated Carcinoma","longName":"7024616","preferredDefinition":"A carcinoma that arises from the endometrium and is characterized by the presence of an undifferentiated carcinomatous component and a second component of either FIGO grade 1 or 2 endometrioid carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Dedifferentiated Carcinoma","conceptCode":"C126769","definition":"A carcinoma that arises from the endometrium and is characterized by the presence of an undifferentiated carcinomatous component and a second component of either FIGO grade 1 or 2 endometrioid carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"959A8920-FC67-580A-E053-F662850AE2F4","latestVersionIndicator":"Yes","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"959A8920-FC82-580A-E053-F662850AE2F4","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","deletedIndicator":"No"},{"value":"Mixed cell carcinoma (specify types and percentages)","valueDescription":"Endometrial Mixed Cell Adenocarcinoma","ValueMeaning":{"publicId":"7024619","version":"1","preferredName":"Endometrial Mixed Cell Adenocarcinoma","longName":"7024619","preferredDefinition":"An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components.  The minor component constitutes at least 5% of the entire tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Mixed Cell Adenocarcinoma","conceptCode":"C40153","definition":"An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components.  The minor component constitutes at least 5% of the entire tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"959A8920-FC8F-580A-E053-F662850AE2F4","latestVersionIndicator":"Yes","beginDate":"2019-10-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"959A8920-FCAA-580A-E053-F662850AE2F4","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-23","modifiedBy":"ONEDATA","dateModified":"2019-10-23","deletedIndicator":"No"},{"value":"Adenosarcoma with sarcomatous overgrowth","valueDescription":"Adenosarcoma Sarcomatous Component Present","ValueMeaning":{"publicId":"7009932","version":"1","preferredName":"Adenosarcoma Sarcomatous Component Present","longName":"7009932","preferredDefinition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: A histopathologic finding characterized by the presence of malignant cells of connective tissue origin in a tumor sample.  Examples of connective tissue cells that can undergo malignant transformation include smooth and skeletal muscle cells, adipose tissue cells, osteocytes, and chondrocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcomatous Component Present","conceptCode":"C54727","definition":"A histopathologic finding characterized by the presence of malignant cells of connective tissue origin in a tumor sample.  Examples of connective tissue cells that can undergo malignant transformation include smooth and skeletal muscle cells, adipose tissue cells, osteocytes, and chondrocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-2258-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-2271-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Malignant perivascular epithelioid cell tumor","valueDescription":"Malignant Perivascular Epithelioid Cell Neoplasm","ValueMeaning":{"publicId":"7009934","version":"1","preferredName":"Malignant Perivascular Epithelioid Cell Neoplasm","longName":"7009934","preferredDefinition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A perivascular cell with abundant clear or eosinophilic cytoplasm that contains glycogen. -- 2005: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Perivascular Epithelioid Cell","conceptCode":"C45634","definition":"A perivascular cell with abundant clear or eosinophilic cytoplasm that contains glycogen. -- 2005","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-2280-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-2299-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma","valueDescription":"Rhabdomyosarcoma","ValueMeaning":{"publicId":"4265253","version":"1","preferredName":"Rhabdomyosarcoma","longName":"4265253","preferredDefinition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyosarcoma","conceptCode":"C3359","definition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4BB4-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-22A3-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Adenosarcoma with other heterologous element (specify)","valueDescription":"Adenosarcoma Heterologous Elements Present","ValueMeaning":{"publicId":"7009935","version":"1","preferredName":"Adenosarcoma Heterologous Elements Present","longName":"7009935","preferredDefinition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: A morphologic finding indicating the presence of tissues that do not normally occur in the specific anatomic site or are found admixed with a neoplastic cellular infiltrate of a different cellular origin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Heterologous Elements Present","conceptCode":"C54559","definition":"A morphologic finding indicating the presence of tissues that do not normally occur in the specific anatomic site or are found admixed with a neoplastic cellular infiltrate of a different cellular origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-22B0-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-22C9-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Adenosarcoma with osseous differentiation","valueDescription":"Adenosarcoma Osseous Differentiation","ValueMeaning":{"publicId":"7009937","version":"1","preferredName":"Adenosarcoma Osseous Differentiation","longName":"7009937","preferredDefinition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Osseous Differentiation","conceptCode":"C53444","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-22D7-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-22F0-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Adenosarcoma with cartilaginous differentiation","valueDescription":"Adenosarcoma Cartilaginous Differentiation","ValueMeaning":{"publicId":"7009939","version":"1","preferredName":"Adenosarcoma Cartilaginous Differentiation","longName":"7009939","preferredDefinition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cartilaginous Differentiation","conceptCode":"C53445","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-22FE-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-2317-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Adenosarcoma with rhabdomyoblastic differentiation","valueDescription":"Adenosarcoma Rhabdomyosarcomatous Differentiation","ValueMeaning":{"publicId":"7009941","version":"1","preferredName":"Adenosarcoma Rhabdomyosarcomatous Differentiation","longName":"7009941","preferredDefinition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma","conceptCode":"C9474","definition":"A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rhabdomyosarcomatous Differentiation","conceptCode":"C35937","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-2325-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-233E-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Undifferentiated uterine/endometrial sarcoma","valueDescription":"Uterine Corpus Undifferentiated Sarcoma","ValueMeaning":{"publicId":"7009943","version":"1","preferredName":"Uterine Corpus Undifferentiated Sarcoma","longName":"7009943","preferredDefinition":"A rare, high grade sarcoma that arises from the endometrial stroma or myometrium without a specific type of differentiation. It was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. Undifferentiated uterine sarcoma has a worse prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Undifferentiated Sarcoma","conceptCode":"C8972","definition":"A rare, high grade sarcoma that arises from the endometrial stroma or myometrium without a specific type of differentiation. It was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. Undifferentiated uterine sarcoma has a worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9570DF73-234B-7DDB-E053-F662850A82D1","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9570DF73-2364-7DDB-E053-F662850A82D1","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Polymorphous adenocarcinoma, cribriform","valueDescription":"Cribriform Adenocarcinoma of Minor Salivary Gland","ValueMeaning":{"publicId":"6785157","version":"1","preferredName":"Cribriform Adenocarcinoma of Minor Salivary Gland","longName":"6785157","preferredDefinition":"A minor salivary gland adenocarcinoma characterized by a cribriform pattern. It often metastasizes to the neck lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cribriform Adenocarcinoma of Minor Salivary Gland","conceptCode":"C160974","definition":"A minor salivary gland adenocarcinoma characterized by a cribriform pattern. It often metastasizes to the neck lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA212CA-2A25-1634-E053-F662850A77C2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92FF572D-3D75-652C-E053-F662850AD7CB","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-20","modifiedBy":"ONEDATA","dateModified":"2019-09-20","deletedIndicator":"No"},{"value":"Endometrial stromal sarcoma with glandular elements","valueDescription":"Endometrioid Stromal Sarcoma Glandular Differentiation","ValueMeaning":{"publicId":"7009912","version":"1","preferredName":"Endometrioid Stromal Sarcoma Glandular Differentiation","longName":"7009912","preferredDefinition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.: A microscopic finding indicating the presence of cells with glandular differentiation in a tumor sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glandular Differentiation","conceptCode":"C43573","definition":"A microscopic finding indicating the presence of cells with glandular differentiation in a tumor sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DD21-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DD3A-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Endometrial stromal sarcoma with sex cord elements","valueDescription":"Endometrioid Stromal Sarcoma Sex Cord-Like Pattern","ValueMeaning":{"publicId":"7009914","version":"1","preferredName":"Endometrioid Stromal Sarcoma Sex Cord-Like Pattern","longName":"7009914","preferredDefinition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.: No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sex Cord-Like Pattern","conceptCode":"C35932","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DD48-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DD61-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Endometrial stromal sarcoma with smooth muscle differentiation","valueDescription":"Endometrioid Stromal Sarcoma Smooth Muscle Cell Cellular Differentiation","ValueMeaning":{"publicId":"7009916","version":"1","preferredName":"Endometrioid Stromal Sarcoma Smooth Muscle Cell Cellular Differentiation","longName":"7009916","preferredDefinition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.: An elongated spindle-shaped contractile cell, peculiar to an involuntary muscle, containing a single nucleus and longitudinally arranged myofibrils.: In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Smooth Muscle Cell","conceptCode":"C13001","definition":"An elongated spindle-shaped contractile cell, peculiar to an involuntary muscle, containing a single nucleus and longitudinally arranged myofibrils.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DD70-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DD89-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Endometrial stromal sarcoma","valueDescription":"Endometrioid Stromal Sarcoma","ValueMeaning":{"publicId":"4265242","version":"1","preferredName":"Endometrioid Stromal Sarcoma","longName":"4265242","preferredDefinition":"A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrioid stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-7909-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DD93-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Leiomyosarcoma, myxoid type","valueDescription":"Myxoid Leiomyosarcoma","ValueMeaning":{"publicId":"7009918","version":"1","preferredName":"Myxoid Leiomyosarcoma","longName":"7009918","preferredDefinition":"A morphologic variant of leiomyosarcoma characterized by the presence of cellular pleomorphism, malignant cells with large nuclei, and a myxoid stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoid Leiomyosarcoma","conceptCode":"C3701","definition":"A morphologic variant of leiomyosarcoma characterized by the presence of cellular pleomorphism, malignant cells with large nuclei, and a myxoid stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DDA0-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DDB9-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Leiomyosarcoma, epithelioid type","valueDescription":"Epithelioid Leiomyosarcoma","ValueMeaning":{"publicId":"7009919","version":"1","preferredName":"Epithelioid Leiomyosarcoma","longName":"7009919","preferredDefinition":"A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Leiomyosarcoma","conceptCode":"C3700","definition":"A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DDC5-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DDDE-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Carcinosarcoma (malignant mixed Mllerian tumor)","valueDescription":"Malignant Mixed Mesodermal (Mullerian) Tumor","ValueMeaning":{"publicId":"4264932","version":"1","preferredName":"Malignant Mixed Mesodermal (Mullerian) Tumor","longName":"4264932","preferredDefinition":"An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Mixed Mesodermal (Mullerian) Tumor","conceptCode":"C8975","definition":"An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67FEF75-A130-6988-E040-BB89AD432041","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DE2D-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Serous endometrial intraepithelial carcinoma","valueDescription":"Serous Endometrial Intraepithelial Carcinoma","ValueMeaning":{"publicId":"7009923","version":"1","preferredName":"Serous Endometrial Intraepithelial Carcinoma","longName":"7009923","preferredDefinition":"A precursor of endometrial serous adenocarcinoma characterized by the replacement of the normal endometrial cells by malignant glandular cells that resemble the malignant cells of invasive serous adenocarcinoma. The endometrial neoplastic process is non-invasive. It may coexist with invasive endometrial adenocarcinoma or can be associated with metastases outside the uterus, in the absence of invasive endometrial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Endometrial Intraepithelial Carcinoma","conceptCode":"C40152","definition":"A precursor of endometrial serous adenocarcinoma characterized by the replacement of the normal endometrial cells by malignant glandular cells that resemble the malignant cells of invasive serous adenocarcinoma. The endometrial neoplastic process is non-invasive. It may coexist with invasive endometrial adenocarcinoma or can be associated with metastases outside the uterus, in the absence of invasive endometrial carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DE4E-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DE67-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Endometrioid carcinoma, other variant (specify)","valueDescription":"Endometrial Carcinoma Other Variation","ValueMeaning":{"publicId":"7009924","version":"1","preferredName":"Endometrial Carcinoma Other Variation","longName":"7009924","preferredDefinition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.: Different than the one(s) previously specified or mentioned.: An alteration or difference from a norm or standard.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Carcinoma","conceptCode":"C7558","definition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Variation","conceptCode":"C25713","definition":"An alteration or difference from a norm or standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DE75-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DE8E-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Biphenotypic sinonasal sarcoma","valueDescription":"Biphenotypic Sinonasal Sarcoma","ValueMeaning":{"publicId":"6943208","version":"1","preferredName":"Biphenotypic Sinonasal Sarcoma","longName":"6943208","preferredDefinition":"A rare, slow-growing, low-grade soft tissue sarcoma arising from the sinonasal tract. It presents with non-specific obstructive nasal symptoms. Morphologically, it is an infiltrative, cellular spindle cell neoplasm. It is associated with rearrangement of the PAX3 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphenotypic Sinonasal Sarcoma","conceptCode":"C164205","definition":"A rare, slow-growing, low-grade soft tissue sarcoma arising from the sinonasal tract. It presents with non-specific obstructive nasal symptoms. Morphologically, it is an infiltrative, cellular spindle cell neoplasm. It is associated with rearrangement of the PAX3 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"933BF2C5-2838-676B-E053-F662850ACE8E","latestVersionIndicator":"Yes","beginDate":"2019-09-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-23","modifiedBy":"ONEDATA","dateModified":"2019-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"933BF2C5-2851-676B-E053-F662850ACE8E","beginDate":"2019-09-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-23","modifiedBy":"ONEDATA","dateModified":"2019-09-23","deletedIndicator":"No"},{"value":"Endometrioid carcinoma with secretory differentiation","valueDescription":"Endometrial Endometrioid Adenocarcinoma, Secretory Variant","ValueMeaning":{"publicId":"7009926","version":"1","preferredName":"Endometrial Endometrioid Adenocarcinoma, Secretory Variant","longName":"7009926","preferredDefinition":"An endometrioid adenocarcinoma arising from the endometrium. Morphologically it is characterized by the presence of malignant glandular cells containing glycogen vacuoles which are usually subnuclear and reminiscent of early secretory endometrium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Endometrioid Adenocarcinoma, Secretory Variant","conceptCode":"C27839","definition":"An endometrioid adenocarcinoma arising from the endometrium. Morphologically it is characterized by the presence of malignant glandular cells containing glycogen vacuoles which are usually subnuclear and reminiscent of early secretory endometrium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DE9B-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DEB4-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Endometrioid carcinoma, villoglandular variant","valueDescription":"Villoglandular Endometrial Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"7009928","version":"1","preferredName":"Villoglandular Endometrial Endometrioid Adenocarcinoma","longName":"7009928","preferredDefinition":"A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of numerous finger-like villi lined by neoplastic columnar cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Villoglandular Endometrial Endometrioid Adenocarcinoma","conceptCode":"C27846","definition":"A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of numerous finger-like villi lined by neoplastic columnar cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DEC1-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DEDA-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Endometrioid carcinoma with squamous differentiation","valueDescription":"Endometrial Squamous Cell Carcinoma","ValueMeaning":{"publicId":"7009930","version":"1","preferredName":"Endometrial Squamous Cell Carcinoma","longName":"7009930","preferredDefinition":"A primary carcinoma of the endometrium characterized by the presence of malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Squamous Cell Carcinoma","conceptCode":"C8719","definition":"A primary carcinoma of the endometrium characterized by the presence of malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FE712-DEE7-0EBA-E053-F662850A907E","latestVersionIndicator":"Yes","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FE712-DF00-0EBA-E053-F662850A907E","beginDate":"2019-10-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Mesothelioma (NOS)","valueDescription":"Not Otherwise Specified Mesothelioma","ValueMeaning":{"publicId":"7589471","version":"1","preferredName":"Not Otherwise Specified Mesothelioma","longName":"7589471","preferredDefinition":"Not characterized in any other way.: A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mesothelioma","conceptCode":"C3234","definition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA53F65-802A-0DEC-E053-4EBD850AD310","latestVersionIndicator":"Yes","beginDate":"2021-03-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCA53F65-8043-0DEC-E053-4EBD850AD310","beginDate":"2021-03-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-03","modifiedBy":"ONEDATA","dateModified":"2021-03-03","deletedIndicator":"No"},{"value":"Neurofibromatosis Type 1 (NF1)","valueDescription":null,"ValueMeaning":{"publicId":"2962080","version":"1","preferredName":"Neurofibromatosis Type 1","longName":"2962080","preferredDefinition":"Type 1 (peripheral) neurofibromatosis (von Recklinghausen's disease), is the most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath neoplasms, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 1","conceptCode":"C3273","definition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A8D-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"GDEEN","dateModified":"2023-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F32E57C0-5BA5-1F92-E053-731AD00A622B","beginDate":"2023-01-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-01-26","modifiedBy":"GDEEN","dateModified":"2023-01-26","deletedIndicator":"No"},{"value":"Neurofibromatosis Type 2 (NF2)","valueDescription":null,"ValueMeaning":{"publicId":"2962078","version":"1","preferredName":"Neurofibromatosis Type 2","longName":"2962078","preferredDefinition":"An autosomal dominant disorder caused by mutations in the NF2 tumor suppressor gene.  It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 2","conceptCode":"C3274","definition":"An autosomal dominant disorder caused by mutations in the NF2 tumor suppressor gene.  It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A67-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"GDEEN","dateModified":"2023-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F32E57C0-5BA6-1F92-E053-731AD00A622B","beginDate":"2023-01-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-01-26","modifiedBy":"GDEEN","dateModified":"2023-01-26","deletedIndicator":"No"},{"value":"Schwannomatosis","valueDescription":null,"ValueMeaning":{"publicId":"6832486","version":"1","preferredName":"Schwannomatosis","longName":"6832486","preferredDefinition":"A rare genetic disorder characterized by the presence of multiple schwannomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schwannomatosis","conceptCode":"C6557","definition":"Rare genetic disorder caused by mutations in the SMARCB1 and LZTR1 genes. It is characterized by the presence of multiple Schwannomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9A76BA-99B0-69B5-E053-F662850AA843","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F32E57C0-5BA7-1F92-E053-731AD00A622B","beginDate":"2023-01-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-01-26","modifiedBy":"GDEEN","dateModified":"2023-01-26","deletedIndicator":"No"},{"value":"Ewing sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"2593150","version":"1","preferredName":"Ewing Sarcoma","longName":"2593150","preferredDefinition":"A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ewing Sarcoma","conceptCode":"C4817","definition":"A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E8E-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3A9C974-62C2-1823-E053-731AD00AE43D","beginDate":"2023-02-01","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-02-01","modifiedBy":"GDEEN","dateModified":"2023-02-01","deletedIndicator":"No"},{"value":"Hairy Cell Leukemia","valueDescription":null,"ValueMeaning":{"publicId":"2838575","version":"1","preferredName":"Hairy Cell Leukemia","longName":"2838575","preferredDefinition":"A rare neoplasm of small B-lymphocytes with \"hairy\" projections in bone marrow, spleen and peripheral blood.  Most patients are middle-aged to elderly adults and present with splenomegaly and pancytopenia. (WHO, 2001) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hairy Cell Leukemia","conceptCode":"C7402","definition":"A neoplasm of small B-lymphocytes with \"hairy\" projections in bone marrow, spleen, and peripheral blood.  Most patients present with splenomegaly and pancytopenia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A51A25-5837-CA49-E040-BB89AD435D3A","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"GDEEN","dateModified":"2023-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F41FF9DD-920A-28B6-E053-731AD00A5F28","beginDate":"2023-02-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-02-07","modifiedBy":"GDEEN","dateModified":"2023-02-07","deletedIndicator":"No"},{"value":"Kaposi-sarcoma Associated Herpesvirus (KSHV) Inflammatory Cytokine Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14666995","version":"1","preferredName":"KSHV Inflammatory Cytokine Syndrome","longName":"14666995v1.00","preferredDefinition":"A syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV) infection. It manifests with fever, weight loss, and fluid retention in the legs or abdomen. Patients are at risk of developing KSHV-related cancers including Kaposi sarcoma and lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KSHV Inflammatory Cytokine Syndrome","conceptCode":"C125711","definition":"A syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV) infection. It manifests with fever, weight loss, and fluid retention in the legs or abdomen. Patients are at risk of developing KSHV-related cancers including Kaposi sarcoma and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D825383-C760-4761-E063-731AD00A87A0","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-27","modifiedBy":"GDEEN","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D825383-C762-4761-E063-731AD00A87A0","beginDate":"2023-12-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-27","modifiedBy":"GDEEN","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Kaposi Sarcoma HHV-Associated Multicentric Castleman Disease","valueDescription":null,"ValueMeaning":{"publicId":"14666996","version":"1","preferredName":"HHV8-Positive Multicentric Castleman Disease","longName":"14666996v1.00","preferredDefinition":"Multicentric Castleman disease associated with HHV8 infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HHV8-Positive Multicentric Castleman Disease","conceptCode":"C150404","definition":"Multicentric Castleman disease associated with HHV8 infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D825383-C761-4761-E063-731AD00A87A0","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-27","modifiedBy":"GDEEN","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D825383-C763-4761-E063-731AD00A87A0","beginDate":"2023-12-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-27","modifiedBy":"GDEEN","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Moderately differentiated adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"14770842","version":"1","preferredName":"Moderately Differentiated Adenocarcinoma Cell","longName":"14770842v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated Adenocarcinoma Cell","conceptCode":"C36797","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11FD025A-6DA2-4E96-E063-731AD00AB0D5","latestVersionIndicator":"Yes","beginDate":"2024-02-22","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-02-22","modifiedBy":"GDEEN","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11FD025A-6DA3-4E96-E063-731AD00AB0D5","beginDate":"2024-02-22","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-02-22","modifiedBy":"GDEEN","dateModified":"2024-02-22","deletedIndicator":"No"},{"value":"Paraganglioma/Pheochromocytoma","valueDescription":null,"ValueMeaning":{"publicId":"14784362","version":"1","preferredName":"Paraganglioma/Adrenal Gland Pheochromocytoma","longName":"14784362v1.00","preferredDefinition":"A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A neuroendocrine neoplasm of the sympathetic nervous system that arises from the chromaffin cells of the adrenal medulla and secretes catecholamines. Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paraganglioma","conceptCode":"C3308","definition":"A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Gland Pheochromocytoma","conceptCode":"C3326","definition":"A neuroendocrine neoplasm of the sympathetic nervous system that arises from the chromaffin cells of the adrenal medulla and secretes catecholamines. Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1214E646-91B3-6927-E063-731AD00AB613","latestVersionIndicator":"Yes","beginDate":"2024-02-23","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-02-23","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1214E646-91B4-6927-E063-731AD00AB613","beginDate":"2024-02-23","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-02-23","modifiedBy":"GDEEN","dateModified":"2024-02-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3081849","version":"1","preferredName":"Malignant Neoplasm Histology Name","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.:The words or language units by which a thing is known.","longName":"C9305:C0344441:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histology","conceptCode":"C0344441","definition":"Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-4642-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"ONEDATA","dateModified":"2010-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"D8FCE429-CD60-B178-E040-BB89AD430EA5","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"5/30/19 tt added 1 PV.  8/21/17 tt transferred context and added registration status, CSI per Round 5 finalization task. Value Domain versioned to remove 6 PVs and add 3 PVs per request of J. Gardner. 8/30/10 mc VD versioned to add 87 new values for consolidation per request by T.Lichtenberg. mc 3/28/13  EDITED to remove special characters that were showing up in the download for PV Stomach, Intestinal Adenocarcinoma, Mucinous Type and Stomach, Intestinal Adenocarcinoma, Papillary Type - DWarzel 09-25-2014, 3/23/2017 added PV for CTSP task, wz. 03-06-2018 fixed 14 PVs with an extra space at the end DW. 6/11/18 Removed 11 duplicate PV/VM. mc","administrativeNotes":"2023.9.20 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"}]}],"AlternateNames":[{"name":"other_malignancy_histological_type","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histologic Diagnosis of Prior","type":"Preferred Question Text","description":"Histologic Diagnosis of Prior/Synchronous Malignancy","url":null,"context":"NCIP"},{"name":"CTSP Question","type":"Alternate Question Text","description":"Histological Type of the Other Malignancy","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1455DBC-9BE8-E74B-E040-BB89AD437D9F","latestVersionIndicator":"Yes","beginDate":"2014-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-31","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for TCGA Other Malignancy Form per request by T.Lichtenberg. mc 1/31/2014. 3/27/2017 added alt question text for CTSP task, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}